{"id": 42568667, "time": "2024-12-19 00:38:55", "headline": "Mohamed El-Erian Warns Fed Faces 'Bigger Problem' As Diverging Views On Rate Policy Highlight Lack Of 'Strategic Anchoring'", "summary": "A significant disparity in Federal Reserve officials&#39; views on future interest rate policy points to deeper strategic challenges that could impact markets through 2025, according to prominent economist Mohamed El-Erian.", "symbols": ["SPY", "UUP"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/24/12/42568667/mohamed-el-erian-warns-fed-faces-bigger-problem-as-diverging-views-on-rate-policy-highlight-lack-of-strategic-anchoring", "tags": []}
{"id": 42568686, "time": "2024-12-19 00:39:33", "headline": "MacKenzie Scott's Mission-Driven Investing Pushes Back Against Wealth Concentration: Amazon Stock Rich Philanthropist Pledges $2 Billion In Donations", "summary": "MacKenzie Scott, one of America&#39;s wealthiest philanthropists, announced $2 billion in new charitable donations for 2024, while revealing a strategic shift toward mission-aligned investments for her remaining fortune. The latest round of giving brings her total donations since 2019 to $19.2 billion. ", "symbols": [], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/tech/24/12/42568686/mackenzie-scotts-mission-driven-investing-pushes-back-against-wealth-concentration-amazon-stock-rich-philanthropist-pledges-2-billion-in-donations", "tags": []}
{"id": 42568699, "time": "2024-12-19 00:40:59", "headline": "Reported Earlier, Japan Interest Rate Decision Unchanged At 0.25%", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42568699/reported-earlier-japan-interest-rate-decision-unchanged-at-0-25", "tags": []}
{"id": 42568740, "time": "2024-12-19 00:46:52", "headline": "Dogecoin Bull Says He 'Had To Sell' As Meme King Plunges To 5-Week Low But Derivative Traders Remain Bullish", "summary": "Popular dog-themed cryptocurrency Dogecoin (CRYPTO: DOGE) dumped hard Wednesday amid the broader market slump precipitated by the Federal Reserve&#39;s hawkish outlook.", "symbols": ["DOGEUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42568740/dogecoin-bull-says-he-had-to-sell-as-meme-king-plunges-to-5-week-low-but-derivative-traders-remain-bullish", "tags": ["guidance"]}
{"id": 42568754, "time": "2024-12-19 00:50:29", "headline": "EPA Greenlights California's Plan To Ban Sale Of New Gas Cars By 2025", "summary": "U.S. Environmental Protection Agency (EPA) on Wednesday gave California the green light to ban the sale of new gasoline-powered light-duty vehicles by 2035.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/24/12/42568754/us-epa-greenlights-californias-plan-to-ban-sale-of-new-gas-cars-by-2025", "tags": []}
{"id": 42569007, "time": "2024-12-19 01:29:26", "headline": "KKR Backs Rebel Foods With Major Investment To Expand World-Class Cloud Kitchen Ecosystem", "summary": "", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569007/kkr-backs-rebel-foods-with-major-investment-to-expand-world-class-cloud-kitchen-ecosystem", "tags": []}
{"id": 42569034, "time": "2024-12-19 01:35:26", "headline": "Franco-Nevada Expands Portfolio With Sibanye-Stillwater's Western Limb Mining Operations In $500M Deal", "summary": "", "symbols": ["FNV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569034/franco-nevada-expands-portfolio-with-sibanye-stillwaters-western-limb-mining-operations-in-500m-deal", "tags": ["contract"]}
{"id": 42569126, "time": "2024-12-19 01:54:00", "headline": "BioArctic Partners With Bristol Myers Squibb In Licensing Deal For PyroGlutamate-Amyloid-Beta Antibody Program", "summary": "", "symbols": ["BMY", "BRCTF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569126/bioarctic-partners-with-bristol-myers-squibb-in-licensing-deal-for-pyroglutamate-amyloid-beta-antibo", "tags": ["contract"]}
{"id": 42569133, "time": "2024-12-19 01:54:54", "headline": "Crypto Wallet Provider Exodus Makes Wall Street Debut, Shares Pop 37%", "summary": "Exodus Movement Inc. (NYSEAMERICAN: EXOD) commenced trading on the NYSE American exchange Wednesday, becoming the latest publicly traded company on Wall Street with cryptocurrency as the core business.", "symbols": ["BTC", "BTCUSD", "ETHUSD", "EXOD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/24/12/42569133/crypto-wallet-provider-exodus-makes-wall-street-debut-shares-pop-37", "tags": []}
{"id": 42569325, "time": "2024-12-19 02:10:32", "headline": "Apple Slams Meta's Interoperability Demands, Cites Privacy Risks \u2014 Instagram Parent Fires Back: Cupertino's Assertions Have 'No Basis In Reality'", "summary": "Apple has criticized Meta&#39;s interoperability requests under the EU&#39;s Digital Markets Act, citing privacy risks, while Meta accuses Apple of using privacy concerns as a pretext for anticompetitive behavior.", "symbols": ["AAPL", "META"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/media/24/12/42569325/apple-slams-metas-interoperability-demands-cites-privacy-risks-instagram-parent-fires-back-cupertinos-assertions-have-no-basis-in-reality", "tags": []}
{"id": 42569478, "time": "2024-12-19 02:19:54", "headline": "Reported Earlier, Montrose Environmental To Deploy PFAS Treatment System For Sydney Water's Cascade Filtration Plant", "summary": "", "symbols": ["MEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569478/reported-earlier-montrose-environmental-to-deploy-pfas-treatment-system-for-sydney-waters-cascade-fi", "tags": []}
{"id": 42569479, "time": "2024-12-19 02:20:07", "headline": "OpenAI Takes A Page From Google's 2007 Playbook, Turns Phones Into AI Hotlines With 1-800-CHATGPT", "summary": "OpenAI has launched a toll-free service, 1-800-CHATGPT, allowing users to access ChatGPT for free with a 15-minute monthly call, echoing Google&#39;s 2007 GOOG-411 initiative.", "symbols": ["GOOG", "GOOGL", "MSFT"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/12/42569479/openai-takes-a-page-from-googles-2007-playbook-by-turning-phones-into-an-ai-hotline-with-toll-free-number-1-800-chatgpt", "tags": []}
{"id": 42569500, "time": "2024-12-19 02:23:28", "headline": "CVS Faces DOJ Lawsuit Alleging Violations Of Controlled Substances Act And False Claims Act Over Opioid Prescriptions", "summary": "The U.S. Department of Justice filed a civil complaint against CVS Pharmacy Inc owned by CVS Health Corp, alleging the nation&#39;s largest pharmacy chain violated the Controlled Substances Act by filling unlawful prescriptions for dangerous opioid combinations and quantities from 2013 onwards. ", "symbols": ["CVS"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/general/health-care/24/12/42569500/cvs-faces-doj-lawsuit-alleging-violations-of-controlled-substances-act-and-false-claims-act-over-opioid-prescriptions", "tags": ["legal"]}
{"id": 42569512, "time": "2024-12-19 02:25:04", "headline": "Valneva Expands Chikungunya Vaccine Access In Asia Through Partnership With Serum Institute", "summary": "", "symbols": ["VALN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569512/valneva-expands-chikungunya-vaccine-access-in-asia-through-partnership-with-serum-institute", "tags": ["contract"]}
{"id": 42569514, "time": "2024-12-19 02:27:02", "headline": "Germany GfK Consumer Climate For January -21.3 Vs. -22.6 Est.; -23.1 (Revised) Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42569514/germany-gfk-consumer-climate-for-january-21-3-vs-22-6-est-23-1-revised-prior", "tags": []}
{"id": 42569579, "time": "2024-12-19 02:36:05", "headline": "Reported Earlier, WM Technology Receives Non-Binding Take-Private Proposal From Co-Founders", "summary": "", "symbols": ["MAPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569579/reported-earlier-wm-technology-receives-non-binding-take-private-proposal-from-co-founders", "tags": []}
{"id": 42569727, "time": "2024-12-19 02:51:59", "headline": "Sangamo Licenses STAC-BBB Technology To Astellas To Drive Genomic Medicine For Neurological Diseases", "summary": "", "symbols": ["SGMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569727/sangamo-licenses-stac-bbb-technology-to-astellas-to-drive-genomic-medicine-for-neurological-diseases", "tags": []}
{"id": 42569742, "time": "2024-12-19 02:55:20", "headline": "Reported Earlier, Marcus & Millichap's IPA Closes $203M Sale And Secures $127.8M Financing For Santa Clara Multifamily Property", "summary": "", "symbols": ["MMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569742/reported-earlier-marcus-millichaps-ipa-closes-203m-sale-and-secures-127-8m-financing-for-santa-clara", "tags": []}
{"id": 42569744, "time": "2024-12-19 02:56:45", "headline": "Apple Reportedly In Talks With Tencent, TikTok-Parent ByteDance To Roll Out AI Features In China", "summary": "The potential collaboration with Tencent and ByteDance is critical for Apple as it navigates the competitive Chinese market. ", "symbols": ["AAPL", "TCEHY"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/news/24/12/42569744/apple-reportedly-in-talks-with-tencent-tiktok-parent-bytedance-to-roll-out-ai-features-in-china", "tags": []}
{"id": 42569768, "time": "2024-12-19 03:01:24", "headline": "Reported Earlier, Leishen Energy Prices $5.5M Initial Public Offering Of 1.375M Common Shares At $4/Share", "summary": "", "symbols": ["LSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569768/reported-earlier-leishen-energy-prices-5-5m-initial-public-offering-of-1-375m-common-shares-at-4shar", "tags": ["offering"]}
{"id": 42569836, "time": "2024-12-19 03:11:28", "headline": "Reported Earlier, Mesoblast's RYONCIL Becomes The First FDA-Approved Mesenchymal Stromal Cell Therapy In The U.S", "summary": "", "symbols": ["MESO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569836/reported-earlier-mesoblasts-ryoncil-becomes-the-first-fda-approved-mesenchymal-stromal-cell-therapy", "tags": ["fda"]}
{"id": 42569883, "time": "2024-12-19 03:14:41", "headline": "Quantum Computing, Rigetti, D-Wave Skyrocket Up To 300% In 5 Sessions After Google Unveils Willow Chip, But Analysts Urge Caution: 'Not Every TikTok Guitarist Is The Next Taylor Swift'", "summary": "Quantum computing stocks have catapulted this year, especially after Dec. 9, when Google announced its latest quantum chip, Willow.", "symbols": ["GOOG", "GOOGL", "IBM", "IONQ", "QBTS", "QUBT", "RGTI"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/24/12/42569883/quantum-computing-rigetti-d-wave-skyrocket-up-to-300-in-5-sessions-after-google-unveils-willow-chip-but-analysts-urge-caution-not-every-tiktok-guitarist-is-the-next-taylor-swift", "tags": []}
{"id": 42569901, "time": "2024-12-19 03:22:48", "headline": "Waymo Completes 4 Million Autonomous Rides In Key US Metropolitan Areas In 2024 Ahead Of Tokyo Launch", "summary": "Alphabet&#39;s autonomous driving unit Waymo said on Wednesday that the company served over 4 million fully autonomous rides in 2024, taking the total number of rides to over 5 million.", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/12/42569901/waymo-completes-4-million-autonomous-rides-in-key-us-metropolitan-areas-in-2024-ahead-of-tokyo-launch", "tags": []}
{"id": 42569930, "time": "2024-12-19 03:25:46", "headline": "Reported Earlier, Woodside Reshapes Portfolio With Chevron Asset Swap, Gaining LNG And CCS Project Interests", "summary": "", "symbols": ["CVX", "WDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569930/reported-earlier-woodside-reshapes-portfolio-with-chevron-asset-swap-gaining-lng-and-ccs-project-int", "tags": []}
{"id": 42569931, "time": "2024-12-19 03:26:21", "headline": "Micron Technology, Accenture And 3 Stocks To Watch Heading Into Thursday", "summary": " ", "symbols": ["ACN", "FDX", "LEN", "MU", "NKE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/12/42569931/micron-technology-accenture-and-3-stocks-to-watch-heading-into-thursday-2", "tags": []}
{"id": 42569943, "time": "2024-12-19 03:28:38", "headline": "Reported Earlier, Itron Partners With Water Corporation To Modernize Perth's Water Distribution System With Smart Meter Technology", "summary": "", "symbols": ["ITRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569943/reported-earlier-itron-partners-with-water-corporation-to-modernize-perths-water-distribution-system", "tags": ["contract"]}
{"id": 42569953, "time": "2024-12-19 03:30:41", "headline": "Dow Dips Over 1,100 Points, Falling For 10th Session As Powell Adopts Hawkish Stance: Greed Index Moves To 'Fear' Zone", "summary": " ", "symbols": ["ACN", "FDX", "GIS", "NKE", "WOR"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/12/42569953/dow-dips-over-1100-points-falling-for-10th-session-as-powell-adopts-hawkish-stance-greed-index-moves-to-fear-zone", "tags": []}
{"id": 42569969, "time": "2024-12-19 03:32:08", "headline": "Earnings Scheduled For December 19, 2024", "summary": " ", "symbols": ["ACN", "AVO", "BB", "CAG", "CTAS", "DRI", "FCEL", "FDS", "FDX", "ISSC", "KMX", "LW", "MBX", "MOBX", "NKE", "PAYX", "SCHL", "SHCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42569969/earnings-scheduled-for-december-19-2024", "tags": ["earnings"]}
{"id": 42569970, "time": "2024-12-19 03:32:24", "headline": "CarMax Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["KMX"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42569970/carmax-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts", "tags": ["guidance"]}
{"id": 42570219, "time": "2024-12-19 04:11:22", "headline": "Wharton's Jeremy Siegel Calls Stock Sell-Off A 'Healthy' Reality Check: 'Market Was Overly Optimistic'", "summary": "The Federal Reserve&#39;s recent decision to cut interest rates by 0.25% was widely anticipated, marking the third consecutive reduction in borrowing costs. ", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42570219/whartons-jeremy-siegel-calls-stock-sell-off-a-healthy-reality-check-market-was-overly-optimistic", "tags": []}
{"id": 42570297, "time": "2024-12-19 04:15:00", "headline": "EV Battery Maker CATL Eyes 2nd Listing In Hong Kong To Raise $5 Billion Or More: Report", "summary": "Chinese electric vehicle battery manufacturer Contemporary Amperex Technology Co. Ltd. or CATL is reportedly considering a second listing in Hong Kong.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/24/12/42570297/ev-battery-maker-catl-eyeing-a-second-listing-in-hong-kong-that-could-raise-5-billion-or-more-report", "tags": []}
{"id": 42570322, "time": "2024-12-19 04:20:50", "headline": "Mizuho Upgrades Stanley Black & Decker to Outperform, Maintains Price Target to $110", "summary": "", "symbols": ["SWK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42570322/mizuho-upgrades-stanley-black-decker-to-outperform-maintains-price-target-to-110", "tags": ["analyst_up", "analyst_other"]}
{"id": 42570362, "time": "2024-12-19 04:28:21", "headline": "Roth MKM Initiates Coverage On HIVE Digital Technologies with Buy Rating, Announces Price Target of $7.5", "summary": "", "symbols": ["HIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42570362/roth-mkm-initiates-coverage-on-hive-digital-technologies-with-buy-rating-announces-price-target-of-7", "tags": ["analyst_init"]}
{"id": 42570376, "time": "2024-12-19 04:30:15", "headline": "Jeff Bezos-Backed Perplexity Raises $500 Million, Tripling Its Valuation To $9 Billion As Competition With Google And OpenAI Heats Up", "summary": "Perplexity AI, backed by Amazon founder Jeff Bezos, secured $500 million in funding led by Institutional Venture Partners, tripling its valuation to $9 billion.", "symbols": ["GOOG", "GOOGL", "META", "MSFT", "NVDA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/tech/24/12/42570376/jeff-bezos-backed-perplexity-raises-500-million-tripling-its-valuation-to-9-billion-as-competition-with-google-and-openai-heats-up", "tags": []}
{"id": 42570393, "time": "2024-12-19 04:30:58", "headline": "Stifel Upgrades DT Midstream to Buy, Raises Price Target to $106", "summary": "", "symbols": ["DTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42570393/stifel-upgrades-dt-midstream-to-buy-raises-price-target-to-106", "tags": ["analyst_up", "price_target_up"]}
{"id": 42570544, "time": "2024-12-19 04:46:02", "headline": "Apple Watch Faces Tough Competition As Huawei Drives 20% Surge In Wearables", "summary": "Chinese tech giants, led by Huawei, are driving a 20% growth in the global wrist-worn device market, challenging Apple&#39;s dominance as its market share declines amid rising competition.", "symbols": ["AAPL", "XIACF"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/12/42570544/apple-watch-is-getting-a-run-for-its-money-as-chinese-tech-giants-led-by-huawei-lead-20-growth-in-global-wrist-worn-device-market", "tags": []}
{"id": 42569114, "time": "2024-12-19 01:48:42", "headline": "Genentech's Prasinezumab Phase IIb Study Misses Primary Endpoint But Shows Potential In Early Parkinson's Disease", "summary": "", "symbols": ["PRTA", "RHHBF", "RHHBY", "RHHVF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42569114/genentechs-prasinezumab-phase-iib-study-misses-primary-endpoint-but-shows-potential-in-early-parkins", "tags": []}
{"id": 42570564, "time": "2024-12-19 04:51:26", "headline": "Tesla Says Powerwall Owners Generated 4.5 TWh Of Solar Energy This Year Amid Energy Segment Revenue Boom", "summary": "Tesla said on Wednesday that the owners of its Powerwall home battery around the globe generated 4.5 TWh of solar energy this year.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/12/42570564/tesla-says-powerwall-owners-generated-4-5-twh-of-solar-energy-this-year-amid-energy-segment-revenue-boom", "tags": ["earnings"]}
{"id": 42570576, "time": "2024-12-19 04:52:53", "headline": "Infosys Earns Binding Corporate Rules Certification For Data Privacy Excellence In AI-Driven Business", "summary": "", "symbols": ["INFY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42570576/infosys-earns-binding-corporate-rules-certification-for-data-privacy-excellence-in-ai-driven-busines", "tags": []}
{"id": 42570755, "time": "2024-12-19 05:07:44", "headline": "Joe Lonsdale Reveals Palantir's 'Close To Dying' Moment, Credits Alex Karp For Securing Key Contracts With FBI And CIA", "summary": "Palantir Technologies co-founder Joe Lonsdale disclosed that the data analytics company nearly collapsed in its early years before CEO Alex Karp secured crucial contracts with federal agencies.", "symbols": ["PLTR"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/24/12/42570755/joe-lonsdale-reveals-palantirs-close-to-dying-moment-credits-alex-karp-for-securing-key-contracts-with-fbi-and-cia", "tags": ["management"]}
{"id": 42570839, "time": "2024-12-19 05:12:25", "headline": "Baird Initiates Coverage On Mirion Technologies with Outperform Rating, Announces Price Target of $22", "summary": "", "symbols": ["MIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42570839/baird-initiates-coverage-on-mirion-technologies-with-outperform-rating-announces-price-target-of-22", "tags": ["analyst_init"]}
{"id": 42571001, "time": "2024-12-19 05:32:47", "headline": "Telsey Advisory Group Downgrades Brilliant Earth Group to Market Perform, Lowers Price Target to $2", "summary": "", "symbols": ["BRLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571001/telsey-advisory-group-downgrades-brilliant-earth-group-to-market-perform-lowers-price-target-to-2", "tags": ["analyst_down", "price_target_down"]}
{"id": 42571007, "time": "2024-12-19 05:34:30", "headline": "Bitcoin ETFs Rise In Pre Market Despite Jerome Powell Says Fed Cannot Hold BTC: What's Going On?", "summary": "Bitcoin ETFs have shown an increase in premarket, even as\u00a0Federal Reserve Chair Jerome Powell\u00a0made it clear that the central bank has no plans to accumulate Bitcoin (CRYPTO: BTC).", "symbols": ["ARKB", "BITB", "BTCUSD", "FBTC", "GBTC", "IBIT"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42571007/bitcoin-etfs-rise-in-pre-market-despite-jerome-powell-says-fed-cannot-hold-btc-whats-going-on", "tags": ["why_moving"]}
{"id": 42571155, "time": "2024-12-19 05:42:02", "headline": "Telsey Advisory Group Downgrades European Wax Center to Market Perform, Lowers Price Target to $6", "summary": "", "symbols": ["EWCZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571155/telsey-advisory-group-downgrades-european-wax-center-to-market-perform-lowers-price-target-to-6", "tags": ["analyst_down", "price_target_down"]}
{"id": 42571257, "time": "2024-12-19 05:44:38", "headline": "Telsey Advisory Group Maintains Outperform on Birkenstock Holding, Maintains $70 Price Target", "summary": "", "symbols": ["BIRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571257/telsey-advisory-group-maintains-outperform-on-birkenstock-holding-maintains-70-price-target", "tags": ["analyst_other"]}
{"id": 42571300, "time": "2024-12-19 05:46:40", "headline": "Telsey Advisory Group Maintains Market Perform on Grocery Outlet Holding, Maintains $18 Price Target", "summary": "", "symbols": ["GO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571300/telsey-advisory-group-maintains-market-perform-on-grocery-outlet-holding-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 42571318, "time": "2024-12-19 05:49:55", "headline": "Astronauts Sunita Williams, Butch Wilmore's Return From ISS Further Delayed: Now Expected No Earlier Than Late March", "summary": "NASA on Tuesday said that it has further delayed the return of astronauts Sunita Williams and Butch Wilmore back to Earth from the International Space Station to at least late March 2025, prolonging their stay at the station for over nine months.", "symbols": ["BA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/24/12/42571318/return-of-astronauts-sunita-williams-and-butch-wilmore-from-iss-further-delayed-now-expected-no-earlier-than-late-march", "tags": []}
{"id": 42571336, "time": "2024-12-19 05:52:07", "headline": "X Financial Enters Repurchase Agreement With A Major Shareholder To Repurchase 6.35M ADSs With Total Repurchase Price Of $48.7M", "summary": "", "symbols": ["XYF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571336/x-financial-enters-repurchase-agreement-with-a-major-shareholder-to-repurchase-6-35m-adss-with-total", "tags": ["contract", "buyback"]}
{"id": 42571395, "time": "2024-12-19 06:00:44", "headline": "Trump's DJT Connection Drives This Lesser-Known Crypto Stock's Nearly 3X Surge In A Month", "summary": "A publicly traded cryptocurrency company\u2019s shares have nearly tripled in a month following reports of a potential acquisition by President-elect Donald Trump\u2019s Trump Media &amp; Technology Group (NASDAQ:DJT).\u00a0", "symbols": ["BKKT", "BTCUSD", "DJT"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42571395/trumps-djt-connection-drives-this-lesser-known-crypto-stocks-nearly-3x-surge-in-a-month", "tags": []}
{"id": 42571416, "time": "2024-12-19 06:01:42", "headline": "Regis Acquires Alline Salon Group In Transaction Valued At $22M Of Initial Consideration, With Ability For ASG To Earn Additional $3M Through Earn Out Payments", "summary": "", "symbols": ["RGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42571416/regis-acquires-alline-salon-group-in-transaction-valued-at-22m-of-initial-consideration-with-ability", "tags": ["merger"]}
{"id": 42571428, "time": "2024-12-19 06:02:00", "headline": "Vertex Pharmaceuticals Announced Results From Its Phase 2 Study Of Suzetrigine For Painful Lumbosacral Radiculopathy, The Study Met Its Primary Endpoint With Statistically Significant And Clinically Meaningful Reduction In Pain On The Numeric Pain Rating Scale", "summary": "", "symbols": ["VRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42571428/vertex-pharmaceuticals-announced-results-from-its-phase-2-study-of-suzetrigine-for-painful-lumbos", "tags": ["fda"]}
{"id": 42571432, "time": "2024-12-19 06:02:31", "headline": "Lamb Weston Hldgs Q2 2025 Adj. EPS $0.66 Misses $1.01 Estimate, Sales $1.600B Miss $1.674B Estimate", "summary": "", "symbols": ["LW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42571432/lamb-weston-hldgs-q2-2025-adj-eps-0-66-misses-1-01-estimate-sales-1-600b-miss-1-674b-estimate", "tags": ["earnings"]}
{"id": 42571434, "time": "2024-12-19 06:03:05", "headline": "Lamb Weston Appoints Michael Smith, Current COO, As President And CEO And As Member Of Board, Effective January 3, 2025", "summary": "", "symbols": ["LW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571434/lamb-weston-appoints-michael-smith-current-coo-as-president-and-ceo-and-as-member-of-board-effective", "tags": ["management"]}
{"id": 42571438, "time": "2024-12-19 06:03:37", "headline": "COTA Announces A New Partnership With Guardant Health That Will Allow Biopharmaceutical Researchers To Access The Combined Resources Of COTA's Research-grade Electronic Health Record Data From Academic And Community Care Centers And Guardant's Clinicogenomic Testing Data To Accelerate The Development Of New Cancer Therapies", "summary": "", "symbols": ["GH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571438/cota-announces-a-new-partnership-with-guardant-health-that-will-allow-biopharmaceutical-researchers", "tags": ["contract"]}
{"id": 42571502, "time": "2024-12-19 06:07:24", "headline": "KBR Says Byron Bright Would Be Appointed To The Position Of COO, Effective May 2025 - Filing", "summary": "", "symbols": ["KBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571502/kbr-says-byron-bright-would-be-appointed-to-the-position-of-coo-effective-may-2025-filing", "tags": []}
{"id": 42571509, "time": "2024-12-19 06:08:38", "headline": "Lamb Weston Lowers FY25 Outlook: Sees Net sales of $6.35B-$6.45B Vs. $6.65B Estimate (Prior View: $6.6B-$6.8B), Projects Adjusted EPS Of $3.05-$3.20 Vs. $4.20 Estimate (Prior View: $4.15-$4.35)", "summary": "", "symbols": ["LW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571509/lamb-weston-lowers-fy25-outlook-sees-net-sales-of-6-35b-6-45b-vs-6-65b-estimate-prior-view-6-6b-6-8b", "tags": ["earnings", "guidance"]}
{"id": 42571618, "time": "2024-12-19 06:09:54", "headline": "KBR Says Board Appointed Its President And CEO Stuart Bradie To Serve As Chair Effective Immediately Upon Conclusion Of General Lyles' Current Term As A Director", "summary": "", "symbols": ["KBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571618/kbr-says-board-appointed-its-president-and-ceo-stuart-bradie-to-serve-as-chair-effective-immediately", "tags": ["management"]}
{"id": 42571638, "time": "2024-12-19 06:11:58", "headline": "HF Foods Group Appoints Felix Lin As Permanent CEO, Effective January 1, 2025", "summary": "", "symbols": ["HFFG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42571638/hf-foods-group-appoints-felix-lin-as-permanent-ceo-effective-january-1-2025", "tags": ["management"]}
{"id": 42571821, "time": "2024-12-19 06:15:36", "headline": "Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["ABL", "AEMD", "APCX", "CURR", "DALN", "DSGN", "ELAB", "KULR", "LITM", "LW", "MESO", "MU", "NVNI", "PTPI", "QNTM", "SGMO", "SLXN", "VRAX", "XCH", "XHG"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42571821/why-sangamo-therapeutics-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
{"id": 42571830, "time": "2024-12-19 06:16:12", "headline": "Sony Signs Strategic Capital And Business Alliance Agreement For Purpose Of Acquiring 12.05M New KADOKAWA Shares For Approximately 50B Yen - Filing", "summary": "", "symbols": ["SONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42571830/sony-signs-strategic-capital-and-business-alliance-agreement-for-purpose-of-acquiring-12-05m-new-kad", "tags": ["merger", "contract"]}
{"id": 42571835, "time": "2024-12-19 06:19:51", "headline": "Trump's Rejection Of Bipartisan Deal Fuels Government Shutdown Fears: How Markets Historically React To Political Turmoil", "summary": "Markets tend to look through the noise as the U.S. stocks have been positive 50% of the times during past 20 government shutdowns since 1976.", "symbols": [], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/24/12/42571835/trumps-rejection-of-bipartisan-deal-fuels-government-shutdown-fears-how-markets-historically-react-to-political-turmoil", "tags": ["contract"]}
{"id": 42571913, "time": "2024-12-19 06:24:23", "headline": "Tesla EU Registrations Plunge 41% In November, Casting Shadow On Q4 Target Of Over 500,000 EV Deliveries", "summary": "Tesla&#39;s new vehicle registrations in the EU are continuing to drop,\u00a0threatening the company&#39;s global EV delivery target\u00a0for the year.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/24/12/42571913/tesla-registrations-drop-by-nearly-41-in-november-in-eu-dragging-down-optimism-for-over-500000-ev-deliveries-in-q4", "tags": []}
{"id": 42571947, "time": "2024-12-19 06:26:18", "headline": "Fennec Pharmaceuticals Announced The Early Repayment Of $13M Of Its Approximately $32M Outstanding Convertible Debt Facility With Petrichor Healthcare Capital Management", "summary": "", "symbols": ["FENC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42571947/fennec-pharmaceuticals-announced-the-early-repayment-of-13m-of-its-approximately-32m-outstanding-", "tags": []}
{"id": 42571954, "time": "2024-12-19 06:27:36", "headline": "Why Is Penny Stock Canoo Falling On Thursday?", "summary": "Canoo shares are falling after the company furloughed 82 employees and idled its Oklahoma factories while securing capital to address financial challenges.", "symbols": ["GOEV"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42571954/why-is-penny-stock-canoo-falling-on-thursday", "tags": ["why_moving"]}
{"id": 42572004, "time": "2024-12-19 06:31:51", "headline": "Hut 8 Reveals Purchase Of Approximately 990 Bitcoin; Aggregate Purchase Price Of Acquired Bitcoin Was $100M, Or An Average Of $101,710 Per Bitcoin", "summary": "", "symbols": ["HUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572004/hut-8-reveals-purchase-of-approximately-990-bitcoin-aggregate-purchase-price-of-acquired-bitcoin-was", "tags": ["merger"]}
{"id": 42572021, "time": "2024-12-19 06:32:38", "headline": "Zomedica Appoints Scott Jordan As Its Executive Vice President, Finance And CFO, Effective January 1, 2025", "summary": "", "symbols": ["ZOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572021/zomedica-appoints-scott-jordan-as-its-executive-vice-president-finance-and-cfo-effective-january-1-2", "tags": ["management"]}
{"id": 42572024, "time": "2024-12-19 06:33:15", "headline": "Global Markets Slide On Fed's Hawkish Rate Policy; U.S. Dollar Eases Slightly After Hitting Two-Year High - Global Markets Today While US Slept", "summary": "US markets close lower on Wed, Fed cuts rates by 0.25% but signals fewer cuts in 2025. S&amp;P 500, Dow, and Nasdaq all down. Asia markets also down.", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/24/12/42572024/global-markets-slide-amid-feds-hawkish-rate-policy-us-dollar-eases-slightly-after-hitting-two-year-high-global-markets-today-while-us-slept", "tags": []}
{"id": 42572067, "time": "2024-12-19 06:35:02", "headline": "Lamb Weston Declared Quarterly Dividend Of $0.37 Per Share, Depicting $0.01 Increase, Dividend Is Payable On February 28", "summary": "", "symbols": ["LW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572067/lamb-weston-declared-quarterly-dividend-of-0-37-per-share-depicting-0-01-increase-dividend-is-payabl", "tags": ["dividend"]}
{"id": 42572076, "time": "2024-12-19 06:36:59", "headline": "Wedbush Reiterates Outperform on Texas Roadhouse, Maintains $200 Price Target", "summary": "", "symbols": ["TXRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572076/wedbush-reiterates-outperform-on-texas-roadhouse-maintains-200-price-target", "tags": ["analyst_other"]}
{"id": 42572083, "time": "2024-12-19 06:38:08", "headline": "Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges", "summary": "Mesoblast&#39;s Ryoncil is now FDA-approved for pediatric SR-aGvHD, marking a milestone in mesenchymal stromal cell therapies in the U.S.", "symbols": ["MESO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42572083/mesoblasts-cell-therapy-treatment-for-graft-versus-host-disease-gets-fda-approval-stock-surges", "tags": ["fda"]}
{"id": 42572197, "time": "2024-12-19 06:40:54", "headline": "Accenture Q1 2025 GAAP EPS $3.59 Beats $3.39 Estimate, Sales $17.69B Beat $17.12B Estimate", "summary": "", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42572197/accenture-q1-2025-gaap-eps-3-59-beats-3-39-estimate-sales-17-69b-beat-17-12b-estimate", "tags": ["earnings"]}
{"id": 42572216, "time": "2024-12-19 06:43:53", "headline": "Accenture Expects Q2 Revenues Of $16.2B - $16.8B, Est $16.625B", "summary": "", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572216/accenture-expects-q2-revenues-of-16-2b-16-8b-est-16-625b", "tags": []}
{"id": 42572217, "time": "2024-12-19 06:43:58", "headline": "Ocugen Announced That The Data And Safety Monitoring Board For OCU410 ArMaDa Clinical Trial Recently Convened And Approved The Continuation Of The Second Phase Of The Phase 1/2 Study", "summary": "", "symbols": ["OCGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42572217/ocugen-announced-that-the-data-and-safety-monitoring-board-for-ocu410-armada-clinical-trial-recen", "tags": ["fda"]}
{"id": 42572321, "time": "2024-12-19 06:45:02", "headline": "DA Davidson Initiates Coverage On IonQ with Buy Rating, Announces Price Target of $50", "summary": "", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572321/da-davidson-initiates-coverage-on-ionq-with-buy-rating-announces-price-target-of-50", "tags": ["analyst_init"]}
{"id": 42572310, "time": "2024-12-19 06:45:08", "headline": "China Accuses US Of Cyber Espionage And Theft Of Business Secrets Amid Rising Tensions", "summary": "Since August, an advanced material\u00a0design research unit in China has reportedly been targeted by suspected American intelligence agencies.", "symbols": [], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/news/24/12/42572310/china-accuses-us-of-cyber-espionage-and-theft-of-business-secrets-amid-rising-tensions", "tags": []}
{"id": 42572339, "time": "2024-12-19 06:46:32", "headline": "Accenture Raises FY25 Revenue Growth To 4% - 7% In Local Currency, Compared To 3% - 6% Previously; Revises GAAP EPS Outlook From $12.55 - $12.91 To $12.43 - $12.79, Est $12.74", "summary": "", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572339/accenture-raises-fy25-revenue-growth-to-4-7-in-local-currency-compared-to-3-6-previously-revises-gaa", "tags": ["earnings", "guidance"]}
{"id": 42572346, "time": "2024-12-19 06:47:25", "headline": "Merck Announced Topline Results From Two Phase 3 Trials Of Doravirine/Islatravir In Adults With HIV-1 Infection That Is Virologically Suppressed On Different Antiretroviral Therapy Regimens, Trials Met Efficacy Success Criteria For Non-inferiority To Comparator Antiretroviral Therapies", "summary": "", "symbols": ["MRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42572346/merck-announced-topline-results-from-two-phase-3-trials-of-doravirineislatravir-in-adults-with-hi", "tags": ["fda"]}
{"id": 42572364, "time": "2024-12-19 06:51:29", "headline": "CarMax Q3 2025 GAAP EPS $0.81 Beats $0.64 Estimate, Sales $6.223B Beat $6.042B Estimate", "summary": "", "symbols": ["KMX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42572364/carmax-q3-2025-gaap-eps-0-81-beats-0-64-estimate-sales-6-223b-beat-6-042b-estimate", "tags": ["earnings"]}
{"id": 42572384, "time": "2024-12-19 06:53:21", "headline": "Palantir Strengthens Army Partnership, Adds AI And Data Enhancements In $618.9 Million Contract", "summary": "Palantir extends partnership with U.S. Army, valued at $400.7M over 4 years. Aims to integrate data &amp; AI capabilities across entire Army.", "symbols": ["ADPV", "DAT", "PLTR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42572384/palantir-strengthens-army-partnership-adds-ai-and-data-enhancements-in-400-million-deal", "tags": ["contract"]}
{"id": 42572423, "time": "2024-12-19 06:57:30", "headline": "Needham Reiterates Buy on Hologic, Maintains $90 Price Target", "summary": "", "symbols": ["HOLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572423/needham-reiterates-buy-on-hologic-maintains-90-price-target", "tags": ["analyst_other"]}
{"id": 42572348, "time": "2024-12-19 06:49:34", "headline": "Brookdale Senior Living Has Entered Into Mutually Beneficial Agreements With Ventas To Amend Its Triple-Net Master Lease Arrangement, Which Can Potentially Provide Over $15M Improvement To The Company's 2025 Cash Flows", "summary": "", "symbols": ["BKD", "VTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572348/brookdale-senior-living-has-entered-into-mutually-beneficial-agreements-with-ventas-to-amend-its-tri", "tags": []}
{"id": 42572430, "time": "2024-12-19 06:58:54", "headline": "DA Davidson Initiates Coverage On MSA Safety with Buy Rating, Announces Price Target of $195", "summary": "", "symbols": ["MSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572430/da-davidson-initiates-coverage-on-msa-safety-with-buy-rating-announces-price-target-of-195", "tags": ["analyst_init"]}
{"id": 42572509, "time": "2024-12-19 07:00:13", "headline": "Forecasting The Future: 9 Analyst Projections For DT Midstream", "summary": " ", "symbols": ["DTM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42572509/forecasting-the-future-9-analyst-projections-for-dt-midstream", "tags": []}
{"id": 42572526, "time": "2024-12-19 07:00:21", "headline": "15 Analysts Have This To Say About Grocery Outlet Holding", "summary": " ", "symbols": ["GO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42572526/15-analysts-have-this-to-say-about-grocery-outlet-holding", "tags": []}
{"id": 42572528, "time": "2024-12-19 07:00:29", "headline": "Deep Dive Into Stanley Black & Decker Stock: Analyst Perspectives (8 Ratings)", "summary": " ", "symbols": ["SWK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42572528/deep-dive-into-stanley-black-decker-stock-analyst-perspectives-8-ratings", "tags": []}
{"id": 42572529, "time": "2024-12-19 07:00:35", "headline": "Jefferies Upgrades Tapestry to Buy, Raises Price Target to $80", "summary": "", "symbols": ["TPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572529/jefferies-upgrades-tapestry-to-buy-raises-price-target-to-80", "tags": ["analyst_up", "price_target_up"]}
{"id": 42572530, "time": "2024-12-19 07:00:35", "headline": "7 Analysts Assess Birkenstock Holding: What You Need To Know", "summary": " ", "symbols": ["BIRK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42572530/7-analysts-assess-birkenstock-holding-what-you-need-to-know", "tags": []}
{"id": 42572544, "time": "2024-12-19 07:01:09", "headline": "Triple Flag To Acquire Existing 0.5% GOR Royalty On Tres Quebradas Construction-stage Lithium Project From Lithium Royalty For Total Cash Consideration Of $28M", "summary": "", "symbols": ["TFPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42572544/triple-flag-to-acquire-existing-0-5-gor-royalty-on-tres-quebradas-construction-stage-lithium-project", "tags": ["merger"]}
{"id": 42572558, "time": "2024-12-19 07:01:30", "headline": "Darden Restaurants Q2 2025 Adj EPS $2.03 Beats $2.02 Estimate, Sales $2.89B Miss $2.90B Estimate", "summary": "", "symbols": ["DRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42572558/darden-restaurants-q2-2025-adj-eps-2-03-beats-2-02-estimate-sales-2-89b-miss-2-90b-estimate", "tags": ["earnings"]}
{"id": 42572575, "time": "2024-12-19 07:02:26", "headline": "FactSet Research Systems Q1 2025 Adj. EPS $4.37 Beats $4.26 Estimate, Sales $568.667M Beat $565.129M Estimate", "summary": "", "symbols": ["FDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42572575/factset-research-systems-q1-2025-adj-eps-4-37-beats-4-26-estimate-sales-568-667m-beat-565-129m-esti", "tags": ["earnings"]}
{"id": 42572581, "time": "2024-12-19 07:02:48", "headline": "Darden Restaurants Reported Q2 2025 Same-Restaurant Sales Of 2.4%", "summary": "", "symbols": ["DRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42572581/darden-restaurants-reported-q2-2025-same-restaurant-sales-of-2-4", "tags": []}
{"id": 42572593, "time": "2024-12-19 07:03:33", "headline": "Jefferies Downgrades NICE to Hold, Lowers Price Target to $200", "summary": "", "symbols": ["NICE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572593/jefferies-downgrades-nice-to-hold-lowers-price-target-to-200", "tags": ["analyst_down", "price_target_down"]}
{"id": 42572599, "time": "2024-12-19 07:04:20", "headline": "Darden Restaurants Expects 2025 Sales Of Approximately $12.1B Vs. Consensus Of $12.084B", "summary": "", "symbols": ["DRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42572599/darden-restaurants-expects-2025-sales-of-approximately-12-1b-vs-consensus-of-12-084b", "tags": []}
{"id": 42572601, "time": "2024-12-19 07:04:29", "headline": "Regeneron Reports Phase 2 Results For Two Novel Monoclonal Antibodies Targeting Distinct Domains Of Factor XI; Says There Was Antithrombotic Effect For Each Antibody; Phase 3 Program To Be Initiated In 2025", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572601/regeneron-reports-phase-2-results-for-two-novel-monoclonal-antibodies-targeting-distinct-domains-of", "tags": ["fda"]}
{"id": 42572674, "time": "2024-12-19 07:05:12", "headline": "HC Wainwright & Co. Reiterates Buy on Uranium Royalty, Maintains $7.7 Price Target", "summary": "", "symbols": ["UROY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572674/hc-wainwright-co-reiterates-buy-on-uranium-royalty-maintains-7-7-price-target", "tags": ["analyst_other"]}
{"id": 42572707, "time": "2024-12-19 07:05:59", "headline": "Lexeo Therapeutics Appoints Dr. Kyle Rasbach As Chief Financial Officer, Effective Immediately.", "summary": "", "symbols": ["LXEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42572707/lexeo-therapeutics-appoints-dr-kyle-rasbach-as-chief-financial-officer-effective-immediately", "tags": ["management"]}
{"id": 42572713, "time": "2024-12-19 07:06:02", "headline": "Jefferies Upgrades Zoom Communications to Buy, Raises Price Target to $100", "summary": "", "symbols": ["ZM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572713/jefferies-upgrades-zoom-communications-to-buy-raises-price-target-to-100", "tags": ["analyst_up", "price_target_up"]}
{"id": 42572714, "time": "2024-12-19 07:06:05", "headline": "Nurix Says FDA Granted Fast Track Designation For NX-5948 For Treatment Of Adult Patients With Relapsed Or Refractory Waldenstrom's Macroglobulinemia After At Least Two Lines Of Therapy", "summary": "", "symbols": ["NRIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572714/nurix-says-fda-granted-fast-track-designation-for-nx-5948-for-treatment-of-adult-patients-with-relap", "tags": ["fda"]}
{"id": 42572742, "time": "2024-12-19 07:07:51", "headline": "Laser Photonics Receives Dual Order From Oil Refiner Phillips 66 For CleanTech And MarkStar Laser Systems; No Terms Disclosed", "summary": "", "symbols": ["LASE", "PSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572742/laser-photonics-receives-dual-order-from-oil-refiner-phillips-66-for-cleantech-and-markstar-laser-sy", "tags": []}
{"id": 42572743, "time": "2024-12-19 07:07:59", "headline": "HC Wainwright & Co. Reiterates Buy on Verastem, Maintains $7 Price Target", "summary": "", "symbols": ["VSTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572743/hc-wainwright-co-reiterates-buy-on-verastem-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 42572744, "time": "2024-12-19 07:08:02", "headline": "FactSet Reaffirms FY25 Guidance: Sees Revenues Of $2.285B - $2.305B Vs. $2.301B Est., And Adjusted EPS Of $16.80 - $17.40 Vs. $17.17 Est.", "summary": "", "symbols": ["FDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42572744/factset-reaffirms-fy25-guidance-sees-revenues-of-2-285b-2-305b-vs-2-301b-est-and-adjusted-eps-of-16", "tags": ["earnings", "guidance"]}
{"id": 42572745, "time": "2024-12-19 07:08:07", "headline": "Jefferies Downgrades ALX Oncology Holdings to Hold, Lowers Price Target to $2", "summary": "", "symbols": ["ALXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572745/jefferies-downgrades-alx-oncology-holdings-to-hold-lowers-price-target-to-2", "tags": ["analyst_down", "price_target_down"]}
{"id": 42572747, "time": "2024-12-19 07:08:47", "headline": "The Glimpse Group's Subsidiary Company Brightline Interactive Has Entered Into An Initial Six Figure Dollar Contract With The U.S. Navy For An Immersive Simulator, To Be Delivered In The First Half Of 2025", "summary": "", "symbols": ["VRAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572747/the-glimpse-groups-subsidiary-company-brightline-interactive-has-entered-into-an-initial-six-figure", "tags": ["contract"]}
{"id": 42572748, "time": "2024-12-19 07:09:23", "headline": "Adicet Bio Says First Patient Dosed In The Phase 1 Clinical Trial Evaluating ADI-270 In Patients With Metastatic/Advanced ccRCC", "summary": "", "symbols": ["ACET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572748/adicet-bio-says-first-patient-dosed-in-the-phase-1-clinical-trial-evaluating-adi-270-in-patients-wit", "tags": ["fda"]}
{"id": 42572786, "time": "2024-12-19 07:09:52", "headline": "The Glimpse Group shares are trading higher after its subsidiary, Brightline Interactive, announced a six-figure contract with the U.S. Navy for an immersive simulator.", "summary": "", "symbols": ["VRAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572786/the-glimpse-group-shares-are-trading-higher-after-its-subsidiary-brightline-interactive-announced-a", "tags": ["why_moving", "contract"]}
{"id": 42572826, "time": "2024-12-19 07:10:13", "headline": "MindMed To Be Added To The Nasdaq Biotechnology Index, Effective At Market Open On December 23, 2024", "summary": "", "symbols": ["MNMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572826/mindmed-to-be-added-to-the-nasdaq-biotechnology-index-effective-at-market-open-on-december-23-2024", "tags": []}
{"id": 42572870, "time": "2024-12-19 07:10:56", "headline": "Bio-Path Reported That Results From Preclinical Studies Of BP1001-A For Obesity Demonstrated Enhanced Insulin Sensitivity, Confirming BP1001-A As A Potential Treatment For Obesity And Related Metabolic Diseases In Type 2 Diabetes Patients", "summary": "", "symbols": ["BPTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42572870/bio-path-reported-that-results-from-preclinical-studies-of-bp1001-a-for-obesity-demonstrated-enha", "tags": []}
{"id": 42572872, "time": "2024-12-19 07:11:05", "headline": "Jefferies Upgrades SentinelOne to Buy, Raises Price Target to $30", "summary": "", "symbols": ["S"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572872/jefferies-upgrades-sentinelone-to-buy-raises-price-target-to-30", "tags": ["analyst_up", "price_target_up"]}
{"id": 42572882, "time": "2024-12-19 07:12:55", "headline": "Needham Reiterates Hold on UiPathto Hold", "summary": "", "symbols": ["PATH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572882/needham-reiterates-hold-on-uipathto-hold", "tags": ["analyst_other"]}
{"id": 42572885, "time": "2024-12-19 07:13:38", "headline": "This Budget US Airline Is Offering A 'GoWild' Pass: Catch Unlimited Flights For A Year At $299", "summary": "Eligibility for the pass requires users to be at least 18 years old, U.S. residents,\u00a0and members of Frontier Miles,\u00a0the airline&#39;s loyalty program. ", "symbols": ["ULCC"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/general/travel/24/12/42572885/this-budget-us-airline-is-offering-a-gowild-pass-catch-unlimited-flights-for-a-year-at-299", "tags": ["offering"]}
{"id": 42572886, "time": "2024-12-19 07:13:39", "headline": "Verde Clean Fuels Entered Into A Stock Purchase Agreement With Cottonmouth Ventures, A Wholly-Owned Subsidiary Of Diamondback Energy, For A $50M Equity Investment", "summary": "", "symbols": ["FANG", "VGAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572886/verde-clean-fuels-entered-into-a-stock-purchase-agreement-with-cottonmouth-ventures-a-wholly-owned-s", "tags": ["contract"]}
{"id": 42572992, "time": "2024-12-19 07:14:47", "headline": "908 Devices And Getinge Announce Their Collaboration To Integrate Getinge's Bioreactors With 908 Devices' MAVEN For Automated Control Of Glucose And Lactate Levels In Cell Cultures", "summary": "", "symbols": ["MASS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572992/908-devices-and-getinge-announce-their-collaboration-to-integrate-getinges-bioreactors-with-908-devi", "tags": []}
{"id": 42572993, "time": "2024-12-19 07:14:57", "headline": "Citigroup Initiates Coverage On Viking Holdings with Buy Rating, Announces Price Target of $54", "summary": "", "symbols": ["VIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42572993/citigroup-initiates-coverage-on-viking-holdings-with-buy-rating-announces-price-target-of-54", "tags": ["analyst_init"]}
{"id": 42573031, "time": "2024-12-19 07:19:06", "headline": "HC Wainwright & Co. Reiterates Sell on Sarepta Therapeutics, Maintains $75 Price Target", "summary": "", "symbols": ["SRPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573031/hc-wainwright-co-reiterates-sell-on-sarepta-therapeutics-maintains-75-price-target", "tags": ["analyst_other"]}
{"id": 42573032, "time": "2024-12-19 07:19:39", "headline": "Armata Pharmaceuticals Announced Topline Results From Its Phase 2 Tailwind Trial Of AP-PA02 For Chronic Pulmonary Pseudomonas Aeruginosa Infections In Non-cystic Fibrosis Bronchiectasis Patients", "summary": "", "symbols": ["ARMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42573032/armata-pharmaceuticals-announced-topline-results-from-its-phase-2-tailwind-trial-of-ap-pa02-for-c", "tags": ["fda"]}
{"id": 42573063, "time": "2024-12-19 07:21:32", "headline": "US Stocks Likely To Open Higher After Plunging On Powell's Hawkish Comments: Analyst Calls It A 'Healthy' Reaction From An 'Overly Optimistic' Market", "summary": "U.S. stock futures climbed on Thursday in premarket hours after a hawkish cut from the Federal Reserve on Wednesday.", "symbols": ["ACN", "KULR", "LEN", "MESO", "MU", "NKE", "QQQ", "SGMO", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/24/12/42573063/us-stocks-to-open-higher-after-a-days-blip-as-analyst-says-markets-are-forward-looking-and-has-already-priced-in-feds-2025-projection", "tags": []}
{"id": 42573069, "time": "2024-12-19 07:21:45", "headline": "Oruka Therapeutics Has Initiated Dosing Of Healthy Volunteers In Its First Clinical Trial Of ORKA-001, The Company's Novel, Subcutaneously Administered, Half-life Extended Monoclonal Antibody Targeting IL-23p19", "summary": "", "symbols": ["ORKA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42573069/oruka-therapeutics-has-initiated-dosing-of-healthy-volunteers-in-its-first-clinical-trial-of-orka", "tags": ["fda"]}
{"id": 42573074, "time": "2024-12-19 07:22:05", "headline": "Needham Maintains Buy on Micron Technology, Lowers Price Target to $120", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573074/needham-maintains-buy-on-micron-technology-lowers-price-target-to-120", "tags": ["analyst_other", "price_target_down"]}
{"id": 42573093, "time": "2024-12-19 07:23:14", "headline": "Aleanna Has Signed An Exclusive Gas Supply Agreement With Shell Energy Europe", "summary": "", "symbols": ["ANNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573093/aleanna-has-signed-an-exclusive-gas-supply-agreement-with-shell-energy-europe", "tags": ["contract"]}
{"id": 42573095, "time": "2024-12-19 07:23:26", "headline": "Bitcoin Reserve Could Call US Solvency Into Question Critic Says, VanEck Exec Fires Back: 'This Is Loserthink'", "summary": "Nic Carter, Founding Partner at Castle Island Ventures, has expressed skepticism about the U.S.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42573095/bitcoin-reserve-could-call-us-solvency-into-question-critic-says-vaneck-exec-fires-back-this-is-loserthink", "tags": []}
{"id": 42573105, "time": "2024-12-19 07:23:52", "headline": "Tripadvisor Agrees To Acquire Liberty TripAdvisor; Aggregate Transaction Value Is Approximately $435M", "summary": "", "symbols": ["LTRPA", "TRIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42573105/tripadvisor-agrees-to-acquire-liberty-tripadvisor-aggregate-transaction-value-is-approximately-435m", "tags": ["merger"]}
{"id": 42573115, "time": "2024-12-19 07:24:54", "headline": "NewGenIvf Announced That It Has Engaged OSL Digital Securities, As Part Of Newgen's Intent To Begin Investing In The Digital Assets Space. Following The Engagement, NewGen Has Transferred Funds In The Amount Of $1M To Its Account", "summary": "", "symbols": ["NIVF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573115/newgenivf-announced-that-it-has-engaged-osl-digital-securities-as-part-of-newgens-intent-to-begin-in", "tags": []}
{"id": 42573178, "time": "2024-12-19 07:26:54", "headline": "Viad Plans To Change Its Corporate Name To Pursuit Attractions And Hospitality, Inc. Effective December 31, 2024; To Begin Trading Under New NYSE Ticker 'PRSU' On January 2, 2025", "summary": "", "symbols": ["VVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573178/viad-plans-to-change-its-corporate-name-to-pursuit-attractions-and-hospitality-inc-effective-decembe", "tags": []}
{"id": 42573191, "time": "2024-12-19 07:27:23", "headline": "HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Raises Price Target to $6", "summary": "", "symbols": ["CGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573191/hc-wainwright-co-maintains-buy-on-cognition-therapeutics-raises-price-target-to-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 42573196, "time": "2024-12-19 07:27:55", "headline": "Bio-Techne Announced Co-marketing And Co-Promotion Agreement With Waters Corporation Aimed At Expanding The Reach Of Advanced Biotherapeutic Characterization And Development Processes", "summary": "", "symbols": ["TECH", "WAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573196/bio-techne-announced-co-marketing-and-co-promotion-agreement-with-waters-corporation-aimed-at-expand", "tags": ["contract"]}
{"id": 42573202, "time": "2024-12-19 07:28:18", "headline": "Integral Ad Science Enters Exclusive First-To-Market Content-Level Brand Safety And Suitability Measurement For Advertisers On Kwai For Business", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573202/integral-ad-science-enters-exclusive-first-to-market-content-level-brand-safety-and-suitability-meas", "tags": []}
{"id": 42573216, "time": "2024-12-19 07:29:23", "headline": "Northland Capital Markets Maintains Outperform on Sezzle, Raises Price Target to $360", "summary": "", "symbols": ["SEZL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573216/northland-capital-markets-maintains-outperform-on-sezzle-raises-price-target-to-360", "tags": ["analyst_other", "price_target_up"]}
{"id": 42573294, "time": "2024-12-19 07:30:00", "headline": "U.K. Interest Rate Decision For December Unchanged At 4.75%", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42573294/u-k-interest-rate-decision-for-december-unchanged-at-4-75", "tags": []}
{"id": 42573438, "time": "2024-12-19 07:30:18", "headline": "AGCO Shareholder TAFE Calls Company To Address Critical Questions Regarding Strategic Priorities During 2024 Analyst Day", "summary": "", "symbols": ["AGCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573438/agco-shareholder-tafe-calls-company-to-address-critical-questions-regarding-strategic-priorities-dur", "tags": []}
{"id": 42573644, "time": "2024-12-19 07:30:45", "headline": "Needham Maintains Buy on Montrose Environmental Gr, Lowers Price Target to $39", "summary": "", "symbols": ["MEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573644/needham-maintains-buy-on-montrose-environmental-gr-lowers-price-target-to-39", "tags": ["analyst_other", "price_target_down"]}
{"id": 42573847, "time": "2024-12-19 07:31:11", "headline": "Northland Capital Markets Maintains Outperform on Universal Technical, Raises Price Target to $30", "summary": "", "symbols": ["UTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42573847/northland-capital-markets-maintains-outperform-on-universal-technical-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 42574727, "time": "2024-12-19 07:32:35", "headline": "FuelCell Energy Q4 2024 GAAP EPS $(2.21) Misses $(1.75) Estimate, Sales $49.300M Beat $39.716M Estimate", "summary": "", "symbols": ["FCEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42574727/fuelcell-energy-q4-2024-gaap-eps-2-21-misses-1-75-estimate-sales-49-300m-beat-39-716m-estimate", "tags": ["earnings"]}
{"id": 42574817, "time": "2024-12-19 07:32:44", "headline": "Northland Capital Markets Maintains Outperform on Adtran Holdings, Raises Price Target to $10", "summary": "", "symbols": ["ADTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42574817/northland-capital-markets-maintains-outperform-on-adtran-holdings-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 42575028, "time": "2024-12-19 07:33:05", "headline": "Conagra Brands Q2 2025 Adj. EPS $0.70 Beats $0.67 Estimate, Sales $3.195B Beat $3.149B Estimate", "summary": "", "symbols": ["CAG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42575028/conagra-brands-q2-2025-adj-eps-0-70-beats-0-67-estimate-sales-3-195b-beat-3-149b-estimate", "tags": ["earnings"]}
{"id": 42575042, "time": "2024-12-19 07:33:06", "headline": "Agnico Eagle Commences Offer To Acquire All Issued And Outstanding Common Shares Of O3 Mining  For C$1.67 In Cash Per Common Share", "summary": "", "symbols": ["AEM", "OIIIF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42575042/agnico-eagle-commences-offer-to-acquire-all-issued-and-outstanding-common-shares-of-o3-mining-for-c", "tags": ["merger"]}
{"id": 42575044, "time": "2024-12-19 07:33:06", "headline": "Palatin Announced Topline Data From BREAKOUT Phase 2b Study Of Bremelanotide In Diabetic Kidney Disease To Assess The Efficacy In Reducing Urinary Protein And Maintaining Podocyte Density And Function", "summary": "", "symbols": ["PTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42575044/palatin-announced-topline-data-from-breakout-phase-2b-study-of-bremelanotide-in-diabetic-kidney-d", "tags": []}
{"id": 42575405, "time": "2024-12-19 07:34:13", "headline": "Needham Maintains Buy on Duolingo, Raises Price Target to $385", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575405/needham-maintains-buy-on-duolingo-raises-price-target-to-385", "tags": ["analyst_other", "price_target_up"]}
{"id": 42575407, "time": "2024-12-19 07:34:21", "headline": "Northland Capital Markets Maintains Outperform on Ribbon Comms, Raises Price Target to $6", "summary": "", "symbols": ["RBBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575407/northland-capital-markets-maintains-outperform-on-ribbon-comms-raises-price-target-to-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 42575431, "time": "2024-12-19 07:34:54", "headline": "Wells Fargo Downgrades Viridian Therapeutics to Equal-Weight, Announces $27 Price Target", "summary": "", "symbols": ["VRDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575431/wells-fargo-downgrades-viridian-therapeutics-to-equal-weight-announces-27-price-target", "tags": ["analyst_down"]}
{"id": 42575432, "time": "2024-12-19 07:35:12", "headline": "Dollar Tree Appoints Interim CEO Michael C. Creedon As Permanent CEO", "summary": "", "symbols": ["DLTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575432/dollar-tree-appoints-interim-ceo-michael-c-creedon-as-permanent-ceo", "tags": ["management"]}
{"id": 42575478, "time": "2024-12-19 07:35:36", "headline": "Altimmune Will Be Added To The Nasdaq Biotechnology Index Effective Prior To The Market Open On December 23, 2024", "summary": "", "symbols": ["ALT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42575478/altimmune-will-be-added-to-the-nasdaq-biotechnology-index-effective-prior-to-the-market-open-on-d", "tags": []}
{"id": 42575483, "time": "2024-12-19 07:36:20", "headline": "Bitcoin Price Rebounds Above $102,000 After Fed Meeting Calamity: Why Is BTC Going Up?", "summary": "Bitcoin (CRYPTO: BTC) has rebounded to $102,250 after taking a nosedive on Thursday following the FOMC meeting.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42575483/bitcoin-price-rebounds-above-102000-after-fed-meeting-calamity-why-is-btc-going-up", "tags": []}
{"id": 42575506, "time": "2024-12-19 07:37:07", "headline": "Deutsche Bank Upgrades Hewlett Packard to Buy, Maintains Price Target to $25", "summary": "", "symbols": ["HPE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575506/deutsche-bank-upgrades-hewlett-packard-to-buy-maintains-price-target-to-25", "tags": ["analyst_up", "analyst_other"]}
{"id": 42575507, "time": "2024-12-19 07:37:10", "headline": "Dragonfly Energy Has Secured A Large Purchase Order For Delivery Of The Company's Battle Born All-Electric APUs From Stevens Transport", "summary": "", "symbols": ["DFLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575507/dragonfly-energy-has-secured-a-large-purchase-order-for-delivery-of-the-companys-battle-born-all-ele", "tags": []}
{"id": 42575520, "time": "2024-12-19 07:37:24", "headline": "ZenaTech Subsidiary Moves Into Its Manufacturing Facility In Phoenix, Arizona To Produce US Defense And Nato Drones, Part Of Efforts To Produce 'Made In America' Drones", "summary": "", "symbols": ["ZENA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575520/zenatech-subsidiary-moves-into-its-manufacturing-facility-in-phoenix-arizona-to-produce-us-defense-a", "tags": []}
{"id": 42575523, "time": "2024-12-19 07:37:58", "headline": "Conagra Brands Lowers FY25 Outlook: Sees Adjusted EPS Between $2.45-$2.50 Vs. $2.58 Estimate (Prior View: $2.60-$2.65), Projects Organic Net Sales Near The Midpoint Of (1.5)% To Flat YoY", "summary": "", "symbols": ["CAG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575523/conagra-brands-lowers-fy25-outlook-sees-adjusted-eps-between-2-45-2-50-vs-2-58-estimate-prior-view-2", "tags": ["earnings", "guidance"]}
{"id": 42575525, "time": "2024-12-19 07:38:13", "headline": "Wells Fargo Downgrades Monte Rosa Therapeutics to Equal-Weight, Lowers Price Target to $11", "summary": "", "symbols": ["GLUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575525/wells-fargo-downgrades-monte-rosa-therapeutics-to-equal-weight-lowers-price-target-to-11", "tags": ["analyst_down", "price_target_down"]}
{"id": 42575579, "time": "2024-12-19 07:39:59", "headline": "Wells Fargo Initiates Coverage On Pennant Gr with Equal-Weight Rating, Announces Price Target of $33", "summary": "", "symbols": ["PNTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575579/wells-fargo-initiates-coverage-on-pennant-gr-with-equal-weight-rating-announces-price-target-of-33", "tags": ["analyst_init"]}
{"id": 42575663, "time": "2024-12-19 07:41:39", "headline": "Wells Fargo Upgrades Tegna to Overweight, Announces $23 Price Target", "summary": "", "symbols": ["TGNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575663/wells-fargo-upgrades-tegna-to-overweight-announces-23-price-target", "tags": ["analyst_up"]}
{"id": 42575665, "time": "2024-12-19 07:42:21", "headline": "Keybanc Upgrades Okta to Overweight, Announces $115 Price Target", "summary": "", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575665/keybanc-upgrades-okta-to-overweight-announces-115-price-target", "tags": ["analyst_up"]}
{"id": 42575674, "time": "2024-12-19 07:42:46", "headline": "Euro Tech Holdings H1 2024 Revenue $7.259M, Down From $7.957M YoY", "summary": "", "symbols": ["CLWT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575674/euro-tech-holdings-h1-2024-revenue-7-259m-down-from-7-957m-yoy", "tags": ["earnings"]}
{"id": 42575675, "time": "2024-12-19 07:42:59", "headline": "NLS Pharmaceutics And Kadimastem In Collaboration With iTolerance Announced That Request For Pre-Investigational New Drug Meeting Has Been Submitted To The FDA For iTOL102 For Type 1 Diabetes", "summary": "", "symbols": ["NLSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42575675/nls-pharmaceutics-and-kadimastem-in-collaboration-with-itolerance-announced-that-request-for-pre-", "tags": ["fda"]}
{"id": 42575676, "time": "2024-12-19 07:43:28", "headline": "Wells Fargo Upgrades C4 Therapeutics to Overweight, Raises Price Target to $12", "summary": "", "symbols": ["CCCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575676/wells-fargo-upgrades-c4-therapeutics-to-overweight-raises-price-target-to-12", "tags": ["analyst_up", "price_target_up"]}
{"id": 42575677, "time": "2024-12-19 07:43:50", "headline": "Deutsche Bank Maintains Buy on Birkenstock Holding, Raises Price Target to $66", "summary": "", "symbols": ["BIRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575677/deutsche-bank-maintains-buy-on-birkenstock-holding-raises-price-target-to-66", "tags": ["analyst_other", "price_target_up"]}
{"id": 42575782, "time": "2024-12-19 07:44:58", "headline": "Deutsche Bank Maintains Hold on General Mills, Lowers Price Target to $68", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575782/deutsche-bank-maintains-hold-on-general-mills-lowers-price-target-to-68", "tags": ["analyst_other", "price_target_down"]}
{"id": 42575814, "time": "2024-12-19 07:45:41", "headline": "Keybanc Upgrades Fortinet to Overweight, Announces $115 Price Target", "summary": "", "symbols": ["FTNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575814/keybanc-upgrades-fortinet-to-overweight-announces-115-price-target", "tags": ["analyst_up"]}
{"id": 42575815, "time": "2024-12-19 07:45:43", "headline": "Wells Fargo Downgrades Cabaletta Bio to Equal-Weight, Lowers Price Target to $6", "summary": "", "symbols": ["CABA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575815/wells-fargo-downgrades-cabaletta-bio-to-equal-weight-lowers-price-target-to-6", "tags": ["analyst_down", "price_target_down"]}
{"id": 42575818, "time": "2024-12-19 07:46:32", "headline": "Deutsche Bank Maintains Buy on Axalta Coating Sys, Lowers Price Target to $42", "summary": "", "symbols": ["AXTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575818/deutsche-bank-maintains-buy-on-axalta-coating-sys-lowers-price-target-to-42", "tags": ["analyst_other", "price_target_down"]}
{"id": 42575819, "time": "2024-12-19 07:46:42", "headline": "Top 3 Industrials Stocks Which Could Rescue Your Portfolio For December", "summary": " ", "symbols": ["AOS", "PAYX", "RUN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42575819/top-3-industrials-stocks-which-could-rescue-your-portfolio-for-december", "tags": []}
{"id": 42575842, "time": "2024-12-19 07:48:21", "headline": "Deutsche Bank Maintains Buy on PPG Indus, Lowers Price Target to $145", "summary": "", "symbols": ["PPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575842/deutsche-bank-maintains-buy-on-ppg-indus-lowers-price-target-to-145", "tags": ["analyst_other", "price_target_down"]}
{"id": 42575845, "time": "2024-12-19 07:49:25", "headline": "Xilio To Present Initial Data From Its Ongoing Phase 2 Trial For Vilastobart At ASCO GI; Reports Preliminary Phase 1 Data For XTX301 Showing Improved Tolerability Profile Over Historical Data For rhIL-12", "summary": "", "symbols": ["XLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575845/xilio-to-present-initial-data-from-its-ongoing-phase-2-trial-for-vilastobart-at-asco-gi-reports-prel", "tags": ["fda"]}
{"id": 42575847, "time": "2024-12-19 07:50:02", "headline": "Phio Pharmaceuticals Announced That The Safety Monitoring Committee Recommended Dose Escalation In Its Phase 1B Trial To Evaluate The Safety And Tolerability Of PH-762 For Stages 1, 2, And 4 Cutaneous Squamous Cell Carcinoma, Stage 4 Melanoma, And Stage 4 Merkel Cell Carcinoma", "summary": "", "symbols": ["PHIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42575847/phio-pharmaceuticals-announced-that-the-safety-monitoring-committee-recommended-dose-escalation-i", "tags": ["fda"]}
{"id": 42575864, "time": "2024-12-19 07:50:45", "headline": "Chardan Capital Maintains Buy on Cognition Therapeutics, Maintains $11 Price Target", "summary": "", "symbols": ["CGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575864/chardan-capital-maintains-buy-on-cognition-therapeutics-maintains-11-price-target", "tags": ["analyst_other"]}
{"id": 42575875, "time": "2024-12-19 07:51:51", "headline": "Baird Maintains Outperform on Birkenstock Holding, Raises Price Target to $72", "summary": "", "symbols": ["BIRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575875/baird-maintains-outperform-on-birkenstock-holding-raises-price-target-to-72", "tags": ["analyst_other", "price_target_up"]}
{"id": 42575876, "time": "2024-12-19 07:52:35", "headline": "Russian President Says He's Willing To Meet Trump 'At Any Time' For Dialogue", "summary": "Vladimir Putin, the President of Russia, has shown his readiness to initiate talks with the incoming U.S. President\u00a0Donald Trump. ", "symbols": [], "source": "benzinga", "author": "Navdeep Yadav", "url": "https://www.benzinga.com/24/12/42575876/russian-president-says-hes-willing-to-meet-trump-at-any-time-for-dialogue", "tags": []}
{"id": 42575891, "time": "2024-12-19 07:53:01", "headline": "Keybanc Downgrades C3.ai to Underweight, Announces $29 Price Target", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575891/keybanc-downgrades-c3-ai-to-underweight-announces-29-price-target", "tags": ["analyst_down"]}
{"id": 42575892, "time": "2024-12-19 07:54:24", "headline": "Baird Maintains Outperform on Micron Technology, Lowers Price Target to $130", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575892/baird-maintains-outperform-on-micron-technology-lowers-price-target-to-130", "tags": ["analyst_other", "price_target_down"]}
{"id": 42575923, "time": "2024-12-19 07:56:19", "headline": "Rodman & Renshaw Initiates Coverage On TuHURA Biosciences with Buy Rating, Announces Price Target of $11", "summary": "", "symbols": ["HURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575923/rodman-renshaw-initiates-coverage-on-tuhura-biosciences-with-buy-rating-announces-price-target-of-11", "tags": ["analyst_init"]}
{"id": 42575935, "time": "2024-12-19 07:57:48", "headline": "Northcoast Research Initiates Coverage On Tennant with Buy Rating, Announces Price Target of $125", "summary": "", "symbols": ["TNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575935/northcoast-research-initiates-coverage-on-tennant-with-buy-rating-announces-price-target-of-125", "tags": ["analyst_init"]}
{"id": 42575937, "time": "2024-12-19 07:58:15", "headline": "Stephens & Co. Reiterates Equal-Weight on Darden Restaurants, Maintains $164 Price Target", "summary": "", "symbols": ["DRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575937/stephens-co-reiterates-equal-weight-on-darden-restaurants-maintains-164-price-target", "tags": ["analyst_other"]}
{"id": 42575940, "time": "2024-12-19 07:58:48", "headline": "D. Boral Capital Maintains Buy on Biomea Fusion, Maintains $128 Price Target", "summary": "", "symbols": ["BMEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42575940/d-boral-capital-maintains-buy-on-biomea-fusion-maintains-128-price-target", "tags": ["analyst_other"]}
{"id": 42576008, "time": "2024-12-19 08:00:12", "headline": "EXCLUSIVE: Vivani Medical Tells Benzinga Co. Announces Initiation Of First In Human Clinical Trial With GLP-1 Implant In Obese And Overweight Individuals In Australia", "summary": "", "symbols": ["VANI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576008/exclusive-vivani-medical-tells-benzinga-co-announces-initiation-of-first-in-human-clinical-trial-wit", "tags": ["fda"]}
{"id": 42576040, "time": "2024-12-19 08:00:20", "headline": "EXCLUSIVE: Vivani Medical Tells Benzinga 'NPM-115 clinical program utilizes a miniature, GLP-1 (exenatide) implant designed to provide comparable efficacy to semaglutide, with twice-yearly administration'", "summary": "", "symbols": ["VANI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576040/exclusive-vivani-medical-tells-benzinga-npm-115-clinical-program-utilizes-a-miniature-glp-1-exenatid", "tags": ["fda"]}
{"id": 42576060, "time": "2024-12-19 08:00:25", "headline": "Expert Outlook: Fortinet Through The Eyes Of 35 Analysts", "summary": " ", "symbols": ["FTNT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42576060/expert-outlook-fortinet-through-the-eyes-of-35-analysts", "tags": ["guidance"]}
{"id": 42576063, "time": "2024-12-19 08:00:28", "headline": "EXCLUSIVE: Vivani Medical Tells Benzinga 'Study represents the first clinical application of NanoPortal, the Company's proprietary drug implant platform technology'", "summary": "", "symbols": ["VANI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576063/exclusive-vivani-medical-tells-benzinga-study-represents-the-first-clinical-application-of-nanoporta", "tags": ["fda"]}
{"id": 42576062, "time": "2024-12-19 08:00:28", "headline": "EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia", "summary": "Vivani Medical launches first-in-human trial of its exenatide implant in Australia, aiming to support chronic weight management with innovative GLP-1 technology.", "symbols": ["VANI"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42576062/exclusive-vivani-medical-initiates-first-human-clinical-trial-with-glp-1-implant-for-weight-loss-in-australia", "tags": ["fda"]}
{"id": 42576078, "time": "2024-12-19 08:00:40", "headline": "Lamb Weston Takes A Hit From High Manufacturing Costs And Softer Volumes, Expects Challenging Conditions Till 2026", "summary": "Lamb Weston shares drop 19.5% after Q2 earnings miss, lower revenues, and a reduced FY25 outlook.\n\n\n\n", "symbols": ["LW"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/12/42576078/lamb-weston-slumps-after-q2-earnings-miss-revenues-down-outlook-slashed", "tags": ["earnings", "guidance"]}
{"id": 42576084, "time": "2024-12-19 08:00:48", "headline": "Demystifying Okta: Insights From 40 Analyst Reviews", "summary": " ", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42576084/demystifying-okta-insights-from-40-analyst-reviews", "tags": []}
{"id": 42576095, "time": "2024-12-19 08:01:00", "headline": "Breaking Down IonQ: 5 Analysts Share Their Views", "summary": " ", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42576095/breaking-down-ionq-5-analysts-share-their-views", "tags": []}
{"id": 42576099, "time": "2024-12-19 08:01:05", "headline": "Maxim Group Initiates Coverage On NIP Group with Buy Rating, Announces Price Target of $12", "summary": "", "symbols": ["NIPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576099/maxim-group-initiates-coverage-on-nip-group-with-buy-rating-announces-price-target-of-12", "tags": ["analyst_init"]}
{"id": 42576105, "time": "2024-12-19 08:01:12", "headline": "A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 15 Analysts", "summary": " ", "symbols": ["SRPT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42576105/a-glimpse-into-the-expert-outlook-on-sarepta-therapeutics-through-15-analysts", "tags": ["guidance"]}
{"id": 42576113, "time": "2024-12-19 08:01:28", "headline": "19 Analysts Assess Tapestry: What You Need To Know", "summary": " ", "symbols": ["TPR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42576113/19-analysts-assess-tapestry-what-you-need-to-know", "tags": []}
{"id": 42576120, "time": "2024-12-19 08:01:39", "headline": "Rosenblatt Maintains Buy on Micron Technology, Maintains $250 Price Target", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576120/rosenblatt-maintains-buy-on-micron-technology-maintains-250-price-target", "tags": ["analyst_other"]}
{"id": 42576123, "time": "2024-12-19 08:01:41", "headline": "Expert Outlook: Universal Technical Through The Eyes Of 8 Analysts", "summary": " ", "symbols": ["UTI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42576123/expert-outlook-universal-technical-through-the-eyes-of-8-analysts", "tags": ["guidance"]}
{"id": 42576179, "time": "2024-12-19 08:03:59", "headline": "Leidos Secures $987M Contract For F-16 Foreign Military Sales Sustainment, Supporting U.S. Air Force's F-16 System Program Office Over 10 Years", "summary": "", "symbols": ["LDOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576179/leidos-secures-987m-contract-for-f-16-foreign-military-sales-sustainment-supporting-u-s-air-forces-f", "tags": ["contract"]}
{"id": 42576210, "time": "2024-12-19 08:05:08", "headline": "Gaxos.ai Announces $5M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules; Totaling 1.45M Shares At $3.32 Per Share, Closing Expected By Dec. 20, 2024", "summary": "", "symbols": ["GXAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576210/gaxos-ai-announces-5m-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-totaling-1", "tags": ["offering"]}
{"id": 42576314, "time": "2024-12-19 08:06:02", "headline": "Ultragenyx Submits Biologics License Application To FDA For UX111 AAV Gene Therapy Seeking Accelerated Approval For Sanfilippo Syndrome Type A Treatment", "summary": "", "symbols": ["RARE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576314/ultragenyx-submits-biologics-license-application-to-fda-for-ux111-aav-gene-therapy-seeking-accele", "tags": ["fda"]}
{"id": 42576326, "time": "2024-12-19 08:06:18", "headline": "Opus Genetics Receives FDA Agreement Under Special Protocol Assessment For Phase 3 Trial Of APX3330 In Diabetic Retinopathy; Agreement Reached On Primary Endpoint And Phase 3 Trial Design", "summary": "", "symbols": ["IRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576326/opus-genetics-receives-fda-agreement-under-special-protocol-assessment-for-phase-3-trial-of-apx33", "tags": ["fda", "contract"]}
{"id": 42576337, "time": "2024-12-19 08:06:57", "headline": "Rosenblatt Maintains Buy on Penguin Solutions, Maintains $27 Price Target", "summary": "", "symbols": ["PENG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576337/rosenblatt-maintains-buy-on-penguin-solutions-maintains-27-price-target", "tags": ["analyst_other"]}
{"id": 42576338, "time": "2024-12-19 08:07:03", "headline": "Alumis Announces Phase 1 Data For CNS Penetrant TYK2 Inhibitor, A-005; A-005 Was Well Tolerated And Demonstrated Ability To Cross Blood-Brain Barrier", "summary": "", "symbols": ["ALMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576338/alumis-announces-phase-1-data-for-cns-penetrant-tyk2-inhibitor-a-005-a-005-was-well-tolerated-and", "tags": ["fda"]}
{"id": 42576359, "time": "2024-12-19 08:07:56", "headline": "AgEagle Aerial Systems Secures Largest Sensor Order In Company History With Milestone Sale Of 60 RedEdge-P Multispectral Sensors To East Asian Reseller, Highlighting 2024 Growth And Focus On Long-Term Shareholder Value", "summary": "", "symbols": ["UAVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576359/ageagle-aerial-systems-secures-largest-sensor-order-in-company-history-with-milestone-sale-of-60-red", "tags": []}
{"id": 42576360, "time": "2024-12-19 08:08:03", "headline": "Quoin Pharmaceuticals Receives FDA Clearance To Initiate A New QRX003 Netherton Syndrome Clinical Study", "summary": "", "symbols": ["QNRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576360/quoin-pharmaceuticals-receives-fda-clearance-to-initiate-a-new-qrx003-netherton-syndrome-clinical-st", "tags": ["fda"]}
{"id": 42576361, "time": "2024-12-19 08:08:03", "headline": "Goldman Sachs Maintains Buy on Jabil, Raises Price Target to $160", "summary": "", "symbols": ["JBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576361/goldman-sachs-maintains-buy-on-jabil-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 42576362, "time": "2024-12-19 08:08:16", "headline": "Assembly Biosciences Announces $30.1M Equity Investment And Accelerated Funding From Gilead To Advance Clinical Development Programs; Additional Equity Investment Raises Gilead's Ownership Stake In Assembly Bio To 29.9%", "summary": "", "symbols": ["ASMB", "GILD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576362/assembly-biosciences-announces-30-1m-equity-investment-and-accelerated-funding-from-gilead-to-adv", "tags": ["fda"]}
{"id": 42576366, "time": "2024-12-19 08:08:54", "headline": "Opus Genetics Secures FDA Agreement Under Special Protocol Assessment For Phase 3 Trial Of Oral APX3330 In Diabetic Retinopathy, Targeting Reduction In Disease Progression With NDA Submission Planned Upon Successful Trial Outcome", "summary": "", "symbols": ["IRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576366/opus-genetics-secures-fda-agreement-under-special-protocol-assessment-for-phase-3-trial-of-oral-a", "tags": ["fda", "contract"]}
{"id": 42576368, "time": "2024-12-19 08:09:03", "headline": "Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity For Libervant Buccal Film In Pediatric Patients With Seizure Clusters Ages 2-5", "summary": "", "symbols": ["AQST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576368/aquestive-therapeutics-receives-u-s-fda-orphan-drug-exclusivity-for-libervant-buccal-film-in-pedi", "tags": ["fda"]}
{"id": 42576369, "time": "2024-12-19 08:09:11", "headline": "CarMax Q3 Earnings: Solid Growth In Auto Finance Income, Retail And Wholesale Units", "summary": "CarMax shares up after beating Q3 FY25 earnings estimates, posting strong sales and growth in CarMax Auto Finance income.", "symbols": ["EQTY", "KMX", "UPGD"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42576369/carmax-q3-earnings-solid-growth-in-caf-income-retail-and-wholesale-units", "tags": ["earnings"]}
{"id": 42576371, "time": "2024-12-19 08:09:26", "headline": "WestPark Capital Initiates Coverage On Microvision with Buy Rating, Announces Price Target of $1.3", "summary": "", "symbols": ["MVIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576371/westpark-capital-initiates-coverage-on-microvision-with-buy-rating-announces-price-target-of-1-3", "tags": ["analyst_init"]}
{"id": 42576391, "time": "2024-12-19 08:09:57", "headline": "Immuneering Launches Pancreatic Cancer Advisory Board; Establishment Reflects The Clinical Progress Of IMM-1-104 And Its Promise In Pancreatic Cancer", "summary": "", "symbols": ["IMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576391/immuneering-launches-pancreatic-cancer-advisory-board-establishment-reflects-the-clinical-progres", "tags": ["fda"]}
{"id": 42576439, "time": "2024-12-19 08:10:06", "headline": "Pluri Applauds Mesoblast For FDA Approval Of First Mesenchymal Stromal Cell Therapy For Steroid-Refractory Acute Graft-Versus-Host Disease, Highlighting Regenerative Medicine's Transformative Potential And Advancing MSC Therapies In Healthcare", "summary": "", "symbols": ["PLUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576439/pluri-applauds-mesoblast-for-fda-approval-of-first-mesenchymal-stromal-cell-therapy-for-steroid-refr", "tags": ["fda"]}
{"id": 42576449, "time": "2024-12-19 08:10:07", "headline": "Leading And Lagging Sectors For December 19, 2024", "summary": " ", "symbols": ["XLC", "XLE", "XLF", "XLI", "XLK", "XLP", "XLRE", "XLU", "XLV", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/24/12/42576449/leading-and-lagging-sectors-for-december-19-2024", "tags": []}
{"id": 42576487, "time": "2024-12-19 08:10:29", "headline": "Telsey Advisory Group Upgrades RH to Outperform, Raises Price Target to $500", "summary": "", "symbols": ["RH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576487/telsey-advisory-group-upgrades-rh-to-outperform-raises-price-target-to-500", "tags": ["analyst_up", "price_target_up"]}
{"id": 42576491, "time": "2024-12-19 08:10:39", "headline": "PTC Therapeutics Submits NDA To FDA For Vatiquinone As Potential First Approved Therapy For Friedreich Ataxia In Children And Adults, Marking Fourth FDA Application In 2024", "summary": "", "symbols": ["PTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576491/ptc-therapeutics-submits-nda-to-fda-for-vatiquinone-as-potential-first-approved-therapy-for-friedrei", "tags": ["fda"]}
{"id": 42576537, "time": "2024-12-19 08:11:04", "headline": "Pulse Biosciences,, On December 18, 2024, The Co's Co-Chairman And Majority Shareholder, Robert W. Duggan, Exercised All Of The Warrants He Acquired In The Co's 2024 Rights Offering, Corresponding To $58.4M Totaling To 5,306,156 Shares Of Company Common Stock", "summary": "", "symbols": ["PLSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576537/pulse-biosciences-on-december-18-2024-the-cos-co-chairman-and-majority-shareholder-robert-w-duggan-e", "tags": ["offering", "merger"]}
{"id": 42576538, "time": "2024-12-19 08:11:17", "headline": "Soho House Receives $9.00 Per Share Acquisition Offer From Third-Party Consortium Backed By Executive Chairman Ron Burkle And Yucaipa, Representing An 83% Premium, With Board Forming Special Committee To Evaluate Proposal", "summary": "", "symbols": ["SHCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42576538/soho-house-receives-9-00-per-share-acquisition-offer-from-third-party-consortium-backed-by-executive", "tags": []}
{"id": 42576541, "time": "2024-12-19 08:12:16", "headline": "NV5 Secures $7M In Infrastructure Design Contracts From City Of Philadelphia To Enhance Green Infrastructure, Safety, And Sustainability With Projects Set For Completion By 2028", "summary": "", "symbols": ["NVEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576541/nv5-secures-7m-in-infrastructure-design-contracts-from-city-of-philadelphia-to-enhance-green-infrast", "tags": []}
{"id": 42576542, "time": "2024-12-19 08:12:16", "headline": "AbbVie's Atogepant And OnabotulinumtoxinA Receive Strong Recommendations In The Newly Updated Canadian Headache Society Migraine Prevention Guideline; A Strong Recommendation Was Issued When An Intervention Was Deemed Suitable For The Majority Of Patients, With Benefits Outweighing Potential Risks", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576542/abbvies-atogepant-and-onabotulinumtoxina-receive-strong-recommendations-in-the-newly-updated-cana", "tags": []}
{"id": 42576543, "time": "2024-12-19 08:12:52", "headline": "Celldex Launches Phase 2 Study Of Barzolvolimab For Atopic Dermatitis, Targeting Mast Cell-Driven Inflammation And Epithelial Barrier Dysfunction With Patient Enrollment Underway", "summary": "", "symbols": ["CLDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576543/celldex-launches-phase-2-study-of-barzolvolimab-for-atopic-dermatitis-targeting-mast-cell-driven-", "tags": ["fda"]}
{"id": 42576545, "time": "2024-12-19 08:13:27", "headline": "Aquestive Therapeutics Secures FDA Orphan Drug Exclusivity For Libervant Buccal Film In Pediatric Seizure Clusters Ages 2 To 5, Highlighting Major Care Advancement With Buccal Administration Over Rectal Route", "summary": "", "symbols": ["AQST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576545/aquestive-therapeutics-secures-fda-orphan-drug-exclusivity-for-libervant-buccal-film-in-pediatric", "tags": ["fda"]}
{"id": 42576555, "time": "2024-12-19 08:13:55", "headline": "Small Cap Consumer Research Reiterates Buy on Vince Holding, Maintains $3 Price Target", "summary": "", "symbols": ["VNCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576555/small-cap-consumer-research-reiterates-buy-on-vince-holding-maintains-3-price-target", "tags": ["analyst_other"]}
{"id": 42576556, "time": "2024-12-19 08:14:05", "headline": "reAlpha Plans To Allocate Up To 25% Of Excess Cash To Cryptocurrency Purchases And To Adopt Bitcoin, Ethereum And Solana", "summary": "", "symbols": ["AIRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42576556/realpha-plans-to-allocate-up-to-25-of-excess-cash-to-cryptocurrency-purchases-and-to-adopt", "tags": []}
{"id": 42576558, "time": "2024-12-19 08:14:09", "headline": "IMUNON Announces FDA Alignment On CMC Strategy For IMNN-001 In Advanced Ovarian Cancer, Phase 3 Trial Set To Begin Q1 2025 With cGMP Manufacturing Process And Potency Assay Approved For Clinical And Commercial Use", "summary": "", "symbols": ["IMNN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576558/imunon-announces-fda-alignment-on-cmc-strategy-for-imnn-001-in-advanced-ovarian-cancer-phase-3-tr", "tags": ["fda"]}
{"id": 42576658, "time": "2024-12-19 08:14:47", "headline": "Marker Therapeutics Secures $16.1M In Private Placement To Advance Phase 1 APOLLO Study Of MT-601 T Cell Therapy For Lymphoma Patients Relapsed After Anti-CD19 CAR-T Treatment", "summary": "", "symbols": ["MRKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576658/marker-therapeutics-secures-16-1m-in-private-placement-to-advance-phase-1-apollo-study-of-mt-601-", "tags": ["offering", "fda"]}
{"id": 42576659, "time": "2024-12-19 08:14:57", "headline": "MetaVia Releases Top-Line Results From Its Phase 2a Clinical Trial Of DA-1241 In Patients With Presumed MASH At The 9th Annual MASH-TAG 2025 Conference", "summary": "", "symbols": ["MTVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576659/metavia-releases-top-line-results-from-its-phase-2a-clinical-trial-of-da-1241-in-patients-with-pr", "tags": ["fda"]}
{"id": 42576681, "time": "2024-12-19 08:15:28", "headline": "BigBear.ai Secures GSA OASIS+ IDIQ Contract Offering 10-Year Access To AI Solutions For Federal Civilian And Defense Agencies With Unlimited Task Orders And No Dollar Ceiling", "summary": "", "symbols": ["BBAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576681/bigbear-ai-secures-gsa-oasis-idiq-contract-offering-10-year-access-to-ai-solutions-for-federal-civil", "tags": ["offering", "contract"]}
{"id": 42576758, "time": "2024-12-19 08:15:57", "headline": "Wall Street's Most Accurate Analysts Give Their Take On 3 Tech Stocks Delivering High-Dividend Yields", "summary": " ", "symbols": ["MCHP", "STX", "SWKS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42576758/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-stocks-delivering-high-dividend-yields-4", "tags": ["dividend"]}
{"id": 42576761, "time": "2024-12-19 08:16:19", "headline": "Mainz Biomed Forms Agreement With Quest Diagnostics  To Support Commercialization Of Mainz Biomed's NextGen Screening Test For Colorectal Cancer", "summary": "", "symbols": ["DGX", "MYNZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576761/mainz-biomed-forms-agreement-with-quest-diagnostics-to-support-commercialization-of-mainz-biomeds", "tags": ["contract"]}
{"id": 42576762, "time": "2024-12-19 08:16:22", "headline": "Marker Therapeutics Reports Results From Phase 1 APOLLO Study Of MT-601 In Relapsed Lymphoma, Showing 78% Objective Response Rate And 44.4% Complete Responses With Well-Tolerated Safety Profile And No ICANS Observed", "summary": "", "symbols": ["MRKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576762/marker-therapeutics-reports-results-from-phase-1-apollo-study-of-mt-601-in-relapsed-lymphoma-show", "tags": ["fda"]}
{"id": 42576784, "time": "2024-12-19 08:17:07", "headline": "Lucid Diagnostics Partners With VITALExam, To Enhance Access To Lucid's EsoGuard Esophageal DNA Test For Firefighters At Risk For Esophageal Precancer", "summary": "", "symbols": ["LUCD", "PAVM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42576784/lucid-diagnostics-partners-with-vitalexam-to-enhance-access-to-lucids-esoguard-esophageal-dna-tes", "tags": ["contract"]}
{"id": 42576789, "time": "2024-12-19 08:18:06", "headline": "Lucid Diagnostics Partners With VITALExam To Expand EsoGuard Testing For Firefighters At Risk Of Esophageal Precancer, Launching With #CheckYourFoodTube Event At Tuscaloosa Fire Rescue", "summary": "", "symbols": ["LUCD", "PAVM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576789/lucid-diagnostics-partners-with-vitalexam-to-expand-esoguard-testing-for-firefighters-at-risk-of-eso", "tags": ["contract"]}
{"id": 42576799, "time": "2024-12-19 08:18:18", "headline": "JANA Partners Comments On Lamb Weston Management Change And Financial Results; Says \"Today's Disastrous Financial Results And Decision To Swap Its CEO For Another Long-Standing Lamb Weston Executive Complicit In Its Widespread Operational And Strategic Debacles Is Just The Latest Stick In The Eye From A Board That Has Completely Failed Shareholders. Enough Is Enough: Lamb Weston Requires Significant Board Change Or, In Its Absence, Should Be Sold.\"", "summary": "", "symbols": ["LW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576799/jana-partners-comments-on-lamb-weston-management-change-and-financial-results-says-todays-disastrous", "tags": ["management"]}
{"id": 42576801, "time": "2024-12-19 08:18:33", "headline": "Amentum Wins $279M U.S. Air Force Contract To Provide Aviation Operations Solutions For Ninth Air Force, Extending Through 2031 To Enhance Mission Readiness And Operational Success", "summary": "", "symbols": ["AMTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576801/amentum-wins-279m-u-s-air-force-contract-to-provide-aviation-operations-solutions-for-ninth-air-forc", "tags": ["contract"]}
{"id": 42576813, "time": "2024-12-19 08:19:38", "headline": "Capital One Gains Delaware Approval For Discover Financial Services Acquisition, Anticipates Early 2025 Closing Pending Federal Approvals And Shareholder Votes, Backed By $265B Community Benefits Plan", "summary": "", "symbols": ["COF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576813/capital-one-gains-delaware-approval-for-discover-financial-services-acquisition-anticipates-early-20", "tags": []}
{"id": 42576814, "time": "2024-12-19 08:19:57", "headline": "Edible Garden Experienced A 51% YoY Increase In Preliminary Sales Results For The Thanksgiving Time-Period", "summary": "", "symbols": ["EDBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576814/edible-garden-experienced-a-51-yoy-increase-in-preliminary-sales-results-for-the-thanksgiving-time-p", "tags": []}
{"id": 42576817, "time": "2024-12-19 08:20:20", "headline": "Edible Garden Reports 51% YoY Surge In Thanksgiving Sales, Achieving Record Results Driven By Core Strengths And Industry-Leading Fulfillment Rates", "summary": "", "symbols": ["EDBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576817/edible-garden-reports-51-yoy-surge-in-thanksgiving-sales-achieving-record-results-driven-by-core-str", "tags": []}
{"id": 42576819, "time": "2024-12-19 08:20:23", "headline": "Palo Alto Networks Achieves FedRAMP's Highest Authorization Across All 3 Industry-Leading Cybersecurity Platforms", "summary": "", "symbols": ["PANW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576819/palo-alto-networks-achieves-fedramps-highest-authorization-across-all-3-industry-leading-cybersecuri", "tags": []}
{"id": 42576823, "time": "2024-12-19 08:20:50", "headline": "BMO Capital Maintains Outperform on Hanover Insurance Gr, Raises Price Target to $180", "summary": "", "symbols": ["THG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576823/bmo-capital-maintains-outperform-on-hanover-insurance-gr-raises-price-target-to-180", "tags": ["analyst_other", "price_target_up"]}
{"id": 42576853, "time": "2024-12-19 08:21:15", "headline": "Nukkleus Rockets Higher: $10 Million Private Placement Fuels Acquisition Of Iron Dome Supplier", "summary": "NUKK announces $10M private placement with NY-based investor. Funds to finance acquisition and for corporate purposes. ", "symbols": ["NUKK"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/offerings/24/12/42576853/nukkleus-rockets-higher-10-million-private-placement-fuels-acquisition-of-iron-dome-supplier", "tags": ["offering"]}
{"id": 42576868, "time": "2024-12-19 08:22:13", "headline": "BMO Capital Maintains Outperform on Birkenstock Holding, Raises Price Target to $70", "summary": "", "symbols": ["BIRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576868/bmo-capital-maintains-outperform-on-birkenstock-holding-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 42576890, "time": "2024-12-19 08:24:02", "headline": "Smurfit Westrock Applies To Cease To Be A Reporting Issuer In Certain Canadian Jurisdictions; If Granted, Co Will No Longer Be Subject To Continuous Disclosure Requirements Under Canadian Securities Legislation", "summary": "", "symbols": ["SW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576890/smurfit-westrock-applies-to-cease-to-be-a-reporting-issuer-in-certain-canadian-jurisdictions-if-gran", "tags": []}
{"id": 42576910, "time": "2024-12-19 08:25:07", "headline": "Soho House Q3 EPS $0.00 Beats $(0.01) Est.; Sales $333.37M Miss $334.62M Estimate", "summary": "", "symbols": ["SHCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42576910/soho-house-q3-sales-333-37m-miss-333-88m-estimate", "tags": ["earnings"]}
{"id": 42575664, "time": "2024-12-19 07:35:31", "headline": "Tesla Reportedly In Talks With Austin To Bring Autonomous Vehicles To Texas Roads: Elon Musk-Led EV Giant Rises 3% In Pre Market", "summary": "Tesla is reportedly in early discussions with officials of the city of Austin, Texas, to roll out its autonomous vehicles for testing as early as 2025.", "symbols": ["TSLA"], "source": "benzinga", "author": "Rounak Jain", "url": "https://www.benzinga.com/markets/equities/24/12/42575664/tesla-reportedly-in-talks-with-austin", "tags": []}
{"id": 42576958, "time": "2024-12-19 08:26:55", "headline": "UBS Initiates Coverage On Palantir Technologies with Neutral Rating, Announces Price Target of $80", "summary": "", "symbols": ["PLTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576958/ubs-initiates-coverage-on-palantir-technologies-with-neutral-rating-announces-price-target-of-80", "tags": ["analyst_init"]}
{"id": 42576961, "time": "2024-12-19 08:27:36", "headline": "Soho House & Co Updates FY24 Revenue Guidance From $1.2B-$1.25B To ~$1.2B Vs $1.23B Est.", "summary": "", "symbols": ["SHCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42576961/soho-house-co-updates-fy24-revenue-guidance-from-1-2b-1-25b-to-1-2b-vs-1-23b-est", "tags": ["earnings", "guidance"]}
{"id": 42576985, "time": "2024-12-19 08:29:22", "headline": "Lamb Weston Posts Weak Q2 Results, Joins Micron, Lennar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session", "summary": " ", "symbols": ["ABL", "AHG", "DSGN", "LEN", "LW", "MU", "QUBT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42576985/lamb-weston-posts-weak-q2-results-joins-micron-lennar-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session", "tags": ["earnings", "why_moving"]}
{"id": 42577070, "time": "2024-12-19 08:30:18", "headline": "USA Initial Jobless Claims 220K Vs 229K Est.; 242K Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42577070/usa-initial-jobless-claims-220k-vs-229k-est-242k-prior", "tags": []}
{"id": 42577086, "time": "2024-12-19 08:30:34", "headline": "USA Philadelphia Fed Manufacturing Index For December -16.4 Vs 2.9 Est.; -5.5 Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42577086/usa-philadelphia-fed-manufacturing-index-for-december-16-4-vs-2-9-est-5-5-prior", "tags": []}
{"id": 42577088, "time": "2024-12-19 08:30:39", "headline": "USA GDP (QoQ) (Q3) +3.1% vs +2.8% Est.; 3.0% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42577088/usa-gdp-qoq-q3-3-1-vs-2-8-est-3-0-prior", "tags": []}
{"id": 42577120, "time": "2024-12-19 08:30:49", "headline": "USA PCE Prices (Q3) 1.5% Vs 1.5% Est.; 2.5% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42577120/usa-pce-prices-q3-1-5-vs-1-5-est-2-5-prior", "tags": []}
{"id": 42577122, "time": "2024-12-19 08:30:50", "headline": "iCoreConnect Announces 1-For-20 Reverse Stock Split, Will Open For Trading On The Nasdaq Capital Market On December 23, 2024, On A Post-Split Basis", "summary": "", "symbols": ["ICCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577122/icoreconnect-announces-1-for-20-reverse-stock-split-will-open-for-trading-on-the-nasdaq-capital-mark", "tags": []}
{"id": 42577124, "time": "2024-12-19 08:30:52", "headline": "Paychex Q2 2025 Adj EPS $1.14 Beats $1.13 Estimate, Sales $1.32B Inline", "summary": "", "symbols": ["PAYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42577124/paychex-q2-2025-adj-eps-1-14-beats-1-13-estimate-sales-1-32b-inline", "tags": ["earnings"]}
{"id": 42577125, "time": "2024-12-19 08:30:54", "headline": "USA Core PCE Prices (Q3) 2.2% vs 2.10% Est.; 2.80% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42577125/usa-core-pce-prices-q3-2-2-vs-2-10-est-2-80-prior", "tags": []}
{"id": 42577143, "time": "2024-12-19 08:31:04", "headline": "USA Continuing Jobless Claims 1,874K Vs 1,890K Est.; 1,879K Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42577143/usa-continuing-jobless-claims-1-874k-vs-1-890k-est-1-879k-prior", "tags": []}
{"id": 42577148, "time": "2024-12-19 08:31:10", "headline": "CorMedix Inc. Added to Nasdaq Biotechnology Index, Effective Prior To The Market Open On Monday, December 23, 2024.", "summary": "", "symbols": ["CRMD", "NBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577148/cormedix-inc-added-to-nasdaq-biotechnology-index-effective-prior-to-the-market-open-on-monday-decemb", "tags": []}
{"id": 42577164, "time": "2024-12-19 08:31:37", "headline": "Cintas Q2 2025 GAAP EPS $1.09 Beats $1.01 Estimate, Sales $2.56B Inline", "summary": "", "symbols": ["CTAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42577164/cintas-q2-2025-gaap-eps-1-09-beats-1-01-estimate-sales-2-56b-inline", "tags": ["earnings"]}
{"id": 42577166, "time": "2024-12-19 08:31:57", "headline": "D. Boral Capital Maintains Buy on Imunon, Maintains $29 Price Target", "summary": "", "symbols": ["IMNN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577166/d-boral-capital-maintains-buy-on-imunon-maintains-29-price-target", "tags": ["analyst_other"]}
{"id": 42577169, "time": "2024-12-19 08:32:09", "headline": "Paychex Says FY25 Business Outlook Remains Unchanged From Previously Provided In Q1", "summary": "", "symbols": ["PAYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577169/paychex-says-fy25-business-outlook-remains-unchanged-from-previously-provided-in-q1", "tags": ["guidance"]}
{"id": 42577170, "time": "2024-12-19 08:32:09", "headline": "Maxim Group Initiates Coverage On TruGolf Holdings with Buy Rating, Announces Price Target of $2", "summary": "", "symbols": ["TRUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577170/maxim-group-initiates-coverage-on-trugolf-holdings-with-buy-rating-announces-price-target-of-2", "tags": ["analyst_init"]}
{"id": 42577172, "time": "2024-12-19 08:32:28", "headline": "EXCLUSIVE: Are Apple, Tesla 2025's Tech Titans Or Bubble Trouble? Kurv CEO Dishes On AI, Cloud And More", "summary": "Tech leaders like Apple and Tesla boast strong fundamentals, but Howard Chan says their valuations are &#34;stretched.&#34;", "symbols": ["AAPL", "AMZN", "KQQQ", "MSFT", "TSLA"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/12/42577172/exclusive-are-apple-tesla-2025s-tech-titans-or-bubble-trouble-kurv-ceo-dishes-on-ai-cloud-and-more", "tags": ["management"]}
{"id": 42577173, "time": "2024-12-19 08:32:36", "headline": "Eos Energy And FlexGen Partner Sign A Joint Development Agreement To Develop And Introduce America's First Fully-Integrated, Domestic BESS Solution To The Market By Combining Eos' Z3 Batteries With The FlexGen HybridOS Energy Management System", "summary": "", "symbols": ["EOSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577173/eos-energy-and-flexgen-partner-sign-a-joint-development-agreement-to-develop-and-introduce-americas", "tags": ["contract"]}
{"id": 42577189, "time": "2024-12-19 08:33:19", "headline": "Trio To Acquire Producing Oil And Gas Assets In Prolific Heavy Oil Region Of Saskatchewan Canada For ~$1.4M", "summary": "", "symbols": ["TPET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42577189/trio-to-acquire-producing-oil-and-gas-assets-in-prolific-heavy-oil-region-of-saskatchewan-canada-for", "tags": ["merger"]}
{"id": 42577191, "time": "2024-12-19 08:33:56", "headline": "TOMI Environmental Says Closely Monitoring Recent Declaration Of State Of Emergency In California Due To H5N1 Bird Flu Outbreak; Says Ready To Deploy SteraMist", "summary": "", "symbols": ["TOMZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577191/tomi-environmental-says-closely-monitoring-recent-declaration-of-state-of-emergency-in-california-du", "tags": []}
{"id": 42577194, "time": "2024-12-19 08:34:09", "headline": "ABVC BioPharma Seeks To Revolutionize Mental Health Treatment With A Safe Prozac Alternative, Boasting A MADRS Score Reduction Of -13.21 From Baseline Over 6 Weeks With A Placebo-subtracted Difference Of -4.1", "summary": "", "symbols": ["ABVC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42577194/abvc-biopharma-seeks-to-revolutionize-mental-health-treatment-with-a-safe-prozac-alternative-boas", "tags": []}
{"id": 42577198, "time": "2024-12-19 08:34:19", "headline": "Cintas Expects 2025 Sales Of $10.255B-$10.32B Compared To Prior Guidance Of $10.22B-$10.32B And Consensus Of $10.29B", "summary": "", "symbols": ["CTAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42577198/cintas-expects-2025-sales-of-10-255b-10-32b-compared-to-prior-guidance-of-10-22b-10-32b-and-consens", "tags": ["guidance"]}
{"id": 42577200, "time": "2024-12-19 08:34:24", "headline": "Tevogen Bio Expands IP Portfolio With Predictive AI Patent Filing To Advance T Cell Therapies And Accelerate AI Integration, Strengthening Position As An Industry Leader In Innovation And Accessibility", "summary": "", "symbols": ["TVGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42577200/tevogen-bio-expands-ip-portfolio-with-predictive-ai-patent-filing-to-advance-t-cell-therapies-and", "tags": []}
{"id": 42577211, "time": "2024-12-19 08:34:54", "headline": "D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target", "summary": "", "symbols": ["CLNN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577211/d-boral-capital-maintains-buy-on-clene-maintains-23-price-target", "tags": ["analyst_other"]}
{"id": 42577229, "time": "2024-12-19 08:35:02", "headline": "CLPS Announces Filing Of Registration Statement For Proposed IPO Of JAJI Global", "summary": "", "symbols": ["CLPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577229/clps-announces-filing-of-registration-statement-for-proposed-ipo-of-jaji-global", "tags": []}
{"id": 42577232, "time": "2024-12-19 08:35:05", "headline": "VSee Health Secures Teleradiology Contract With Major Post-Acute Care Hospital System, Launching In Q1 2025 With Potential $1.5M Annual Revenue And Focus On Improving Diagnostic Accuracy And Patient Outcomes", "summary": "", "symbols": ["VSEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42577232/vsee-health-secures-teleradiology-contract-with-major-post-acute-care-hospital-system-launching-i", "tags": ["earnings", "contract"]}
{"id": 42577233, "time": "2024-12-19 08:35:08", "headline": "Soho House Earnings Review: Q3 Summary", "summary": " ", "symbols": ["SHCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42577233/soho-house-earnings-review-q3-summary", "tags": ["earnings"]}
{"id": 42577242, "time": "2024-12-19 08:35:21", "headline": "Ondas Unit Airobotics Receives Purchase Order From A Large Semiconductor Manufacturer To Renew Ongoing Aerial Security And Data Services", "summary": "", "symbols": ["ONDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577242/ondas-unit-airobotics-receives-purchase-order-from-a-large-semiconductor-manufacturer-to-renew-ongoi", "tags": []}
{"id": 42577244, "time": "2024-12-19 08:35:34", "headline": "Lake Street Initiates Coverage On Lifevantage with Buy Rating, Announces Price Target of $26", "summary": "", "symbols": ["LFVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577244/lake-street-initiates-coverage-on-lifevantage-with-buy-rating-announces-price-target-of-26", "tags": ["analyst_init"]}
{"id": 42577245, "time": "2024-12-19 08:35:40", "headline": "GreenPower Announces Order Of 11 BEAST All-Electric School Buses For School Districts In Arizona, California And Oregon", "summary": "", "symbols": ["GP", "TSXV:GPV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577245/greenpower-announces-order-of-11-beast-all-electric-school-buses-for-school-districts-in-arizona-cal", "tags": []}
{"id": 42577320, "time": "2024-12-19 08:36:27", "headline": "Banzai Finalizes OpenReel Acquisition, Anticipates Surpassing $10M 2024 Revenue Guidance While Expanding MarTech Solutions To Drive Long-Term Shareholder Value", "summary": "", "symbols": ["BNZI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577320/banzai-finalizes-openreel-acquisition-anticipates-surpassing-10m-2024-revenue-guidance-while-expandi", "tags": ["earnings", "guidance"]}
{"id": 42577330, "time": "2024-12-19 08:36:47", "headline": "How To Earn $500 A Month From Nike Stock Ahead Of Q2 Earnings", "summary": " ", "symbols": ["NKE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42577330/how-to-earn-500-a-month-from-nike-stock-ahead-of-q2-earnings", "tags": ["earnings"]}
{"id": 42577340, "time": "2024-12-19 08:37:01", "headline": "BitFuFu Surpasses 520K Registered Cloud-Mining Users Globally, Achieving 67% CAGR Growth And Expanding Across 150 Countries Following Recent Platform Revamp", "summary": "", "symbols": ["FUFU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577340/bitfufu-surpasses-520k-registered-cloud-mining-users-globally-achieving-67-cagr-growth-and-expanding", "tags": []}
{"id": 42577506, "time": "2024-12-19 08:37:33", "headline": "Amazon Shares Rise As Company Says Operations Remain Unaffected Despite Workers At Seven US Facilities Going On Strike Amid Peak Holiday Shopping", "summary": "The company accused the Teamsters of misleading the public and attempting to coerce employees and drivers into joining the strike.", "symbols": ["AMZN"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/news/24/12/42577506/amazon-shares-rise-as-company-says-operations-remain-unaffected-despite-workers-at-seven-us-facilities-going-on-strike-amid-peak-holiday-shopping", "tags": []}
{"id": 42577577, "time": "2024-12-19 08:37:35", "headline": "NaaS Technology Expands Strategic Partnership With NHOA.TCC Aiming To Advance Integrated Solar-Charging-Storage Solutions, Leveraging AI-Driven Technology To Optimize Operational Efficiency And Enhance User Experience", "summary": "", "symbols": ["NAAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42577577/naas-technology-expands-strategic-partnership-with-nhoa-tcc-aiming-to-advance-integrated-solar-charg", "tags": ["contract"]}
{"id": 42578036, "time": "2024-12-19 08:38:36", "headline": "Star Equity's KBS Builders Has Signed A $2.1M Contract To Manufacture Multifamily Apartments In Vermont", "summary": "", "symbols": ["STRR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42578036/star-equitys-kbs-builders-has-signed-a-2-1m-contract-to-manufacture-multifamily-apartments-in-vermon", "tags": ["contract"]}
{"id": 42578950, "time": "2024-12-19 08:40:07", "headline": "Cintas Q2 Earnings Assessment", "summary": " ", "symbols": ["CTAS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42578950/cintas-q2-earnings-assessment", "tags": ["earnings"]}
{"id": 42579096, "time": "2024-12-19 08:40:23", "headline": "HWH International Expands Hapi Cafe Brand Across Asia With Outlets In Singapore, South Korea, Taiwan, And China, Launching Hapi Cafe X Initiative To Promote Health, Wealth, And Happiness Through Keto Meal Plans", "summary": "", "symbols": ["HWH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42579096/hwh-international-expands-hapi-cafe-brand-across-asia-with-outlets-in-singapore-south-korea-taiwan-a", "tags": []}
{"id": 42579105, "time": "2024-12-19 08:40:45", "headline": "Byrna LATAM Is Expanding Its Manufacturing Capacity In Argentina To Meet Growing Demand, With Plans To Produce 3,000 Launchers Per Month Starting In Q1 2025 And Scale Ammunition Production", "summary": "", "symbols": ["BYRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42579105/byrna-latam-is-expanding-its-manufacturing-capacity-in-argentina-to-meet-growing-demand-with-plans-t", "tags": []}
{"id": 42579143, "time": "2024-12-19 08:41:08", "headline": "Bitcoin Trust, Cheniere Energy And More On CNBC's 'Final Trades'", "summary": "On CNBC&#39;s &#34;Halftime Report Final Trades,&#34; Stephen Weiss of Short Hills Capital Partners named iShares Bitcoin Trust ETF as his final trade.", "symbols": ["EIS", "IBIT", "IYR", "LNG"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42579143/cheniere-energy-bitcoin-trust-and-more-on-cnbcs-final-trades", "tags": []}
{"id": 42579152, "time": "2024-12-19 08:41:23", "headline": "Prenetics' IM8 Announces Collaboration With Mayo Clinic To Develop New Line Of Premium Supplements To Focus On Nutrition, Cellular Rejuvenation, Protein, Collagen And Overall Wellness", "summary": "", "symbols": ["PRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42579152/prenetics-im8-announces-collaboration-with-mayo-clinic-to-develop-new-line-of-premium-supplements", "tags": []}
{"id": 42579168, "time": "2024-12-19 08:42:18", "headline": "Wedbush Initiates Coverage On SolarWinds with Outperform Rating, Announces Price Target of $20", "summary": "", "symbols": ["SWI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42579168/wedbush-initiates-coverage-on-solarwinds-with-outperform-rating-announces-price-target-of-20", "tags": ["analyst_init"]}
{"id": 42579241, "time": "2024-12-19 08:42:29", "headline": "Ascendis Pharma's YORVIPATH Now Commercially Available In The U.S. For The Treatment Of Hypoparathyroidism In Adults", "summary": "", "symbols": ["ASND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42579241/ascendis-pharmas-yorvipath-now-commercially-available-in-the-u-s-for-the-treatment-of-hypoparathy", "tags": []}
{"id": 42579637, "time": "2024-12-19 08:43:14", "headline": "Stadium Capital Issues Letter Stating Pat Hopf and Gary Fazio As Executive Chair And Senior Advisor To Sleep Number's Board", "summary": "", "symbols": ["SNBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42579637/stadium-capital-issues-letter-stating-pat-hopf-and-gary-fazio-as-executive-chair-and-senior-advisor", "tags": []}
{"id": 42580042, "time": "2024-12-19 08:43:49", "headline": "Evoke Pharma Highlights GIMOTI As A Leading Solution For Gastroparesis Treatment As Domperidone Supply Ends; FDA Posts Update As Mechanism To Obtain Unapproved Domperidone Expected To Lose Supply In Early 2025", "summary": "", "symbols": ["EVOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42580042/evoke-pharma-highlights-gimoti-as-a-leading-solution-for-gastroparesis-treatment-as-domperidone-s", "tags": ["fda"]}
{"id": 42580117, "time": "2024-12-19 08:43:56", "headline": "Wedbush Initiates Coverage On OneStream with Outperform Rating, Announces Price Target of $40", "summary": "", "symbols": ["OS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42580117/wedbush-initiates-coverage-on-onestream-with-outperform-rating-announces-price-target-of-40", "tags": ["analyst_init"]}
{"id": 42580359, "time": "2024-12-19 08:44:17", "headline": "Adeia Enters Into Multi-Year IP License Agreement With Canon, Providing Access To Adeia's Media Portfolio", "summary": "", "symbols": ["ADEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42580359/adeia-enters-into-multi-year-ip-license-agreement-with-canon-providing-access-to-adeias-media-portfo", "tags": ["contract"]}
{"id": 42581335, "time": "2024-12-19 08:45:37", "headline": "Wedbush Initiates Coverage On Innodata with Outperform Rating, Announces Price Target of $48", "summary": "", "symbols": ["INOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42581335/wedbush-initiates-coverage-on-innodata-with-outperform-rating-announces-price-target-of-48", "tags": ["analyst_init"]}
{"id": 42581759, "time": "2024-12-19 08:46:18", "headline": "This Zoom Communications Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday", "summary": " ", "symbols": ["HPE", "OKTA", "RH", "SWK", "ZM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42581759/this-zoom-communications-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday", "tags": ["analyst_up"]}
{"id": 42582001, "time": "2024-12-19 08:46:42", "headline": "EzFill Holdings Finalizes Letter Of Understanding For Purchase Of 78 Trucks From Shell; No Financial Terms Disclosed", "summary": "", "symbols": ["EZFL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42582001/ezfill-holdings-finalizes-letter-of-understanding-for-purchase-of-78-trucks-from-shell-no-financial", "tags": []}
{"id": 42582254, "time": "2024-12-19 08:47:06", "headline": "Top 3 Consumer Stocks You May Want To Dump This Quarter", "summary": " ", "symbols": ["BIRK", "CANG", "VNCE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42582254/top-3-consumer-stocks-you-may-want-to-dump-this-quarter", "tags": []}
{"id": 42582371, "time": "2024-12-19 08:47:20", "headline": "Wedbush Initiates Coverage On Lithium Americas with Neutral Rating, Announces Price Target of $5", "summary": "", "symbols": ["LAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42582371/wedbush-initiates-coverage-on-lithium-americas-with-neutral-rating-announces-price-target-of-5", "tags": ["analyst_init"]}
{"id": 42582888, "time": "2024-12-19 08:48:07", "headline": "Cintas Expects 2025 EPS of $4.28-$4.34 Compared To Prior Guidance Of $4.17-$4.25 And Consensus Of $4.24", "summary": "", "symbols": ["CTAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42582888/cintas-expects-2025-eps-of-4-28-4-34-compared-to-prior-guidance-of-4-17-4-25-and-consensus-of-4-24", "tags": ["earnings", "guidance"]}
{"id": 42583023, "time": "2024-12-19 08:48:19", "headline": "UBS Maintains Neutral on ABM Indus, Raises Price Target to $56", "summary": "", "symbols": ["ABM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42583023/ubs-maintains-neutral-on-abm-indus-raises-price-target-to-56", "tags": ["analyst_other", "price_target_up"]}
{"id": 42583653, "time": "2024-12-19 08:49:17", "headline": "Wedbush Initiates Coverage On Oklo with Outperform Rating, Announces Price Target of $26", "summary": "", "symbols": ["OKLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42583653/wedbush-initiates-coverage-on-oklo-with-outperform-rating-announces-price-target-of-26", "tags": ["analyst_init"]}
{"id": 42583878, "time": "2024-12-19 08:49:47", "headline": "VCI Global Signs A Term Sheet To Acquire A Solar Farm With An Estimated Capacity Of 1.14 Megawatts, Located In Novo Selo, North Macedonia For ~$1.26M", "summary": "", "symbols": ["VCIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42583878/vci-global-signs-a-term-sheet-to-acquire-a-solar-farm-with-an-estimated-capacity-of-1-14-megawatts-l", "tags": ["merger"]}
{"id": 42584142, "time": "2024-12-19 08:50:14", "headline": "UBS Maintains Buy on Birkenstock Holding, Raises Price Target to $95", "summary": "", "symbols": ["BIRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42584142/ubs-maintains-buy-on-birkenstock-holding-raises-price-target-to-95", "tags": ["analyst_other", "price_target_up"]}
{"id": 42584936, "time": "2024-12-19 08:51:38", "headline": "Chevron, Woodside Finalize Asset Swap In $400 Million Deal", "summary": "Chevron and Woodside finalize asset swap deal with cash payments and future opportunities for decarbonization and LNG production.", "symbols": ["CVX", "WDS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/24/12/42584936/chevron-secures-larger-north-west-shelf-stake-in-asset-swap-400m-payment-to-woodside", "tags": ["contract"]}
{"id": 42584989, "time": "2024-12-19 08:51:46", "headline": "UBS Maintains Neutral on Jabil, Raises Price Target to $152", "summary": "", "symbols": ["JBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42584989/ubs-maintains-neutral-on-jabil-raises-price-target-to-152", "tags": ["analyst_other", "price_target_up"]}
{"id": 42585699, "time": "2024-12-19 08:53:16", "headline": "Sonoco To Divest Business Unit To TOPPAN For $1.8 Billion, Focus On Core Packaging Businesses", "summary": "SON shares surge on agreement to sell Thermoformed &amp; Flexibles Packaging business for $1.8 billion. Proceeds will be used to repay debt. Deal aligns with portfolio simplification strategy.", "symbols": ["MDPL", "SON"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/asset-sales/24/12/42585699/sonoco-to-divest-business-unit-to-toppan-for-18-billion-focus-on-core-packaging-businesses", "tags": ["contract"]}
{"id": 42585710, "time": "2024-12-19 08:54:03", "headline": "Wedbush Reiterates Neutral on Lennar, Maintains $164 Price Target", "summary": "", "symbols": ["LEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42585710/wedbush-reiterates-neutral-on-lennar-maintains-164-price-target", "tags": ["analyst_other"]}
{"id": 42585715, "time": "2024-12-19 08:54:36", "headline": "US GDP Revised To 3.1%, Jobless Claims Dip More Than Expected, Treasury Yields Hit 7-Month High", "summary": "The US economy grew 3.1% in Q3 2024, surpassing the prior estimate of 2.8%. Consumer spending drove the growth, while inflation and labor market remain strong. Market sentiment rebounded after earlier selloff due to hawkish Fed meeting.", "symbols": ["SPY", "UUP"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42585715/us-gdp-upwardly-revised-to-31-in-q3-jobless-claims-drop-more-than-expected-treasury-yields-hit-7-month-highs", "tags": []}
{"id": 42585797, "time": "2024-12-19 08:57:04", "headline": "Darden Restaurants Stock Gains After Q2 Earnings Beat Estimates, Sales Jump 6%", "summary": "Darden Restaurants stock rises after Q2 earnings beat estimates, with 6% sales growth and an optimistic FY25 outlook.", "symbols": ["DRI"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/12/42585797/darden-restaurants-stock-gains-after-q2-earnings-beat-estimates-sales-jump-6", "tags": ["earnings", "guidance"]}
{"id": 42585798, "time": "2024-12-19 08:57:16", "headline": "Stephen Colbert Jokes Fartcoin Is 'Silent But Wealthy' As Meme Coin Hits $1 Billion All-Time High Valuation", "summary": "Fartcoin has reached an all-time high, sparking discussions on the legitimacy of meme coins. Its unconventional origin adds to the debate.", "symbols": [], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42585798/stephen-colbert-jokes-fartcoin-is-silent-but-wealthy-as-meme-coin-hits-1-billion-all-time-high-valuation", "tags": []}
{"id": 42585826, "time": "2024-12-19 08:58:13", "headline": "Stablecoins Can Redefine Global Finance, VanEck CEO Says: Are Banks Falling Behind?", "summary": "Stablecoins are transforming global finance, with growing adoption in payments and cross-border transactions.", "symbols": [], "source": "benzinga", "author": "Abbey Higginbotham", "url": "https://www.benzinga.com/24/12/42585826/stablecoins-redefining-global-finance-are-banks-falling-behind", "tags": ["management"]}
{"id": 42585829, "time": "2024-12-19 08:58:19", "headline": "Wedbush Maintains Outperform on HomeStreet, Raises Price Target to $15", "summary": "", "symbols": ["HMST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42585829/wedbush-maintains-outperform-on-homestreet-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 42585889, "time": "2024-12-19 09:00:05", "headline": "Mizuho Maintains Outperform on Verastem, Raises Price Target to $9", "summary": "", "symbols": ["VSTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42585889/mizuho-maintains-outperform-on-verastem-raises-price-target-to-9", "tags": ["analyst_other", "price_target_up"]}
{"id": 42585967, "time": "2024-12-19 09:00:14", "headline": "NICE Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)", "summary": " ", "symbols": ["NICE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42585967/nice-stock-a-deep-dive-into-analyst-perspectives-7-ratings", "tags": []}
{"id": 42585971, "time": "2024-12-19 09:00:15", "headline": "Looking Into Red Rock Resorts's Recent Short Interest", "summary": " ", "symbols": ["RRR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42585971/looking-into-red-rock-resortss-recent-short-interest", "tags": []}
{"id": 42585982, "time": "2024-12-19 09:00:18", "headline": "Shiba Inu Whale Nets $109M Profit After Holding Since 2020, But Why Is SHIB Price Falling?", "summary": "\u2018Dogecoin Killer&#39; Shiba Inu (CRYPTO: SHIB) is expected to see a major rally despite its current stagnation.", "symbols": ["DOGEUSD", "PEPEUSD", "SHIBUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42585982/shiba-inu-whale-nets-109m-profit-after-holding-since-2020-but-why-is-shib-price-falling", "tags": []}
{"id": 42585994, "time": "2024-12-19 09:00:21", "headline": "Peering Into CDW's Recent Short Interest", "summary": " ", "symbols": ["CDW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42585994/peering-into-cdws-recent-short-interest", "tags": []}
{"id": 42586003, "time": "2024-12-19 09:00:22", "headline": "Assessing Hanover Insurance Gr: Insights From 9 Financial Analysts", "summary": " ", "symbols": ["THG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42586003/assessing-hanover-insurance-gr-insights-from-9-financial-analysts", "tags": []}
{"id": 42586011, "time": "2024-12-19 09:00:24", "headline": "$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42586011/100-invested-in-this-stock-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42586019, "time": "2024-12-19 09:00:26", "headline": "This Tennant Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday", "summary": " ", "symbols": ["IONQ", "PLTR", "SWI", "TNC", "VIK"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42586019/this-tennant-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday", "tags": ["analyst_init"]}
{"id": 42586020, "time": "2024-12-19 09:00:27", "headline": "How Is The Market Feeling About Fabrinet?", "summary": " ", "symbols": ["FN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42586020/how-is-the-market-feeling-about-fabrinet", "tags": []}
{"id": 42586025, "time": "2024-12-19 09:00:34", "headline": "What 6 Analyst Ratings Have To Say About PPG Indus", "summary": " ", "symbols": ["PPG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42586025/what-6-analyst-ratings-have-to-say-about-ppg-indus", "tags": []}
{"id": 42586032, "time": "2024-12-19 09:00:52", "headline": "Deep Dive Into Penguin Solutions Stock: Analyst Perspectives (6 Ratings)", "summary": " ", "symbols": ["PENG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42586032/deep-dive-into-penguin-solutions-stock-analyst-perspectives-6-ratings", "tags": []}
{"id": 42586046, "time": "2024-12-19 09:01:00", "headline": "22 Analysts Assess Zoom Communications: What You Need To Know", "summary": " ", "symbols": ["ZM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42586046/22-analysts-assess-zoom-communications-what-you-need-to-know", "tags": []}
{"id": 42586064, "time": "2024-12-19 09:01:09", "headline": "Assessing SentinelOne: Insights From 18 Financial Analysts", "summary": " ", "symbols": ["S"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42586064/assessing-sentinelone-insights-from-18-financial-analysts", "tags": []}
{"id": 42586077, "time": "2024-12-19 09:01:18", "headline": "Zhibao Technology Announces Expansion Into Pet Insurance Market In China", "summary": "", "symbols": ["ZBAO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/24/12/42586077/zhibao-technology-announces-expansion-into-pet-insurance-market-in-china", "tags": []}
{"id": 42586101, "time": "2024-12-19 09:01:54", "headline": "Wedbush Maintains Outperform on Micron Technology, Lowers Price Target to $125", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586101/wedbush-maintains-outperform-on-micron-technology-lowers-price-target-to-125", "tags": ["analyst_other", "price_target_down"]}
{"id": 42586116, "time": "2024-12-19 09:02:24", "headline": "Merck Agrees To Purchase $50M Of Personalis Common Stock In A Private Placement At A Price Of $3.56 Per Share", "summary": "", "symbols": ["MRK", "PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586116/merck-agrees-to-purchase-50m-of-personalis-common-stock-in-a-private-placement-at-a-price-of-3-56-pe", "tags": ["offering"]}
{"id": 42586121, "time": "2024-12-19 09:02:26", "headline": "Mizuho Maintains Neutral on uniQure, Raises Price Target to $20", "summary": "", "symbols": ["QURE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586121/mizuho-maintains-neutral-on-uniqure-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 42586130, "time": "2024-12-19 09:02:45", "headline": "Sony Becomes KADOKAWA's Largest Shareholder - What's On the Cards?", "summary": "Sony and KADOKAWA CORPORATION formed a strategic alliance, with Sony taking 10% of shares and aiming to maximize IP value through joint initiatives.", "symbols": ["BLCR", "SONY", "SROI"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/24/12/42586130/sony-becomes-kadokawas-largest-shareholder-whats-on-the-cards", "tags": []}
{"id": 42586145, "time": "2024-12-19 09:03:13", "headline": "Personalis Signs Multi-Year Extension With Moderna To Utilize Its ImmunoID NeXT Platform And Technology For V940/mRNA-4157", "summary": "", "symbols": ["MRNA", "PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42586145/personalis-signs-multi-year-extension-with-moderna-to-utilize-its-immunoid-next-platform-and-tech", "tags": []}
{"id": 42586160, "time": "2024-12-19 09:03:56", "headline": "The Information: 'U.S. Prompts Nvidia, Supermicro Probe Into How Chips Ended Up in China'", "summary": "", "symbols": ["NVDA", "SMCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586160/the-information-u-s-prompts-nvidia-supermicro-probe-into-how-chips-ended-up-in-china", "tags": []}
{"id": 42586206, "time": "2024-12-19 09:05:34", "headline": "Mizuho Maintains Outperform on Booking Holdings, Raises Price Target to $6000", "summary": "", "symbols": ["BKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586206/mizuho-maintains-outperform-on-booking-holdings-raises-price-target-to-6000", "tags": ["analyst_other", "price_target_up"]}
{"id": 42586212, "time": "2024-12-19 09:05:50", "headline": "Are Outdated Rules Slowing Tokenized Assets? 'We Need To Align With Regulators'", "summary": "Industry leaders stress need for infrastructure and regulatory coordination to drive adoption of tokenized assets. Collaboration is key for success.", "symbols": [], "source": "benzinga", "author": "Abbey Higginbotham", "url": "https://www.benzinga.com/24/12/42586212/are-outdated-rules-slowing-tokenized-assets-we-need-to-align-with-regulators", "tags": []}
{"id": 42586366, "time": "2024-12-19 09:07:50", "headline": "This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday", "summary": " ", "symbols": ["AI", "CABA", "EWCZ", "NICE", "VRDN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42586366/this-c3-ai-analyst-turns-bearish-here-are-top-5-downgrades-for-thursday", "tags": ["analyst_down"]}
{"id": 42586380, "time": "2024-12-19 09:08:25", "headline": "HF Foods Group Inc. Names Felix Lin As Chief Executive Officer", "summary": "", "symbols": ["HFFG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586380/hf-foods-group-inc-names-felix-lin-as-chief-executive-officer", "tags": []}
{"id": 42586384, "time": "2024-12-19 09:08:49", "headline": "Mizuho Maintains Outperform on Micron Technology, Lowers Price Target to $115", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586384/mizuho-maintains-outperform-on-micron-technology-lowers-price-target-to-115", "tags": ["analyst_other", "price_target_down"]}
{"id": 42586386, "time": "2024-12-19 09:09:04", "headline": "RTX Invests In India: 1,000 New Jobs, Bengaluru Expansion, Plans For Global Talent Hub", "summary": "RTX Corp (NYSE: RTX) to add 1,000 employees in India by 2027. Focus on talent hub, plans to hire 300 engineers in 18 months and consolidate manufacturing sites.", "symbols": ["RTX"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/24/12/42586386/rtx-bets-big-on-india-1000-new-jobs-major-bengaluru-expansion-and-a-global-talent-hub-vision-report", "tags": []}
{"id": 42586515, "time": "2024-12-19 09:10:54", "headline": "Shuttle Pharma Enters Sponsored Research Agreement With University of California, San Francisco To Advance PSMA Development Program", "summary": "", "symbols": ["SHPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42586515/shuttle-pharma-enters-sponsored-research-agreement-with-university-of-california-san-francisco-to", "tags": ["contract"]}
{"id": 42586516, "time": "2024-12-19 09:10:59", "headline": "UBS Maintains Buy on Netflix, Raises Price Target to $1040", "summary": "", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586516/ubs-maintains-buy-on-netflix-raises-price-target-to-1040", "tags": ["analyst_other", "price_target_up"]}
{"id": 42586612, "time": "2024-12-19 09:11:29", "headline": "Accenture Q1 Earnings: Revenue And EPS Beat Bolstered By Consulting And Managed Services, Raises Annual Revenue Outlook", "summary": "Accenture surpasses Q1 FY2025 expectations with $17.69 billion in revenue and $3.59 EPS, driven by broad growth and $1.2 billion in generative AI bookings.", "symbols": ["ACN"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/12/42586612/accenture-delivers-q1-revenue-growth-bolstered-by-consulting-and-managed-services", "tags": ["earnings", "guidance"]}
{"id": 42586613, "time": "2024-12-19 09:11:41", "headline": "Arthur J. Gallagher & Co. Acquires Durham & Bates Agencies; Terms Of The Transaction Were Not Disclosed", "summary": "", "symbols": ["AJG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42586613/arthur-j-gallagher-co-acquires-durham-bates-agencies-terms-of-the-transaction-were-not-disclosed", "tags": ["merger"]}
{"id": 42586622, "time": "2024-12-19 09:12:01", "headline": "B of A Securities Downgrades Micron Technology to Neutral, Lowers Price Target to $110", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586622/b-of-a-securities-downgrades-micron-technology-to-neutral-lowers-price-target-to-110", "tags": ["analyst_down", "price_target_down"]}
{"id": 42586745, "time": "2024-12-19 09:12:35", "headline": "Motorola Solutions Awarded A 5-year Contract By The Norwegian Directorate For Civil Protection, Starting At The Beginning Of 2027, To Continue To Manage Norway's Nationwide Critical Communications Network, N\u00f8dnett, Valued At ~$160M", "summary": "", "symbols": ["MSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42586745/motorola-solutions-awarded-a-5-year-contract-by-the-norwegian-directorate-for-civil-protection-start", "tags": ["contract"]}
{"id": 42587073, "time": "2024-12-19 09:13:38", "headline": "Ansys Collaborates with Sony Semiconductor Solutions To Advance OEMs And Tier 1 Suppliers To Reliably Evaluate And Verify Performance Of ADAS/AV Functionality In All Weather And Lighting Conditions", "summary": "", "symbols": ["ANSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42587073/ansys-collaborates-with-sony-semiconductor-solutions-to-advance-oems-and-tier-1-suppliers-to-reliabl", "tags": []}
{"id": 42587084, "time": "2024-12-19 09:13:40", "headline": "UBS Maintains Neutral on RPM Intl, Raises Price Target to $130", "summary": "", "symbols": ["RPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42587084/ubs-maintains-neutral-on-rpm-intl-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 42587153, "time": "2024-12-19 09:13:54", "headline": "Wedbush Reiterates Outperform on Trade Desk, Maintains $135 Price Target", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42587153/wedbush-reiterates-outperform-on-trade-desk-maintains-135-price-target", "tags": ["analyst_other"]}
{"id": 42587261, "time": "2024-12-19 09:14:17", "headline": "FDA Issued A New Decision Determining The Tirzepatide Injection Shortage Is Resolved", "summary": "", "symbols": ["HIMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42587261/fda-issued-a-new-decision-determining-the-tirzepatide-injection-shortage-is-resolved", "tags": ["fda"]}
{"id": 42587462, "time": "2024-12-19 09:14:53", "headline": "B of A Securities Initiates Coverage On Camping World Holdings with Buy Rating, Announces Price Target of $30", "summary": "", "symbols": ["CWH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42587462/b-of-a-securities-initiates-coverage-on-camping-world-holdings-with-buy-rating-announces-price-targe", "tags": ["analyst_init"]}
{"id": 42587591, "time": "2024-12-19 09:15:09", "headline": "Great Lakes Announces $182M In Awarded Work", "summary": "", "symbols": ["GLDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42587591/great-lakes-announces-182m-in-awarded-work", "tags": ["contract"]}
{"id": 42587618, "time": "2024-12-19 09:15:14", "headline": "Castor Maritime Announces The Sale Of The M/V Gabriela A For A Price Of $19.3M With An Expected Net Gain Of $800K", "summary": "", "symbols": ["CTRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42587618/castor-maritime-announces-the-sale-of-the-mv-gabriela-a-for-a-price-of-19-3m-with-an-expected-net-ga", "tags": []}
{"id": 42587619, "time": "2024-12-19 09:15:15", "headline": "$100 Invested In Marvell Tech 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["MRVL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42587619/100-invested-in-marvell-tech-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42587780, "time": "2024-12-19 09:15:43", "headline": "UBS Maintains Buy on AT&T, Raises Price Target to $30", "summary": "", "symbols": ["T"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42587780/ubs-maintains-buy-on-at-t-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 42587962, "time": "2024-12-19 09:16:16", "headline": "WiMi Hologram Cloud Announces The Research Of A New Quantum Algorithm, The Holographic Quantum Linear Solver, Aiming To Provide A More Efficient And Resource-Efficient Quantum Algorithm For Solving The Quantum Linear System Problem", "summary": "", "symbols": ["WIMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42587962/wimi-hologram-cloud-announces-the-research-of-a-new-quantum-algorithm-the-holographic-quantum-linear", "tags": []}
{"id": 42588142, "time": "2024-12-19 09:16:44", "headline": "Nuwellis Regains Compliance With Nasdaq Listing Requirements", "summary": "", "symbols": ["NUWE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42588142/nuwellis-regains-compliance-with-nasdaq-listing-requirements", "tags": []}
{"id": 42588190, "time": "2024-12-19 09:16:53", "headline": "Benchmark Maintains Buy on Live Nation Entertainment, Raises Price Target to $160", "summary": "", "symbols": ["LYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42588190/benchmark-maintains-buy-on-live-nation-entertainment-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 42588404, "time": "2024-12-19 09:17:36", "headline": "Cintas Slips Despite Q2 Earnings Beat And Margin Growth: Details", "summary": "Cintas Corporation reports strong Q2 FY25 earnings, beating analyst expectations. Raised revenue and EPS guidance for FY25.", "symbols": ["CTAS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42588404/cintas-q2-results-beat-consensus-raising-fy25-revenue-and-eps-forecast", "tags": ["earnings", "guidance"]}
{"id": 42588435, "time": "2024-12-19 09:17:39", "headline": "TNF Pharmaceuticals Enters Collaborative Agreement With Renova Health For A Planned Trial Of Its TNF-\u03b1 Inhibitor Drug Isomyosamine", "summary": "", "symbols": ["TNFA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42588435/tnf-pharmaceuticals-enters-collaborative-agreement-with-renova-health-for-a-planned-trial-of-its-", "tags": ["fda", "contract"]}
{"id": 42588503, "time": "2024-12-19 09:17:49", "headline": "Optimum Bank Transfers Listing Of Common Stock From The Nasdaq Stock Market To The NYSE American, Expected To Begin Trading On December 31, 2024", "summary": "", "symbols": ["OPHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42588503/optimum-bank-transfers-listing-of-common-stock-from-the-nasdaq-stock-market-to-the-nyse-american-exp", "tags": []}
{"id": 42588578, "time": "2024-12-19 09:17:56", "headline": "UBS Maintains Neutral on Edison Intl, Lowers Price Target to $87", "summary": "", "symbols": ["EIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42588578/ubs-maintains-neutral-on-edison-intl-lowers-price-target-to-87", "tags": ["analyst_other", "price_target_down"]}
{"id": 42588679, "time": "2024-12-19 09:18:10", "headline": "Deutsche Bank Maintains Buy on Heico, Lowers Price Target to $266", "summary": "", "symbols": ["HEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42588679/deutsche-bank-maintains-buy-on-heico-lowers-price-target-to-266", "tags": ["analyst_other", "price_target_down"]}
{"id": 42589105, "time": "2024-12-19 09:19:13", "headline": "Neo-Concept International Group H1 2024 EPS $0.01; Revenue $10.15M", "summary": "", "symbols": ["NCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42589105/neo-concept-international-group-h1-2024-eps-0-01-revenue-10-15m", "tags": ["earnings"]}
{"id": 42589480, "time": "2024-12-19 09:20:25", "headline": "UBS Maintains Buy on Micron Technology, Lowers Price Target to $125", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42589480/ubs-maintains-buy-on-micron-technology-lowers-price-target-to-125", "tags": ["analyst_other", "price_target_down"]}
{"id": 42589521, "time": "2024-12-19 09:20:34", "headline": "Inspirato Chairman & CEO Payam Zamani Significantly Increases Ownership To ~8.2M Shares, Or ~50% Of Fully Diluted Shares Outstanding", "summary": "", "symbols": ["ISPO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42589521/inspirato-chairman-ceo-payam-zamani-significantly-increases-ownership-to-8-2m-shares-or-50-of-fully", "tags": ["offering", "management"]}
{"id": 42589921, "time": "2024-12-19 09:21:34", "headline": "Truist Securities Maintains Buy on AGCO, Raises Price Target to $116", "summary": "", "symbols": ["AGCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42589921/truist-securities-maintains-buy-on-agco-raises-price-target-to-116", "tags": ["analyst_other", "price_target_up"]}
{"id": 42590035, "time": "2024-12-19 09:21:47", "headline": "Lexaria Bioscience Announces It Has Begun Dosing In The Phase 1b, 12-Week Chronic Study GLP-1-H24-4 To Investigate Safety, Diabetes Control, And Weight Loss", "summary": "", "symbols": ["LEXX", "LEXXW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42590035/lexaria-bioscience-announces-it-has-begun-dosing-in-the-phase-1b-12-week-chronic-study-glp-1-h24-", "tags": []}
{"id": 42590080, "time": "2024-12-19 09:21:52", "headline": "UBS Maintains Buy on PG&E, Lowers Price Target to $24", "summary": "", "symbols": ["PCG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42590080/ubs-maintains-buy-on-pg-e-lowers-price-target-to-24", "tags": ["analyst_other", "price_target_down"]}
{"id": 42590488, "time": "2024-12-19 09:22:34", "headline": "Benchmark Reiterates Buy on Western Digital, Maintains $70 Price Target", "summary": "", "symbols": ["WDC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42590488/benchmark-reiterates-buy-on-western-digital-maintains-70-price-target", "tags": ["analyst_other"]}
{"id": 42590948, "time": "2024-12-19 09:23:30", "headline": "MicroVision Increases Production Capacity For Its MOVIA L Sensor", "summary": "", "symbols": ["MVIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42590948/microvision-increases-production-capacity-for-its-movia-l-sensor", "tags": []}
{"id": 42591070, "time": "2024-12-19 09:23:44", "headline": "LakeShore Biopharma H1 2025 EPS $0.02; Revenue $53.08M", "summary": "", "symbols": ["LSB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42591070/lakeshore-biopharma-h1-2025-eps-0-02-revenue-53-08m", "tags": ["earnings"]}
{"id": 42591307, "time": "2024-12-19 09:24:16", "headline": "Truist Securities Maintains Buy on CNH Industrial, Raises Price Target to $17", "summary": "", "symbols": ["CNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591307/truist-securities-maintains-buy-on-cnh-industrial-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 42591365, "time": "2024-12-19 09:24:40", "headline": "LakeShore Biopharma Sees FY25 Revenues To Be Between RMB 665 Million - RMB 700 Million, Indicating Growth Of 16%-22% YoY", "summary": "", "symbols": ["LSB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591365/lakeshore-biopharma-sees-fy25-revenues-to-be-between-rmb-665-million-rmb-700-million-indicating-grow", "tags": []}
{"id": 42591388, "time": "2024-12-19 09:25:34", "headline": "Benchmark Reiterates Buy on BioLife Solns, Maintains $30 Price Target", "summary": "", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591388/benchmark-reiterates-buy-on-biolife-solns-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 42589555, "time": "2024-12-19 09:20:44", "headline": "Omeros' Narsoplimab Met Pivotal Trial Primary Endpoint; Given These Results, Omeros Will Resubmit To FDA As Soon As Possible Its Narsoplimab Biologics License Application For TA-TMA", "summary": "", "symbols": ["OMER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42589555/omeros-narsoplimab-met-pivotal-trial-primary-endpoint-in-patients-treated-with-narsoplimab", "tags": ["fda"]}
{"id": 42591390, "time": "2024-12-19 09:26:14", "headline": "Truist Securities Maintains Buy on Caterpillar, Raises Price Target to $471", "summary": "", "symbols": ["CAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591390/truist-securities-maintains-buy-on-caterpillar-raises-price-target-to-471", "tags": ["analyst_other", "price_target_up"]}
{"id": 42591446, "time": "2024-12-19 09:27:48", "headline": "Truist Securities Maintains Hold on Cognex, Lowers Price Target to $42", "summary": "", "symbols": ["CGNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591446/truist-securities-maintains-hold-on-cognex-lowers-price-target-to-42", "tags": ["analyst_other", "price_target_down"]}
{"id": 42591448, "time": "2024-12-19 09:28:11", "headline": "Benchmark Reiterates Buy on Healthcare Services Group, Maintains $17 Price Target", "summary": "", "symbols": ["HCSG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591448/benchmark-reiterates-buy-on-healthcare-services-group-maintains-17-price-target", "tags": ["analyst_other"]}
{"id": 42591471, "time": "2024-12-19 09:29:47", "headline": "Zapp EV Opens New Microfactory Reference Site In Bangkok Free Trade Zone Industrial Park", "summary": "", "symbols": ["ZAPP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591471/zapp-ev-opens-new-microfactory-reference-site-in-bangkok-free-trade-zone-industrial-park", "tags": []}
{"id": 42591520, "time": "2024-12-19 09:30:12", "headline": "Here's How Much $100 Invested In Keurig Dr Pepper 15 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["KDP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42591520/heres-how-much-100-invested-in-keurig-dr-pepper-15-years-ago-would-be-worth-today", "tags": []}
{"id": 42591521, "time": "2024-12-19 09:30:15", "headline": "(BAC) - Analyzing Bank of America's Short Interest", "summary": " ", "symbols": ["BAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42591521/bac-analyzing-bank-of-americas-short-interest", "tags": []}
{"id": 42591524, "time": "2024-12-19 09:30:21", "headline": "Looking Into FedEx's Recent Short Interest", "summary": " ", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42591524/looking-into-fedexs-recent-short-interest", "tags": []}
{"id": 42591533, "time": "2024-12-19 09:30:26", "headline": "Truist Securities Maintains Hold on Cummins, Raises Price Target to $424", "summary": "", "symbols": ["CMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591533/truist-securities-maintains-hold-on-cummins-raises-price-target-to-424", "tags": ["analyst_other", "price_target_up"]}
{"id": 42591534, "time": "2024-12-19 09:30:26", "headline": "(WYNN) - Analyzing Wynn Resorts's Short Interest", "summary": " ", "symbols": ["WYNN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42591534/wynn-analyzing-wynn-resortss-short-interest", "tags": []}
{"id": 42591599, "time": "2024-12-19 09:32:24", "headline": "AT&T To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Thursday", "summary": " ", "symbols": ["BIRK", "BKNG", "CCCC", "DTM", "JBL", "MU", "PPG", "RH", "S", "T"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42591599/att-to-rally-more-than-33-here-are-10-top-analyst-forecasts-for-thursday", "tags": []}
{"id": 42591601, "time": "2024-12-19 09:32:45", "headline": "Benchmark Upgrades KULR Tech Gr to Buy, Raises Price Target to $5", "summary": "", "symbols": ["KULR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591601/benchmark-upgrades-kulr-tech-gr-to-buy-raises-price-target-to-5", "tags": ["analyst_up", "price_target_up"]}
{"id": 42591611, "time": "2024-12-19 09:33:43", "headline": "Currenc Group Shares Halted On Circuit Breaker To The Downside, Stock Now Up 75%", "summary": "", "symbols": ["CURR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42591611/currenc-group-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-75", "tags": ["halt"]}
{"id": 42591612, "time": "2024-12-19 09:33:52", "headline": "Polyrizon Shares Halted On Circuit Breaker", "summary": "", "symbols": ["PLRZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42591612/polyrizon-shares-halted-on-circuit-breaker", "tags": ["halt"]}
{"id": 42591618, "time": "2024-12-19 09:34:23", "headline": "The Glimpse Group Shares Halted On Circuit Breaker To The Upside, Stock Now Up 44.4%", "summary": "", "symbols": ["VRAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42591618/the-glimpse-group-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-44-4", "tags": ["halt"]}
{"id": 42591619, "time": "2024-12-19 09:34:24", "headline": "Nukkleus Shares Halted On Circuit Breaker", "summary": "", "symbols": ["NUKK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42591619/nukkleus-shares-halted-on-circuit-breaker", "tags": ["halt"]}
{"id": 42591632, "time": "2024-12-19 09:34:59", "headline": "Bio-Path Shares Halted On Circuit Breaker", "summary": "", "symbols": ["BPTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42591632/bio-path-shares-halted-on-circuit-breaker", "tags": ["halt"]}
{"id": 42591654, "time": "2024-12-19 09:36:19", "headline": "Knightscope Announces That It Has Closed 12 New Contracts In 7 U.S. States For Its K1B Emergency Communication Devices And Related Services", "summary": "", "symbols": ["KSCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42591654/knightscope-announces-that-it-has-closed-12-new-contracts-in-7-u-s-states-for-its-k1b-emergency-comm", "tags": []}
{"id": 42591689, "time": "2024-12-19 09:36:43", "headline": "Immix Biopharma Announces Initial Data From First Four Patients In NEXICART-2 US Study; Says All Four Patients Treated With NXC-201 Normalized Disease Markers Within 30 Days Of Dosing, Of Which, Two Are Already Classified As Complete", "summary": "", "symbols": ["IMMX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42591689/immix-biopharma-announces-initial-data-from-first-four-patients-in-nexicart-2-us-study-says-all-f", "tags": []}
{"id": 42591701, "time": "2024-12-19 09:38:36", "headline": "AppTech Payments Shares Halted On Circuit Breaker", "summary": "", "symbols": ["APCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42591701/apptech-payments-shares-halted-on-circuit-breaker", "tags": ["halt"]}
{"id": 42591703, "time": "2024-12-19 09:38:57", "headline": "FuelCell Energy Q4 Revenue Surges 120%, Backlog Climbs 13%, But Losses Persist Amid Restructuring Efforts", "summary": "FCEL reported Q4 2024 results with total revenues of $49.326 million, beating consensus. The company recently announced a global restructuring and has $318.0 million in cash.", "symbols": ["FCEL"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/news/earnings/24/12/42591703/fuelcell-energy-q4-revenue-surges-120-backlog-climbs-13-but-losses-persist-amid-restructuring-efforts", "tags": ["earnings"]}
{"id": 42591814, "time": "2024-12-19 09:40:45", "headline": "Afya To Acquire Faculdade \u00danica De Contagem For R$100M, Adding 60 Medical School Seats In Minas Gerais With Potential For 60 More, Targeting R$52.4M Annual Revenue And 3.3x EV/EBITDA By 2030", "summary": "", "symbols": ["AFYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42591814/afya-to-acquire-faculdade-nica-de-contagem-for-r-100m-adding-60-medical-school-seats-in-minas-gerais", "tags": ["earnings", "merger"]}
{"id": 42591842, "time": "2024-12-19 09:41:38", "headline": "Trio Petroleum Shares Halted On Circuit Breaker To The Downside, Stock Now Up 146.2%", "summary": "", "symbols": ["TPET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42591842/trio-petroleum-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-146-2", "tags": ["halt"]}
{"id": 42591894, "time": "2024-12-19 09:42:20", "headline": "Bio-Path Holdings Shares Halted On Circuit Breaker To The Downside, Stock Now Up 341%", "summary": "", "symbols": ["BPTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42591894/bio-path-holdings-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-341", "tags": ["halt"]}
{"id": 42591895, "time": "2024-12-19 09:42:33", "headline": "Currenc Group Shares Resume Trade", "summary": "", "symbols": ["CURR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42591895/currenc-group-shares-resume-trade", "tags": []}
{"id": 42591898, "time": "2024-12-19 09:42:48", "headline": "AppTech Payments Shares Resume Trade", "summary": "", "symbols": ["APCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42591898/apptech-payments-shares-resume-trade", "tags": []}
{"id": 42591910, "time": "2024-12-19 09:43:47", "headline": "AppTech Payments Shares Halted On Circuit Breaker To The Downside, Stock Now Up 183.5%", "summary": "", "symbols": ["APCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42591910/apptech-payments-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-183-5", "tags": ["halt"]}
{"id": 42591920, "time": "2024-12-19 09:43:58", "headline": "Trio Petroleum Shares Resume Trade", "summary": "", "symbols": ["TPET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42591920/trio-petroleum-shares-resume-trade", "tags": []}
{"id": 42592130, "time": "2024-12-19 09:45:18", "headline": "$1000 Invested In Booking Holdings 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["BKNG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42592130/1000-invested-in-booking-holdings-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42592147, "time": "2024-12-19 09:45:29", "headline": "Trio Petroleum Shares Halted On Circuit Breaker To The Upside, Stock Now Up 220.5%", "summary": "", "symbols": ["TPET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592147/trio-petroleum-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-220-5", "tags": ["halt"]}
{"id": 42592209, "time": "2024-12-19 09:46:21", "headline": "Behind the Scenes of Target's Latest Options Trends", "summary": " ", "symbols": ["TGT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42592209/behind-the-scenes-of-targets-latest-options-trends", "tags": []}
{"id": 42592221, "time": "2024-12-19 09:46:32", "headline": "AppLovin Unusual Options Activity For December 19", "summary": " ", "symbols": ["APP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42592221/applovin-unusual-options-activity-for-december-19", "tags": []}
{"id": 42592236, "time": "2024-12-19 09:46:48", "headline": "Wells Fargo Maintains Equal-Weight on General Mills, Lowers Price Target to $68", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42592236/wells-fargo-maintains-equal-weight-on-general-mills-lowers-price-target-to-68", "tags": ["analyst_other", "price_target_down"]}
{"id": 42592254, "time": "2024-12-19 09:47:07", "headline": "The Glimpse Group Shares Resume Trade", "summary": "", "symbols": ["VRAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592254/the-glimpse-group-shares-resume-trade", "tags": []}
{"id": 42592317, "time": "2024-12-19 09:48:39", "headline": "FDA Clarifies Policies For Compounders As National GLP-1 Supply Begins To Stabilize; Does Not Intend To Take Action Against Compounders For Violations Of FD&C Act Arising From Conditions That Depend On Tirzepatide Injection", "summary": "", "symbols": ["HIMS", "LLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42592317/fda-clarifies-policies-for-compounders-as-national-glp-1-supply-begins-to-stabilize-does-not-inte", "tags": ["fda"]}
{"id": 42592331, "time": "2024-12-19 09:49:00", "headline": "Wells Fargo Maintains Overweight on Immunovant, Lowers Price Target to $45", "summary": "", "symbols": ["IMVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42592331/wells-fargo-maintains-overweight-on-immunovant-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 42592360, "time": "2024-12-19 09:49:59", "headline": "PainReform Shares Halted On Circuit Breaker To The Upside, Stock Now Up 359.4%", "summary": "", "symbols": ["PRFX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592360/painreform-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-359-4", "tags": ["halt"]}
{"id": 42592403, "time": "2024-12-19 09:51:13", "headline": "Bio-Path Holdings Shares Resume Trade", "summary": "", "symbols": ["BPTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592403/bio-path-holdings-shares-resume-trade", "tags": []}
{"id": 42592406, "time": "2024-12-19 09:51:15", "headline": "Wells Fargo Maintains Equal-Weight on Incyte, Raises Price Target to $70", "summary": "", "symbols": ["INCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42592406/wells-fargo-maintains-equal-weight-on-incyte-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 42592421, "time": "2024-12-19 09:51:35", "headline": "ConAgra Brands Stock Slips After Lowering FY25 Earnings Outlook, CEO Cautions Of Headwinds Ahead", "summary": "ConAgra Brands stock dips after lowering its FY25 EPS outlook, citing higher inflation and unfavorable foreign exchange rates as headwinds.", "symbols": ["CAG"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/12/42592421/conagra-brands-stock-slips-after-lowering-fy25-outlook-ceo-cautions-of-headwinds-ahead", "tags": ["earnings", "guidance", "management"]}
{"id": 42592477, "time": "2024-12-19 09:52:25", "headline": "Wells Fargo Maintains Equal-Weight on Kezar Life Sciences, Lowers Price Target to $9", "summary": "", "symbols": ["KZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42592477/wells-fargo-maintains-equal-weight-on-kezar-life-sciences-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 42592478, "time": "2024-12-19 09:52:25", "headline": "DevvStream Shares Halted On Circuit Breaker To The Downside, Stock Now Up 18.5%", "summary": "", "symbols": ["DEVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592478/devvstream-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-18-5", "tags": ["halt"]}
{"id": 42592528, "time": "2024-12-19 09:53:48", "headline": "PainReform Shares Resume Trade", "summary": "", "symbols": ["PRFX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592528/painreform-shares-resume-trade", "tags": []}
{"id": 42592551, "time": "2024-12-19 09:54:09", "headline": "The Glimpse Group Shares Resume Trading", "summary": "", "symbols": ["VRAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592551/the-glimpse-group-shares-resume-trading", "tags": []}
{"id": 42592563, "time": "2024-12-19 09:54:30", "headline": "Wells Fargo Maintains Equal-Weight on Zymeworks, Raises Price Target to $14", "summary": "", "symbols": ["ZYME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42592563/wells-fargo-maintains-equal-weight-on-zymeworks-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 42592629, "time": "2024-12-19 09:56:16", "headline": "Wells Fargo Maintains Overweight on argenx, Raises Price Target to $723", "summary": "", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42592629/wells-fargo-maintains-overweight-on-argenx-raises-price-target-to-723", "tags": ["analyst_other", "price_target_up"]}
{"id": 42592671, "time": "2024-12-19 09:56:57", "headline": "Nukkleus Shares Halted On Circuit Breaker To The Upside, Stock Now Up 27.6%", "summary": "", "symbols": ["NUKK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592671/nukkleus-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-27-6", "tags": ["halt"]}
{"id": 42592683, "time": "2024-12-19 09:57:13", "headline": "PainReform Shares Halted On Circuit Breaker To The Upside, Stock Now Up 463.6%", "summary": "", "symbols": ["PRFX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592683/painreform-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-463-6", "tags": ["halt"]}
{"id": 42592734, "time": "2024-12-19 09:58:40", "headline": "Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $19", "summary": "", "symbols": ["ITOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42592734/wells-fargo-maintains-overweight-on-iteos-therapeutics-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 42592760, "time": "2024-12-19 09:59:20", "headline": "Intel Stock Charts Suggests Bearish Trend, Fundamentals Hint At Potential Rebound", "summary": "Despite bad press and a declining stock price, Intel generates $50 billion in annual revenue and maintains a healthy debt-to-equity ratio.", "symbols": ["AMD", "AMZN", "INTC"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/12/42592760/intel-stock-fundamentals-hint-at-potential-rebound", "tags": ["analyst_other", "earnings"]}
{"id": 42592774, "time": "2024-12-19 09:59:45", "headline": "AppTech Payments Shares Halted On Circuit Breaker To The Upside, Stock Now Up 236%", "summary": "", "symbols": ["APCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42592774/apptech-payments-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-236", "tags": ["halt"]}
{"id": 42592836, "time": "2024-12-19 10:00:13", "headline": "Performance Comparison: NVIDIA And Competitors In Semiconductors &amp; Semiconductor Equipment Industry", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42592836/performance-comparison-nvidia-and-competitors-in-semiconductors-amp-semiconductor-equipment-industr", "tags": []}
{"id": 42592841, "time": "2024-12-19 10:00:14", "headline": "Price Over Earnings Overview: WillScot Holdings", "summary": " ", "symbols": ["WSC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42592841/price-over-earnings-overview-willscot-holdings", "tags": ["earnings"]}
{"id": 42592847, "time": "2024-12-19 10:00:16", "headline": "$100 Invested In TransMedics Gr 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["TMDX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42592847/100-invested-in-transmedics-gr-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42592850, "time": "2024-12-19 10:00:22", "headline": "Evaluating Microsoft Against Peers In Software Industry", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42592850/evaluating-microsoft-against-peers-in-software-industry", "tags": []}
{"id": 42592861, "time": "2024-12-19 10:00:30", "headline": "In-Depth Analysis: Apple Versus Competitors In Technology Hardware, Storage &amp; Peripherals Industry", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42592861/in-depth-analysis-apple-versus-competitors-in-technology-hardware-storage-amp-peripherals-industry", "tags": []}
{"id": 42592865, "time": "2024-12-19 10:00:38", "headline": "Industry Comparison: Evaluating Meta Platforms Against Competitors In Interactive Media &amp; Services Industry", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42592865/industry-comparison-evaluating-meta-platforms-against-competitors-in-interactive-media-amp-services", "tags": []}
{"id": 42592873, "time": "2024-12-19 10:00:48", "headline": "Comparative Study: Amazon.com And Industry Competitors In Broadline Retail Industry", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42592873/comparative-study-amazon-com-and-industry-competitors-in-broadline-retail-industry", "tags": []}
{"id": 42593013, "time": "2024-12-19 10:02:35", "headline": "Luigi Mangione Faces Extradition, Possible Federal Charges May Carry Death Penalty", "summary": "Luigi Mangione faces an extradition hearing Thursday and could be arraigned in New York if a judge approves the request.", "symbols": ["DIS", "UNH"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/legal/24/12/42593013/luigi-mangione-faces-extradition-possible-federal-charges-may-carry-death-penalty", "tags": []}
{"id": 42593033, "time": "2024-12-19 10:03:04", "headline": "'Near-Instant Finality': Are Stablecoins Ready To Fix Settlement Inefficiencies?", "summary": "Stablecoins offer faster settlements &amp; reduced costs in financial systems. But regulatory, infrastructure &amp; institutional challenges remain.", "symbols": [], "source": "benzinga", "author": "Abbey Higginbotham", "url": "https://www.benzinga.com/news/events/24/12/42593033/near-instant-finality-are-stablecoins-ready-to-fix-settlement-inefficiencies", "tags": ["legal"]}
{"id": 42593057, "time": "2024-12-19 10:03:31", "headline": "USA Existing Home Sales For November 4.15M Vs 4.09M Est.; 3.96M Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42593057/usa-existing-home-sales-for-november-4-15m-vs-4-09m-est-3-96m-prior", "tags": []}
{"id": 42593069, "time": "2024-12-19 10:03:43", "headline": "Wells Fargo Maintains Underweight on Sirius XM Holdings, Lowers Price Target to $16", "summary": "", "symbols": ["SIRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593069/wells-fargo-maintains-underweight-on-sirius-xm-holdings-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 42593077, "time": "2024-12-19 10:04:02", "headline": "USA Existing Home Sales (MoM) For November 4.8% Vs 3.4% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42593077/usa-existing-home-sales-mom-for-november-4-8-vs-3-4-prior", "tags": []}
{"id": 42593099, "time": "2024-12-19 10:04:23", "headline": "US Leading Index (MoM) For November 0.3% Vs -0.1% Est.; -0.4% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42593099/us-leading-index-mom-for-november-0-3-vs-0-1-est-0-4-prior", "tags": []}
{"id": 42593112, "time": "2024-12-19 10:04:46", "headline": "AppTech Payments Shares Resume Trading", "summary": "", "symbols": ["APCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42593112/apptech-payments-shares-resume-trading", "tags": []}
{"id": 42593159, "time": "2024-12-19 10:05:11", "headline": "DevvStream Shares Halted On Circuit Breaker To The Downside, Stock Now Down -4.09%", "summary": "", "symbols": ["DEVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42593159/devvstream-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-4-09", "tags": ["halt"]}
{"id": 42593190, "time": "2024-12-19 10:05:40", "headline": "Wells Fargo Maintains Overweight on Micron Technology, Lowers Price Target to $140", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593190/wells-fargo-maintains-overweight-on-micron-technology-lowers-price-target-to-140", "tags": ["analyst_other", "price_target_down"]}
{"id": 42593443, "time": "2024-12-19 10:10:03", "headline": "DA Davidson Maintains Neutral on Tripadvisor, Maintains $16 Price Target", "summary": "", "symbols": ["TRIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593443/da-davidson-maintains-neutral-on-tripadvisor-maintains-16-price-target", "tags": ["analyst_other"]}
{"id": 42593562, "time": "2024-12-19 10:11:21", "headline": "Truist Securities Maintains Buy on Deere, Raises Price Target to $550", "summary": "", "symbols": ["DE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593562/truist-securities-maintains-buy-on-deere-raises-price-target-to-550", "tags": ["analyst_other", "price_target_up"]}
{"id": 42593616, "time": "2024-12-19 10:11:57", "headline": "MSA Safety Makes Analyst's Best-Of-Breed Bison List: 'Strong Long-Term Value Creation Potential'", "summary": "DA Davidson initiated coverage of MSA Safety with Buy rating. The company has strong growth potential in safety equipment market.", "symbols": ["MSA"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/24/12/42593616/why-msa-safety-is-added-to-da-davidsons-best-of-breed-bison-list", "tags": []}
{"id": 42593691, "time": "2024-12-19 10:12:29", "headline": "Truist Securities Maintains Buy on Fluor, Raises Price Target to $66", "summary": "", "symbols": ["FLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593691/truist-securities-maintains-buy-on-fluor-raises-price-target-to-66", "tags": ["analyst_other", "price_target_up"]}
{"id": 42585846, "time": "2024-12-19 08:59:45", "headline": "TOMI Environmental Solutions shares are trading higher after the company announced it's ready to deploy Steramist in response to California's recent declaration of a state of emergency due to the H5N1 bird flu outbreak.", "summary": "", "symbols": ["TOMZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42585846/tomi-environmental-solutions-shares-are-trading-higher-after-the-company-announced-its-ready-to-depl", "tags": ["why_moving"]}
{"id": 42593724, "time": "2024-12-19 10:13:36", "headline": "JMP Securities Reiterates Market Outperform on Churchill Downs, Maintains $166 Price Target", "summary": "", "symbols": ["CHDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593724/jmp-securities-reiterates-market-outperform-on-churchill-downs-maintains-166-price-target", "tags": ["analyst_other"]}
{"id": 42593725, "time": "2024-12-19 10:13:37", "headline": "Truist Securities Maintains Buy on Fortive, Raises Price Target to $90", "summary": "", "symbols": ["FTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593725/truist-securities-maintains-buy-on-fortive-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 42577199, "time": "2024-12-19 08:34:23", "headline": "BigBear.Ai shares are trading higher after the company announced it secured an HSA Oasis + IDIQ contract for federal civilian and defense agencies.", "summary": "", "symbols": ["BBAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42577199/bigbear-ai-shares-are-trading-higher-after-the-company-announced-it-secured-an-hsa-oasis-idiq-contra", "tags": ["why_moving", "contract"]}
{"id": 42593740, "time": "2024-12-19 10:13:55", "headline": "Paychex Delivers Q2 Earnings Beat As HR Solutions Demand Stays Strong", "summary": "Paychex, Inc reported Q2 results with 5% sales growth and $1.14 adjusted EPS. Fiscal 2025 outlook unchanged with 4%-5.5% revenue growth.", "symbols": ["PAYX"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/24/12/42593740/paychex-maintains-fiscal-2025-outlook-as-q2-results-show-mixed-performance-across-key-revenue-segments", "tags": ["earnings", "guidance"]}
{"id": 42593774, "time": "2024-12-19 10:14:45", "headline": "Truist Securities Maintains Buy on Illinois Tool Works, Raises Price Target to $318", "summary": "", "symbols": ["ITW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593774/truist-securities-maintains-buy-on-illinois-tool-works-raises-price-target-to-318", "tags": ["analyst_other", "price_target_up"]}
{"id": 42593840, "time": "2024-12-19 10:15:14", "headline": "Peering Into Norfolk Southern's Recent Short Interest", "summary": " ", "symbols": ["NSC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42593840/peering-into-norfolk-southerns-recent-short-interest", "tags": []}
{"id": 42593842, "time": "2024-12-19 10:15:16", "headline": "$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["WING"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42593842/100-invested-in-this-stock-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42593843, "time": "2024-12-19 10:15:19", "headline": "Peering Into Advanced Drainage Systems's Recent Short Interest", "summary": " ", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42593843/peering-into-advanced-drainage-systemss-recent-short-interest", "tags": []}
{"id": 42593845, "time": "2024-12-19 10:15:24", "headline": "Peering Into Toyota Motor's Recent Short Interest", "summary": " ", "symbols": ["TM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42593845/peering-into-toyota-motors-recent-short-interest", "tags": []}
{"id": 42593865, "time": "2024-12-19 10:15:45", "headline": "JMP Securities Reiterates Market Outperform on Elevation Oncology, Maintains $7 Price Target", "summary": "", "symbols": ["ELEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593865/jmp-securities-reiterates-market-outperform-on-elevation-oncology-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 42593867, "time": "2024-12-19 10:15:47", "headline": "DA Davidson Maintains Buy on e.l.f. Beauty, Maintains $170 Price Target", "summary": "", "symbols": ["ELF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593867/da-davidson-maintains-buy-on-e-l-f-beauty-maintains-170-price-target", "tags": ["analyst_other"]}
{"id": 42593878, "time": "2024-12-19 10:15:55", "headline": "Truist Securities Maintains Hold on Jacobs Solutions, Raises Price Target to $142", "summary": "", "symbols": ["J"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593878/truist-securities-maintains-hold-on-jacobs-solutions-raises-price-target-to-142", "tags": ["analyst_other", "price_target_up"]}
{"id": 42593957, "time": "2024-12-19 10:17:15", "headline": "Truist Securities Maintains Buy on MasTec, Raises Price Target to $189", "summary": "", "symbols": ["MTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593957/truist-securities-maintains-buy-on-mastec-raises-price-target-to-189", "tags": ["analyst_other", "price_target_up"]}
{"id": 42593961, "time": "2024-12-19 10:17:22", "headline": "Alpha Modus Files Patent Infringement Lawsuit Against Wakefern Food Corp And Shelf Nine; Lawsuit Was Filed Alleging Infringement Of Several Alpha Modus Patents Pertaining To The Company's '571 Patent Portfolio, '825 Patent Portfolio, '672 Patent Portfolio, '890 Patent Portfolio And '880 Patent Portfolio", "summary": "", "symbols": ["AMOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593961/alpha-modus-files-patent-infringement-lawsuit-against-wakefern-food-corp-and-shelf-nine-lawsuit-was", "tags": ["legal"]}
{"id": 42593977, "time": "2024-12-19 10:18:01", "headline": "JMP Securities Reiterates Market Outperform on Chicago Atlantic Real, Maintains $20 Price Target", "summary": "", "symbols": ["REFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42593977/jmp-securities-reiterates-market-outperform-on-chicago-atlantic-real-maintains-20-price-target", "tags": ["analyst_other"]}
{"id": 42594003, "time": "2024-12-19 10:18:37", "headline": "Truist Securities Maintains Hold on Medical Properties Trust, Lowers Price Target to $4", "summary": "", "symbols": ["MPW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594003/truist-securities-maintains-hold-on-medical-properties-trust-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 42594045, "time": "2024-12-19 10:19:42", "headline": "Truist Securities Maintains Hold on Oshkosh, Raises Price Target to $116", "summary": "", "symbols": ["OSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594045/truist-securities-maintains-hold-on-oshkosh-raises-price-target-to-116", "tags": ["analyst_other", "price_target_up"]}
{"id": 42594052, "time": "2024-12-19 10:19:55", "headline": "Polyrizon Shares Resume Trade, Stock Now Down -35%", "summary": "", "symbols": ["PLRZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42594052/polyrizon-shares-resume-trade-stock-now-down-35", "tags": []}
{"id": 42594067, "time": "2024-12-19 10:20:20", "headline": "Nukkleus Shares Resume Trade, Stock Now Down -14%", "summary": "", "symbols": ["NUKK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42594067/nukkleus-shares-resume-trade-stock-now-down-14", "tags": []}
{"id": 42594082, "time": "2024-12-19 10:20:45", "headline": "Nukkleus Shares Halted On Circuit Breaker To The Downside, Stock Now Down -14%", "summary": "", "symbols": ["NUKK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42594082/nukkleus-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-14", "tags": ["halt"]}
{"id": 42594097, "time": "2024-12-19 10:21:15", "headline": "Truist Securities Maintains Hold on PACCAR, Raises Price Target to $110", "summary": "", "symbols": ["PCAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594097/truist-securities-maintains-hold-on-paccar-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 42594168, "time": "2024-12-19 10:22:20", "headline": "\"G-7 Considering Options To Harden Price Cap On Russian Oil; Options Include Lowering The Cap Or Replacing It With A Ban; Ukraine's Allies Seek To Further Limit Moscow's Revenues; Options Under Consideration Also Include Lowering Price Threshold On Russian Oil From Current $60 To About $40\" - Bloomberg News", "summary": "", "symbols": ["SPY", "USO", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42594168/g-7-considering-options-to-harden-price-cap-on-russian-oil-options-include-loweri", "tags": []}
{"id": 42594170, "time": "2024-12-19 10:22:24", "headline": "JMP Securities Reiterates Market Outperform on Savara, Maintains $9 Price Target", "summary": "", "symbols": ["SVRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594170/jmp-securities-reiterates-market-outperform-on-savara-maintains-9-price-target", "tags": ["analyst_other"]}
{"id": 42594179, "time": "2024-12-19 10:22:39", "headline": "Truist Securities Maintains Buy on Parker Hannifin, Raises Price Target to $842", "summary": "", "symbols": ["PH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594179/truist-securities-maintains-buy-on-parker-hannifin-raises-price-target-to-842", "tags": ["analyst_other", "price_target_up"]}
{"id": 42594213, "time": "2024-12-19 10:23:48", "headline": "Truist Securities Maintains Buy on Quanta Services, Raises Price Target to $399", "summary": "", "symbols": ["PWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594213/truist-securities-maintains-buy-on-quanta-services-raises-price-target-to-399", "tags": ["analyst_other", "price_target_up"]}
{"id": 42594237, "time": "2024-12-19 10:25:10", "headline": "Truist Securities Maintains Buy on Shake Shack, Raises Price Target to $147", "summary": "", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594237/truist-securities-maintains-buy-on-shake-shack-raises-price-target-to-147", "tags": ["analyst_other", "price_target_up"]}
{"id": 42594282, "time": "2024-12-19 10:26:18", "headline": "Truist Securities Maintains Buy on Terex, Lowers Price Target to $58", "summary": "", "symbols": ["TEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594282/truist-securities-maintains-buy-on-terex-lowers-price-target-to-58", "tags": ["analyst_other", "price_target_down"]}
{"id": 42594334, "time": "2024-12-19 10:27:36", "headline": "Truist Securities Maintains Buy on United Rentals, Raises Price Target to $965", "summary": "", "symbols": ["URI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594334/truist-securities-maintains-buy-on-united-rentals-raises-price-target-to-965", "tags": ["analyst_other", "price_target_up"]}
{"id": 42594359, "time": "2024-12-19 10:28:35", "headline": "Micron Stock Is Moving Lower Thursday: What's Driving The Action?", "summary": "Micron Technology Inc (NASDAQ:MU) shares are trading lower Thursday after the company reported mixed earnings results and issued weak guidance for the current quarter. Multiple analysts also lowered price targets following the print.", "symbols": ["MU"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/24/12/42594359/micron-stock-is-moving-lower-thursday-whats-driving-the-action", "tags": ["earnings", "guidance", "why_moving"]}
{"id": 42594375, "time": "2024-12-19 10:29:01", "headline": "Saia Powers Up With Tesla Semis - Details Here", "summary": "Saia announced a partnership with Tesla to add electric Tesla Semi trucks to its fleet.", "symbols": ["SAIA"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/12/42594375/whats-going-on-with-saia-stock-after-inking-new-pact-with-tesla", "tags": ["contract"]}
{"id": 42594398, "time": "2024-12-19 10:29:28", "headline": "Truist Securities Maintains Hold on Zebra Technologies, Raises Price Target to $408", "summary": "", "symbols": ["ZBRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594398/truist-securities-maintains-hold-on-zebra-technologies-raises-price-target-to-408", "tags": ["analyst_other", "price_target_up"]}
{"id": 42594440, "time": "2024-12-19 10:30:09", "headline": "US Stocks Higher, Micron Reports Downbeat Sales", "summary": " ", "symbols": ["AEMD", "BPTH", "LITM", "MU", "PRFX", "TPET", "WLGS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42594440/us-stocks-higher-micron-reports-downbeat-sales", "tags": []}
{"id": 42594442, "time": "2024-12-19 10:30:12", "headline": "Here's How Much $100 Invested In Cleanspark 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["CLSK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42594442/heres-how-much-100-invested-in-cleanspark-5-years-ago-would-be-worth-today", "tags": []}
{"id": 42594480, "time": "2024-12-19 10:30:43", "headline": "This Is What Whales Are Betting On Quantum Computing", "summary": " ", "symbols": ["QUBT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42594480/this-is-what-whales-are-betting-on-quantum-computing", "tags": []}
{"id": 42594488, "time": "2024-12-19 10:30:49", "headline": "Smart Money Is Betting Big In IREN Options", "summary": " ", "symbols": ["IREN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42594488/smart-money-is-betting-big-in-iren-options", "tags": []}
{"id": 42594493, "time": "2024-12-19 10:30:55", "headline": "Decoding IonQ's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42594493/decoding-ionqs-options-activity-whats-the-big-picture", "tags": []}
{"id": 42594505, "time": "2024-12-19 10:31:04", "headline": "What's Going On With BigBear.AI Stock Thursday?", "summary": "BigBear.ai Inc (NYSE:BBAI) shares are trading higher Thursday after the company announced it secured a contract for federal civilian and defense agencies.", "symbols": ["BBAI"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/contracts/24/12/42594505/whats-going-on-with-bigbear-ai-stock-thursday", "tags": ["why_moving", "contract"]}
{"id": 42594555, "time": "2024-12-19 10:31:58", "headline": "Canaccord Genuity Maintains Hold on Worthington Enterprises, Raises Price Target to $49", "summary": "", "symbols": ["WOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594555/canaccord-genuity-maintains-hold-on-worthington-enterprises-raises-price-target-to-49", "tags": ["analyst_other", "price_target_up"]}
{"id": 42594556, "time": "2024-12-19 10:32:00", "headline": "US Natural Gas Storage: -125B vs -123B Est.", "summary": "", "symbols": ["UNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594556/us-natural-gas-storage-125b-vs-123b-est", "tags": []}
{"id": 42594671, "time": "2024-12-19 10:33:49", "headline": "Nvni Group Shares Resume Trade, Then Again Halted On Circuit Breaker To The Upside, Stock Now Up 134.4%", "summary": "", "symbols": ["NVNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42594671/nvni-group-shares-resume-trade-then-again-halted-on-circuit-breaker-to-the-upside-stock-now-up-134-", "tags": ["halt"]}
{"id": 42594707, "time": "2024-12-19 10:34:51", "headline": "Compass Point Maintains Neutral on American Express, Raises Price Target to $325", "summary": "", "symbols": ["AXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594707/compass-point-maintains-neutral-on-american-express-raises-price-target-to-325", "tags": ["analyst_other", "price_target_up"]}
{"id": 42594713, "time": "2024-12-19 10:35:06", "headline": "Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["LSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42594713/trading-halt-halt-status-updated-at-10-35-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 42594729, "time": "2024-12-19 10:35:20", "headline": "XChange TEC.INC Shares Halted On Circuit Breaker To The Upside, Stock Now Up 201.1%", "summary": "", "symbols": ["XHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42594729/xchange-tec-inc-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-201-1", "tags": ["halt"]}
{"id": 42592818, "time": "2024-12-19 10:00:10", "headline": "Chainlink Falls More Than 8% In 24 hours", "summary": "Chainlink&#39;s (CRYPTO: LINK) price has decreased 8.53% over the past 24 hours to $24.59, continuing its downward trend over the past week of -13.0%, moving from $28.4 to its current price. ", "symbols": ["LINKUSD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cryptocurrency/24/12/42592818/test0-9931786450199349-chainlink-falls-more-than-8-in-24-hours", "tags": []}
{"id": 42594796, "time": "2024-12-19 10:36:33", "headline": "Bio-Path Holdings Shares Resume", "summary": "", "symbols": ["BPTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42594796/bio-path-holdings-shares-resume", "tags": []}
{"id": 42594797, "time": "2024-12-19 10:36:44", "headline": "Trump Would 'Lead The Charge' To Scrap Debt Ceiling: 30-Year Treasury Bonds Slide To 2024 Lows, Stocks Cut Gains", "summary": "Trump advocates for removal of US debt ceiling, causing bond market shock and tempering Wall Street gains. Uncertain how Congress will react.", "symbols": ["SPY", "TLT"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/24/12/42594797/trump-wants-to-get-rid-of-the-debt-ceiling-30-year-treasury-bonds-fall-to-2024-lows-stocks-cut-gains", "tags": []}
{"id": 42594809, "time": "2024-12-19 10:36:45", "headline": "RBC Capital Downgrades Pactiv Evergreen to Sector Perform, Raises Price Target to $18", "summary": "", "symbols": ["PTVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594809/rbc-capital-downgrades-pactiv-evergreen-to-sector-perform-raises-price-target-to-18", "tags": ["analyst_down", "price_target_up"]}
{"id": 42594867, "time": "2024-12-19 10:37:30", "headline": "Pegasus Airlines Orders Up To 200 Boeing 737-10 Airplanes; Purchase Includes A Firm Order For 100 737-10 Jets, Plus Options For 100 More", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42594867/pegasus-airlines-orders-up-to-200-boeing-737-10-airplanes-purchase-includes-a-firm-order-for-100-737", "tags": []}
{"id": 42594872, "time": "2024-12-19 10:38:26", "headline": "Bio-Path Shares Halted On Circuit Breaker, Stock Now Up 278.2%", "summary": "", "symbols": ["BPTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42594872/bio-path-shares-halted-on-circuit-breaker-stock-now-up-278-2", "tags": ["halt"]}
{"id": 42594875, "time": "2024-12-19 10:38:50", "headline": "Nvni Group Shares Resume Trade", "summary": "", "symbols": ["NVNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42594875/nvni-group-shares-resume-trade", "tags": []}
{"id": 42594883, "time": "2024-12-19 10:39:50", "headline": "Nvni Group Shares Halted On Circuit Breaker To The Downside, Stock Now Up 128.1%", "summary": "", "symbols": ["NVNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42594883/nvni-group-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-128-1", "tags": ["halt"]}
{"id": 42594884, "time": "2024-12-19 10:40:02", "headline": "XChange TEC.INC Shares Resume Trade", "summary": "", "symbols": ["XHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42594884/xchange-tec-inc-shares-resume-trade", "tags": []}
{"id": 42595024, "time": "2024-12-19 10:41:37", "headline": "RBC Capital Downgrades General Dynamics to Sector Perform, Lowers Price Target to $290", "summary": "", "symbols": ["GD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595024/rbc-capital-downgrades-general-dynamics-to-sector-perform-lowers-price-target-to-290", "tags": ["analyst_down", "price_target_down"]}
{"id": 42595089, "time": "2024-12-19 10:44:02", "headline": "RBC Capital Upgrades Hexcel to Outperform, Raises Price Target to $74", "summary": "", "symbols": ["HXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595089/rbc-capital-upgrades-hexcel-to-outperform-raises-price-target-to-74", "tags": ["analyst_up", "price_target_up"]}
{"id": 42595095, "time": "2024-12-19 10:44:20", "headline": "What's Going On With Dollar Tree Stock Today?", "summary": "Dollar Tree appoints Michael C. Creedon as permanent CEO, with shares slightly lower in amid a challenging year for the stock.", "symbols": ["DLTR", "RSPS"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/12/42595095/whats-going-on-with-dollar-tree-stock-today", "tags": ["why_moving", "management"]}
{"id": 42595123, "time": "2024-12-19 10:44:56", "headline": "FedEx Charts Flash Bearish Signals Ahead Of Q2 Earnings, Analysts See 26% Upside", "summary": "FedEx reports Q2 earnings on Thursday. EPS expected at $3.91 and revenue at $22.11 billion. Stock is down 1.45% in past year.", "symbols": ["FDX"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/12/42595123/fedex-charts-flash-bearish-signals-ahead-of-q2-earnings-analysts-see-26-upside", "tags": ["earnings"]}
{"id": 42595174, "time": "2024-12-19 10:45:16", "headline": "If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["EAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42595174/if-you-invested-100-in-this-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 42595190, "time": "2024-12-19 10:45:39", "headline": "Leishen Energy Shares Open For Trade At $4.25/Share; IPO Priced At $4/Share", "summary": "", "symbols": ["LSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42595190/leishen-energy-shares-open-for-trade-at-4-25share-ipo-priced-at-4share", "tags": []}
{"id": 42595209, "time": "2024-12-19 10:46:01", "headline": "Leishen Energy Shares Halted On Circuit Breaker To The Downside", "summary": "", "symbols": ["LSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42595209/leishen-energy-shares-halted-on-circuit-breaker-to-the-downside", "tags": ["halt"]}
{"id": 42595215, "time": "2024-12-19 10:46:06", "headline": "Goldman Sachs Maintains Buy on Aris Water Solutions, Raises Price Target to $30", "summary": "", "symbols": ["ARIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595215/goldman-sachs-maintains-buy-on-aris-water-solutions-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595224, "time": "2024-12-19 10:46:19", "headline": "Unpacking the Latest Options Trading Trends in Bank of America", "summary": " ", "symbols": ["BAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42595224/unpacking-the-latest-options-trading-trends-in-bank-of-america", "tags": []}
{"id": 42595226, "time": "2024-12-19 10:46:24", "headline": "Behind the Scenes of Intuitive Surgical's Latest Options Trends", "summary": " ", "symbols": ["ISRG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42595226/behind-the-scenes-of-intuitive-surgicals-latest-options-trends", "tags": []}
{"id": 42595234, "time": "2024-12-19 10:46:49", "headline": "RBC Capital Upgrades RTX to Outperform, Raises Price Target to $140", "summary": "", "symbols": ["RTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595234/rbc-capital-upgrades-rtx-to-outperform-raises-price-target-to-140", "tags": ["analyst_up", "price_target_up"]}
{"id": 42595320, "time": "2024-12-19 10:48:24", "headline": "Goldman Sachs Maintains Neutral on Azul, Lowers Price Target to $3.1", "summary": "", "symbols": ["AZUL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595320/goldman-sachs-maintains-neutral-on-azul-lowers-price-target-to-3-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 42595352, "time": "2024-12-19 10:49:14", "headline": "Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday", "summary": " ", "symbols": ["ACN", "DRI", "INOD", "JWN", "KMX", "MESO", "MVST", "OMER", "PRTA", "SHCO", "SOC", "TRIP", "VALN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42595352/accenture-posts-upbeat-results-joins-darden-restaurants-carmax-and-other-big-stocks-moving-higher-on-thursday", "tags": ["why_moving"]}
{"id": 42595364, "time": "2024-12-19 10:49:37", "headline": "Jefferies Maintains Hold on Fortinet, Raises Price Target to $105", "summary": "", "symbols": ["FTNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595364/jefferies-maintains-hold-on-fortinet-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595371, "time": "2024-12-19 10:49:55", "headline": "Goldman Sachs Maintains Buy on Cheniere Energy, Raises Price Target to $261", "summary": "", "symbols": ["LNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595371/goldman-sachs-maintains-buy-on-cheniere-energy-raises-price-target-to-261", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595383, "time": "2024-12-19 10:49:58", "headline": "RBC Capital Downgrades V2X to Sector Perform, Lowers Price Target to $58", "summary": "", "symbols": ["VVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595383/rbc-capital-downgrades-v2x-to-sector-perform-lowers-price-target-to-58", "tags": ["analyst_down", "price_target_down"]}
{"id": 42595414, "time": "2024-12-19 10:50:42", "headline": "Leishen Energy Shares Resume Trade", "summary": "", "symbols": ["LSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42595414/leishen-energy-shares-resume-trade", "tags": []}
{"id": 42595421, "time": "2024-12-19 10:51:04", "headline": "Leishen Energy Shares Halted On Circuit Breaker To The Upside", "summary": "", "symbols": ["LSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42595421/leishen-energy-shares-halted-on-circuit-breaker-to-the-upside", "tags": ["halt"]}
{"id": 42595430, "time": "2024-12-19 10:51:16", "headline": "Goldman Sachs Maintains Sell on DT Midstream, Raises Price Target to $94", "summary": "", "symbols": ["DTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595430/goldman-sachs-maintains-sell-on-dt-midstream-raises-price-target-to-94", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595444, "time": "2024-12-19 10:51:40", "headline": "Nvni Group Shares Resume Trade Then Again Halted On Circuit Breaker To The Upside, Stock Now Up 160.9%", "summary": "", "symbols": ["NVNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42595444/nvni-group-shares-resume-trade-then-again-halted-on-circuit-breaker-to-the-upside-stock-now-up-160-", "tags": ["halt"]}
{"id": 42595448, "time": "2024-12-19 10:51:57", "headline": "Jefferies Maintains Buy on Check Point Software, Raises Price Target to $225", "summary": "", "symbols": ["CHKP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595448/jefferies-maintains-buy-on-check-point-software-raises-price-target-to-225", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595449, "time": "2024-12-19 10:51:58", "headline": "RBC Capital Upgrades MannKind to Outperform, Raises Price Target to $10", "summary": "", "symbols": ["MNKD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595449/rbc-capital-upgrades-mannkind-to-outperform-raises-price-target-to-10", "tags": ["analyst_up", "price_target_up"]}
{"id": 42595471, "time": "2024-12-19 10:52:52", "headline": "Goldman Sachs Maintains Neutral on Energy Transfer, Raises Price Target to $20", "summary": "", "symbols": ["ET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595471/goldman-sachs-maintains-neutral-on-energy-transfer-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595476, "time": "2024-12-19 10:53:03", "headline": "AI Drone Company ZenaTech Soars Higher: Arizona Facility Sets Stage For 'Made In America' Military Drones", "summary": "ZenaTech stock rises after announcing its subsidiary, ZenaDrone, moved into a new Arizona facility to produce NDAA-compliant military drones.", "symbols": ["ZENA"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/12/42595476/why-is-zenatech-stock-gaining-today", "tags": []}
{"id": 42595485, "time": "2024-12-19 10:53:17", "headline": "Bitcoin Rebounds Above $102,000 Post-Fed Meeting; Us GDP Hits 3.1%, Jobless Claims Drop, Treasury Yields Peak; Tesla's Eu Registrations Fall 41% - Top Headlines Today While US Slept", "summary": " ", "symbols": ["BTCUSD", "ETHUSD", "SPY"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/24/12/42595485/bitcoin-rebounds-above-102000-post-fed-meeting-us-gdp-hits-31-jobless-claims-drop-treasury-yields-peak-teslas-eu-registrations-fall-41-q4-ev-target-in-doubt-top-headlines-today-while-us-slept", "tags": []}
{"id": 42595531, "time": "2024-12-19 10:54:03", "headline": "Goldman Sachs Maintains Buy on Fox, Raises Price Target to $57", "summary": "", "symbols": ["FOXA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595531/goldman-sachs-maintains-buy-on-fox-raises-price-target-to-57", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595597, "time": "2024-12-19 10:55:43", "headline": "Nvni Group Shares Resume Trade Then Again Halted On Circuit Breaker To The Upside, Stock Now Up 196.6%", "summary": "", "symbols": ["NVNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42595597/nvni-group-shares-resume-trade-then-again-halted-on-circuit-breaker-to-the-upside-stock-now-up-196-", "tags": ["halt"]}
{"id": 42595602, "time": "2024-12-19 10:55:55", "headline": "Goldman Sachs Maintains Buy on Kinetik Holdings, Raises Price Target to $61", "summary": "", "symbols": ["KNTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595602/goldman-sachs-maintains-buy-on-kinetik-holdings-raises-price-target-to-61", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595651, "time": "2024-12-19 10:57:08", "headline": "Jefferies Maintains Hold on Cloudflare, Raises Price Target to $125", "summary": "", "symbols": ["NET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595651/jefferies-maintains-hold-on-cloudflare-raises-price-target-to-125", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595685, "time": "2024-12-19 10:57:27", "headline": "Roadzen's drivebuddyAI And Bosch Collaborate, Expanding The Global Reach Of Roadzen's ADAS And Driver Monitoring System Platforms", "summary": "", "symbols": ["RDZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595685/roadzens-drivebuddyai-and-bosch-collaborate-expanding-the-global-reach-of-roadzens-adas-and-driver-m", "tags": []}
{"id": 42595704, "time": "2024-12-19 10:57:54", "headline": "RBC Capital Reiterates Market Outperform on Civitas Resources, Maintains $70 Price Target", "summary": "", "symbols": ["CIVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595704/rbc-capital-reiterates-market-outperform-on-civitas-resources-maintains-70-price-target", "tags": ["analyst_other"]}
{"id": 42595705, "time": "2024-12-19 10:57:55", "headline": "Goldman Sachs Maintains Buy on Micron Technology, Lowers Price Target to $128", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595705/goldman-sachs-maintains-buy-on-micron-technology-lowers-price-target-to-128", "tags": ["analyst_other", "price_target_down"]}
{"id": 42595756, "time": "2024-12-19 10:59:27", "headline": "Jefferies Maintains Hold on Okta, Lowers Price Target to $90", "summary": "", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595756/jefferies-maintains-hold-on-okta-lowers-price-target-to-90", "tags": ["analyst_other", "price_target_down"]}
{"id": 42595772, "time": "2024-12-19 10:59:55", "headline": "KC Fed Composite Index (Dec) -4, Prior -2", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42595772/kc-fed-composite-index-dec-4-prior-2", "tags": []}
{"id": 42595787, "time": "2024-12-19 11:00:07", "headline": "Goldman Sachs Maintains Neutral on Par Pacific Hldgs, Lowers Price Target to $23", "summary": "", "symbols": ["PARR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595787/goldman-sachs-maintains-neutral-on-par-pacific-hldgs-lowers-price-target-to-23", "tags": ["analyst_other", "price_target_down"]}
{"id": 42595805, "time": "2024-12-19 11:00:15", "headline": "KC Fed Manufacturing Index (Dec) -5, Prior -4", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42595805/kc-fed-manufacturing-index-dec-5-prior-4", "tags": []}
{"id": 42595807, "time": "2024-12-19 11:00:15", "headline": "Here's How Much You Would Have Made Owning McDonald's Stock In The Last 20 Years", "summary": " ", "symbols": ["MCD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42595807/heres-how-much-you-would-have-made-owning-mcdonalds-stock-in-the-last-20-years", "tags": []}
{"id": 42586395, "time": "2024-12-19 09:09:36", "headline": "HWH International shares are trading higher after the company announced the expanding of its Hapi Cafe brand across Asia.", "summary": "", "symbols": ["HWH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42586395/hwh-international-shares-are-trading-higher-after-the-company-announced-the-expanding-of-its-hapi-ca", "tags": ["why_moving"]}
{"id": 42584635, "time": "2024-12-19 08:51:04", "headline": "Nukkleus shares are trading higher after the company announced it entered into a $10 million private placement and will use proceeds to fund the acquisition of an Iron Dome supplier.", "summary": "", "symbols": ["NUKK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42584635/nukkleus-shares-are-trading-higher-after-the-company-announced-it-entered-into-a-10-million-private", "tags": ["why_moving", "offering"]}
{"id": 42576671, "time": "2024-12-19 08:15:20", "headline": "AgEagle Aerial Systems shares are trading higher after the company announced it secured the largest sensor order in its history.", "summary": "", "symbols": ["UAVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42576671/ageagle-aerial-systems-shares-are-trading-higher-after-the-company-announced-it-secured-the-largest", "tags": ["why_moving"]}
{"id": 42595905, "time": "2024-12-19 11:01:51", "headline": "Goldman Sachs Maintains Buy on Targa Resources, Raises Price Target to $223", "summary": "", "symbols": ["TRGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595905/goldman-sachs-maintains-buy-on-targa-resources-raises-price-target-to-223", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595940, "time": "2024-12-19 11:02:03", "headline": "RBC Capital Maintains Outperform on Cormedix, Raises Price Target to $12", "summary": "", "symbols": ["CRMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595940/rbc-capital-maintains-outperform-on-cormedix-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 42595984, "time": "2024-12-19 11:03:20", "headline": "Goldman Sachs Maintains Buy on Telefonica Brasil, Lowers Price Target to $9.2", "summary": "", "symbols": ["VIV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42595984/goldman-sachs-maintains-buy-on-telefonica-brasil-lowers-price-target-to-9-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 42596022, "time": "2024-12-19 11:04:58", "headline": "Goldman Sachs Maintains Neutral on TIM, Lowers Price Target to $14", "summary": "", "symbols": ["TIMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596022/goldman-sachs-maintains-neutral-on-tim-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 42596055, "time": "2024-12-19 11:05:32", "headline": "RBC Capital Reiterates Sector Perform on General Mills, Maintains $70 Price Target", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596055/rbc-capital-reiterates-sector-perform-on-general-mills-maintains-70-price-target", "tags": ["analyst_other"]}
{"id": 42596088, "time": "2024-12-19 11:06:41", "headline": "Goldman Sachs Maintains Neutral on Warner Bros. Discovery, Raises Price Target to $10.75", "summary": "", "symbols": ["WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596088/goldman-sachs-maintains-neutral-on-warner-bros-discovery-raises-price-target-to-10-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 42596151, "time": "2024-12-19 11:07:26", "headline": "3M And US Conec Announce Licensing Agreement For 3M Expanded Beam Optical Interconnect Technology", "summary": "", "symbols": ["MMM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/24/12/42596151/3m-and-us-conec-announce-licensing-agreement-for-3m-expanded-beam-optical-interconnect-technology", "tags": ["contract"]}
{"id": 42596176, "time": "2024-12-19 11:08:00", "headline": "RH Demand Soars In December: Analyst Predicts Big Moves In 2025", "summary": "RH reported Q3 earnings miss but raised guidance. Demand trends have been better than expected, leading to market share gains and an upgrade by analyst Cristina Fern\u00e1ndez. ", "symbols": ["RH"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/24/12/42596176/rh-share-gains-strong-demand-trend-to-continue-in-2025", "tags": ["analyst_up", "earnings", "guidance"]}
{"id": 42596202, "time": "2024-12-19 11:08:49", "headline": "Jefferies Maintains Buy on CrowdStrike Holdings, Raises Price Target to $450", "summary": "", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596202/jefferies-maintains-buy-on-crowdstrike-holdings-raises-price-target-to-450", "tags": ["analyst_other", "price_target_up"]}
{"id": 42596293, "time": "2024-12-19 11:10:49", "headline": "RBC Capital Assumes Secure Energy Services at Sector Perform, Announces Price Target of C$17", "summary": "", "symbols": ["TSX:SES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596293/rbc-capital-assumes-secure-energy-services-at-sector-perform-announces-price-target-of-c-17", "tags": []}
{"id": 42596350, "time": "2024-12-19 11:12:11", "headline": "Jefferies Maintains Hold on Tenable Holdings, Raises Price Target to $45", "summary": "", "symbols": ["TENB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596350/jefferies-maintains-hold-on-tenable-holdings-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 42596440, "time": "2024-12-19 11:14:01", "headline": "Jefferies Upgrades Affirm Holdings to Buy, Raises Price Target to $82", "summary": "", "symbols": ["AFRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596440/jefferies-upgrades-affirm-holdings-to-buy-raises-price-target-to-82", "tags": ["analyst_up", "price_target_up"]}
{"id": 42596538, "time": "2024-12-19 11:15:19", "headline": "Here's How Much You Would Have Made Owning Ameriprise Finl Stock In The Last 10 Years", "summary": " ", "symbols": ["AMP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42596538/heres-how-much-you-would-have-made-owning-ameriprise-finl-stock-in-the-last-10-years", "tags": []}
{"id": 42596547, "time": "2024-12-19 11:15:27", "headline": "Guggenheim Initiates Coverage On Bruker with Buy Rating, Announces Price Target of $72", "summary": "", "symbols": ["BRKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596547/guggenheim-initiates-coverage-on-bruker-with-buy-rating-announces-price-target-of-72", "tags": ["analyst_init"]}
{"id": 42596574, "time": "2024-12-19 11:16:29", "headline": "Unpacking the Latest Options Trading Trends in Accenture", "summary": " ", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42596574/unpacking-the-latest-options-trading-trends-in-accenture", "tags": []}
{"id": 42596578, "time": "2024-12-19 11:16:34", "headline": "Decoding United Parcel Service's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["UPS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42596578/decoding-united-parcel-services-options-activity-whats-the-big-picture", "tags": []}
{"id": 42596581, "time": "2024-12-19 11:16:39", "headline": "Check Out What Whales Are Doing With DELL", "summary": " ", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42596581/check-out-what-whales-are-doing-with-dell", "tags": []}
{"id": 42596596, "time": "2024-12-19 11:17:01", "headline": "Why Snow Lake Resources (LITM) Stock Is Getting Hammered", "summary": "Snow Lake Resources shares are trading lower by 60% during Thursday&#39;s session. The company earlier priced a public offering.", "symbols": ["LITM"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42596596/why-snow-lake-resources-litm-stock-is-getting-hammered", "tags": ["why_moving", "offering"]}
{"id": 42596607, "time": "2024-12-19 11:17:13", "headline": "Guggenheim Initiates Coverage On Neogen with Buy Rating, Announces Price Target of $15", "summary": "", "symbols": ["NEOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596607/guggenheim-initiates-coverage-on-neogen-with-buy-rating-announces-price-target-of-15", "tags": ["analyst_init"]}
{"id": 42596681, "time": "2024-12-19 11:17:43", "headline": "JP Morgan Downgrades Imperial Oil to Underweight, Maintains Price Target to C$100", "summary": "", "symbols": ["TSX:IMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596681/jp-morgan-downgrades-imperial-oil-to-underweight-maintains-price-target-to-c-100", "tags": ["analyst_down", "analyst_other"]}
{"id": 42596722, "time": "2024-12-19 11:18:24", "headline": "Stifel Maintains Buy on General Mills, Lowers Price Target to $78", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596722/stifel-maintains-buy-on-general-mills-lowers-price-target-to-78", "tags": ["analyst_other", "price_target_down"]}
{"id": 42596766, "time": "2024-12-19 11:18:49", "headline": "Guggenheim Initiates Coverage On Kroger with Buy Rating, Announces Price Target of $68", "summary": "", "symbols": ["KR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596766/guggenheim-initiates-coverage-on-kroger-with-buy-rating-announces-price-target-of-68", "tags": ["analyst_init"]}
{"id": 42596774, "time": "2024-12-19 11:19:07", "headline": "What's Going On With Hut 8 Shares Today?", "summary": "Hut 8 Corp (NASDAQ:HUT) shares are bouncing around Thursday.", "symbols": ["BTCUSD", "HUT"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/24/12/42596774/whats-going-on-with-hut-8-shares-today", "tags": ["why_moving"]}
{"id": 42596826, "time": "2024-12-19 11:20:43", "headline": "Stifel Reiterates Buy on Jabil, Raises Price Target to $160", "summary": "", "symbols": ["JBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596826/stifel-reiterates-buy-on-jabil-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 42596877, "time": "2024-12-19 11:22:17", "headline": "Nvni Group Shares Halted On Circuit Breaker To The Upside, Stock Now Up 345.3%", "summary": "", "symbols": ["NVNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42596877/nvni-group-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-345-3", "tags": ["halt"]}
{"id": 42596902, "time": "2024-12-19 11:22:49", "headline": "Stifel Maintains Buy on Micron Technology, Lowers Price Target to $130", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596902/stifel-maintains-buy-on-micron-technology-lowers-price-target-to-130", "tags": ["analyst_other", "price_target_down"]}
{"id": 42596964, "time": "2024-12-19 11:25:03", "headline": "B. Riley Securities Maintains Buy on Bitdeer Technologies, Raises Price Target to $24", "summary": "", "symbols": ["BTDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42596964/b-riley-securities-maintains-buy-on-bitdeer-technologies-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 42596979, "time": "2024-12-19 11:25:30", "headline": "Ethereum Price Plummets 5%: Why Is ETH Going Down?", "summary": "Ethereum&#39;s (CRYPTO: ETH) 5% drop on Thursday has sparked speculation among traders about its ability to recover and close above the critical $3,700 mark by year-end.", "symbols": ["BTCUSD", "ETHA", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42596979/ethereum-price-plummets-5-why-is-eth-going-down", "tags": []}
{"id": 42597051, "time": "2024-12-19 11:26:36", "headline": "B. Riley Securities Upgrades Cognition Therapeutics to Buy, Raises Price Target to $1.5", "summary": "", "symbols": ["CGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597051/b-riley-securities-upgrades-cognition-therapeutics-to-buy-raises-price-target-to-1-5", "tags": ["analyst_up", "price_target_up"]}
{"id": 42597071, "time": "2024-12-19 11:27:34", "headline": "Cantor Fitzgerald Initiates Coverage On Cognex with Overweight Rating, Announces Price Target of $49", "summary": "", "symbols": ["CGNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597071/cantor-fitzgerald-initiates-coverage-on-cognex-with-overweight-rating-announces-price-target-of-49", "tags": ["analyst_init"]}
{"id": 42597073, "time": "2024-12-19 11:27:36", "headline": "FactSet Beats Q1 Earnings On Higher Subscriptions, Sticks to Annual Guidance", "summary": "FactSet Q1 2025 sales rose 4.9% YoY to $568.7M. Adjusted EPS beat expectations at $4.37. FY25 revenue outlook reaffirmed at $2.285B\u2013$2.305B.", "symbols": ["FDS"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/12/42597073/financial-data-and-analytics-service-provider-factset-beats-q1-earnings-on-higher-subscriptions-sticks-to-annual-guidance", "tags": ["earnings", "guidance"]}
{"id": 42597113, "time": "2024-12-19 11:27:57", "headline": "B. Riley Securities Maintains Buy on IREN, Raises Price Target to $16", "summary": "", "symbols": ["IREN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597113/b-riley-securities-maintains-buy-on-iren-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 42597149, "time": "2024-12-19 11:29:28", "headline": "What's Going On With SoundHound AI Stock?", "summary": "SoundHound AI shares are trading lower by 4.8% during Wednesday&#39;s session. The stock may be experiencing a pullback due to profit-taking after a 47% surge over the past week.", "symbols": ["SOUN"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42597149/whats-going-on-with-soundhound-ai-stock", "tags": ["why_moving"]}
{"id": 42597157, "time": "2024-12-19 11:29:44", "headline": "Cantor Fitzgerald Initiates Coverage On Ranpak Hldgs with Overweight Rating, Announces Price Target of $11.5", "summary": "", "symbols": ["PACK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597157/cantor-fitzgerald-initiates-coverage-on-ranpak-hldgs-with-overweight-rating-announces-price-target-o", "tags": ["analyst_init"]}
{"id": 42597176, "time": "2024-12-19 11:30:09", "headline": "B. Riley Securities Maintains Neutral on MARA Holdings, Raises Price Target to $23", "summary": "", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597176/b-riley-securities-maintains-neutral-on-mara-holdings-raises-price-target-to-23", "tags": ["analyst_other", "price_target_up"]}
{"id": 42597179, "time": "2024-12-19 11:30:14", "headline": "Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years", "summary": " ", "symbols": ["CNC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42597179/heres-how-much-you-would-have-made-owning-centene-stock-in-the-last-15-years", "tags": []}
{"id": 42597198, "time": "2024-12-19 11:30:48", "headline": "Archer Aviation Unusual Options Activity", "summary": " ", "symbols": ["ACHR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42597198/archer-aviation-unusual-options-activity", "tags": []}
{"id": 42597204, "time": "2024-12-19 11:30:54", "headline": "Vistra's Options: A Look at What the Big Money is Thinking", "summary": " ", "symbols": ["VST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42597204/vistras-options-a-look-at-what-the-big-money-is-thinking", "tags": []}
{"id": 42597206, "time": "2024-12-19 11:30:59", "headline": "What the Options Market Tells Us About Nike", "summary": " ", "symbols": ["NKE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42597206/what-the-options-market-tells-us-about-nike", "tags": []}
{"id": 42597209, "time": "2024-12-19 11:31:02", "headline": "Sonic And Injective Pioneer Cross-Chain AI Agent Platform", "summary": "Sonic, a gaming platform on the Solana (CRYPTO: SOL) blockchain, and Injective, a Layer-1 blockchain, on Thursday announced a strategic partnership to develop what they claim to be the industry\u2019s first cross-chain ", "symbols": ["INJUSD", "SOLUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42597209/sonic-and-injective-pioneer-cross-chain-ai-agent-platform", "tags": ["contract"]}
{"id": 42597229, "time": "2024-12-19 11:31:21", "headline": "ABC Correspondent Jonathan Karl Posts On X: 'In a conversation a few minutes ago, @realDonaldTrump told me, \"There won't be anything approved unless the debt ceiling is done with.\"'", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42597229/abc-correspondent-jonathan-karl-posts-on-x-in-a-conversation-a-few-minutes-ago-re", "tags": []}
{"id": 42597231, "time": "2024-12-19 11:31:24", "headline": "B. Riley Securities Maintains Neutral on NewtekOne, Raises Price Target to $14", "summary": "", "symbols": ["NEWT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597231/b-riley-securities-maintains-neutral-on-newtekone-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 42597251, "time": "2024-12-19 11:31:56", "headline": "Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits", "summary": "Prothena and Roche report Phase 2b PADOVA results on prasinezumab in Parkinson&#39;s, showing promising trends and nominal significance in key analyses.", "symbols": ["PRTA", "RHHBY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42597251/roche-prothena-partnered-mid-stage-parkinsons-trial-misses-primary-endpoint-but-cling-on-signs-of-clinical-benefits", "tags": ["fda"]}
{"id": 42597260, "time": "2024-12-19 11:32:07", "headline": "Oklo Business Model Supports Recurring Revenues, AI Revolution Creates Elevated Demand", "summary": "Oklo&#39;s business model supports recurring revenues. The company aims to develop its first SMR by 2027. Analyst initiates with Outperform. ", "symbols": ["OKLO"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/24/12/42597260/oklo-business-model-supports-recurring-revenues-ai-revolution-creates-elevated-demand", "tags": []}
{"id": 42597340, "time": "2024-12-19 11:34:15", "headline": "B. Riley Securities Reiterates Buy on Sezzle, Raises Price Target to $372", "summary": "", "symbols": ["SEZL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597340/b-riley-securities-reiterates-buy-on-sezzle-raises-price-target-to-372", "tags": ["analyst_other", "price_target_up"]}
{"id": 42597354, "time": "2024-12-19 11:35:05", "headline": "Cantor Fitzgerald Maintains Overweight on Micron Technology, Lowers Price Target to $130", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597354/cantor-fitzgerald-maintains-overweight-on-micron-technology-lowers-price-target-to-130", "tags": ["analyst_other", "price_target_down"]}
{"id": 42597408, "time": "2024-12-19 11:36:56", "headline": "B. Riley Securities Maintains Buy on TeraWulf, Raises Price Target to $10", "summary": "", "symbols": ["WULF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597408/b-riley-securities-maintains-buy-on-terawulf-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 42597459, "time": "2024-12-19 11:39:12", "headline": "HC Wainwright & Co. Reiterates Neutral on Adicet Bioto Neutral", "summary": "", "symbols": ["ACET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597459/hc-wainwright-co-reiterates-neutral-on-adicet-bioto-neutral", "tags": ["analyst_other"]}
{"id": 42597465, "time": "2024-12-19 11:39:33", "headline": "Nvni Group Shares Halted On Circuit Breaker To The Upside, Stock Now Up 446.9%", "summary": "", "symbols": ["NVNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42597465/nvni-group-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-446-9", "tags": ["halt"]}
{"id": 42597562, "time": "2024-12-19 11:42:59", "headline": "HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $10 Price Target", "summary": "", "symbols": ["SGMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597562/hc-wainwright-co-reiterates-buy-on-sangamo-therapeutics-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 42597566, "time": "2024-12-19 11:43:33", "headline": "Nvni Group Shares Halted On Circuit Breaker To The Upside, Stock Now Up 496.9%", "summary": "", "symbols": ["NVNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42597566/nvni-group-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-496-9", "tags": ["halt"]}
{"id": 42597593, "time": "2024-12-19 11:45:12", "headline": "Here's How Much $1000 Invested In Eaton Corp 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["ETN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42597593/heres-how-much-1000-invested-in-eaton-corp-5-years-ago-would-be-worth-today", "tags": []}
{"id": 42597652, "time": "2024-12-19 11:46:56", "headline": "Market Whales and Their Recent Bets on Deere Options", "summary": " ", "symbols": ["DE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42597652/market-whales-and-their-recent-bets-on-deere-options", "tags": []}
{"id": 42597655, "time": "2024-12-19 11:47:04", "headline": "HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target", "summary": "", "symbols": ["ARMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597655/hc-wainwright-co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 42597656, "time": "2024-12-19 11:47:07", "headline": "Looking At Schlumberger's Recent Unusual Options Activity", "summary": " ", "symbols": ["SLB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42597656/looking-at-schlumbergers-recent-unusual-options-activity", "tags": []}
{"id": 42597739, "time": "2024-12-19 11:51:23", "headline": "HC Wainwright & Co. Reiterates Buy on Celldex Therapeutics, Maintains $80 Price Target", "summary": "", "symbols": ["CLDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597739/hc-wainwright-co-reiterates-buy-on-celldex-therapeutics-maintains-80-price-target", "tags": ["analyst_other"]}
{"id": 42597755, "time": "2024-12-19 11:51:38", "headline": "Oppenheimer Upgrades Block to Outperform, Announces $115 Price Target", "summary": "", "symbols": ["SQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597755/oppenheimer-upgrades-block-to-outperform-announces-115-price-target", "tags": ["analyst_up"]}
{"id": 42597776, "time": "2024-12-19 11:52:58", "headline": "Oppenheimer Maintains Outperform on Euronet Worldwide, Lowers Price Target to $128", "summary": "", "symbols": ["EEFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597776/oppenheimer-maintains-outperform-on-euronet-worldwide-lowers-price-target-to-128", "tags": ["analyst_other", "price_target_down"]}
{"id": 42597799, "time": "2024-12-19 11:54:04", "headline": "HC Wainwright & Co. Reiterates Buy on Imunon, Maintains $12 Price Target", "summary": "", "symbols": ["IMNN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597799/hc-wainwright-co-reiterates-buy-on-imunon-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 42597807, "time": "2024-12-19 11:54:36", "headline": "Stock Of The Day: Where Does The Merck Downtrend End?", "summary": "Shares of Merck &amp; Co (MRK) continue to trend lower. If they reach the $95.00 level, there is a good chance they find support and reverse.", "symbols": ["HNSPF", "MRK", "PSNL"], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/24/12/42597807/stock-of-the-day-where-does-the-merck-downtrend-end", "tags": []}
{"id": 42597812, "time": "2024-12-19 11:54:54", "headline": "Soho House Jumps On Receiving Acquisition Offer With 83% Premium", "summary": "Soho House is up after receiving a $9.00 per share acquisition offer and reporting third-quarter results.", "symbols": ["SHCO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42597812/soho-house-jumps-over-50-on-receiving-acquisition-offer-with-83-premium", "tags": []}
{"id": 42597866, "time": "2024-12-19 11:55:51", "headline": "Liberty Media Confirms European Commission Phase II Investigation Into MotoGP Acquisition, Extends Longstop Date To June 30, 2025", "summary": "", "symbols": ["FWONA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597866/liberty-media-confirms-european-commission-phase-ii-investigation-into-motogp-acquisition-extends-lo", "tags": ["fda", "legal"]}
{"id": 42597894, "time": "2024-12-19 11:57:49", "headline": "HC Wainwright & Co. Reiterates Buy on Structure Therapeutics, Maintains $80 Price Target", "summary": "", "symbols": ["GPCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597894/hc-wainwright-co-reiterates-buy-on-structure-therapeutics-maintains-80-price-target", "tags": ["analyst_other"]}
{"id": 42597912, "time": "2024-12-19 11:57:55", "headline": "Pesticides In Pot: Overlooked Dangers Of California's Legal Weed", "summary": "Legal marijuana products are not always safer than illicit ones, as a study found similar rates of pesticide contamination in both markets.", "symbols": [], "source": "benzinga", "author": "Maureen Meehan", "url": "https://www.benzinga.com/markets/cannabis/24/12/42597912/pesticides-in-pot-the-overlooked-dangers-of-californias-legal-weed", "tags": []}
{"id": 42597945, "time": "2024-12-19 11:59:45", "headline": "Trump Prosecutor Fani Willis Removed From Election Case, Indictment Stands", "summary": "Georgia court removes Fani Willis from Trump election interference case due to concerns of impartiality. Indictment remains intact.", "symbols": [], "source": "benzinga", "author": "Michael Cohen", "url": "https://www.benzinga.com/news/legal/24/12/42597945/trump-prosecutor-fani-willis-removed-from-election-case-indictment-stands", "tags": ["legal"]}
{"id": 42597982, "time": "2024-12-19 12:00:16", "headline": "P/E Ratio Insights for Verisk Analytics", "summary": " ", "symbols": ["VRSK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42597982/pe-ratio-insights-for-verisk-analytics", "tags": []}
{"id": 42597997, "time": "2024-12-19 12:00:58", "headline": "Oppenheimer Maintains Outperform on Fiserv, Raises Price Target to $239", "summary": "", "symbols": ["FI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42597997/oppenheimer-maintains-outperform-on-fiserv-raises-price-target-to-239", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598003, "time": "2024-12-19 12:01:25", "headline": "JP Morgan Maintains Neutral on Canadian Natural Res, Raises Price Target to C$53", "summary": "", "symbols": ["TSX:CNQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598003/jp-morgan-maintains-neutral-on-canadian-natural-res-raises-price-target-to-c-53", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598016, "time": "2024-12-19 12:01:34", "headline": "What's Going On With Applied Materials (AMAT) Stock?", "summary": "Applied Materials shares are trading lower by 2.1% during Wednesday&#39;s session. The stock is falling amid the Federal Reserve&#39;s cautious pivot on interest rate policy, alongside Micron&#39;s disappointing Q2 guidance.", "symbols": ["AMAT"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42598016/whats-going-on-with-applied-materials-amat-stock", "tags": ["guidance", "why_moving"]}
{"id": 42598035, "time": "2024-12-19 12:02:41", "headline": "Oppenheimer Maintains Outperform on Mastercard, Lowers Price Target to $588", "summary": "", "symbols": ["MA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598035/oppenheimer-maintains-outperform-on-mastercard-lowers-price-target-to-588", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598036, "time": "2024-12-19 12:02:49", "headline": "MoneyLion Partners With MrBeast For $4.2M At-Home Giveaway Tied To New 'Beast Games' Show, Offering Over 1,000 Prizes In Year-Long Sweepstakes With Daily Free Entries For Viewers And MoneyLion Users", "summary": "", "symbols": ["ML"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598036/moneylion-partners-with-mrbeast-for-4-2m-at-home-giveaway-tied-to-new-beast-games-show-offering-over", "tags": ["offering", "contract"]}
{"id": 42598053, "time": "2024-12-19 12:03:27", "headline": "Zoomcar Holdings Shares Halted On A Circuit Breaker", "summary": "", "symbols": ["ZCAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42598053/zoomcar-holdings-shares-halted-on-a-circuit-breaker", "tags": ["halt"]}
{"id": 42598062, "time": "2024-12-19 12:04:19", "headline": "Oppenheimer Maintains Outperform on Shift4 Payments, Raises Price Target to $121", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598062/oppenheimer-maintains-outperform-on-shift4-payments-raises-price-target-to-121", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598083, "time": "2024-12-19 12:05:28", "headline": "Teamsters At Sysco Houston Authorize Strike", "summary": "", "symbols": ["SYY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598083/teamsters-at-sysco-houston-authorize-strike", "tags": []}
{"id": 42598097, "time": "2024-12-19 12:05:44", "headline": "HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target", "summary": "", "symbols": ["PTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598097/hc-wainwright-co-reiterates-buy-on-palatin-techs-maintains-17-price-target", "tags": ["analyst_other"]}
{"id": 42598099, "time": "2024-12-19 12:05:48", "headline": "JP Morgan Maintains Overweight on AnaptysBio, Lowers Price Target to $36", "summary": "", "symbols": ["ANAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598099/jp-morgan-maintains-overweight-on-anaptysbio-lowers-price-target-to-36", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598122, "time": "2024-12-19 12:07:02", "headline": "Oppenheimer Maintains Outperform on Visa, Raises Price Target to $375", "summary": "", "symbols": ["V"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598122/oppenheimer-maintains-outperform-on-visa-raises-price-target-to-375", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598134, "time": "2024-12-19 12:07:45", "headline": "JP Morgan Maintains Overweight on Micron Technology, Lowers Price Target to $145", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598134/jp-morgan-maintains-overweight-on-micron-technology-lowers-price-target-to-145", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598200, "time": "2024-12-19 12:09:09", "headline": "AGCO Targeting To Improve Adjusted Mid-Cycle Adj. Operating Margins To 14-15% And Annually Deliver Free Cash Flow Conversion Of 75-100% By 2029", "summary": "", "symbols": ["AGCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598200/agco-targeting-to-improve-adjusted-mid-cycle-adj-operating-margins-to-14-15-and-annually-deliver-fre", "tags": []}
{"id": 42598201, "time": "2024-12-19 12:09:11", "headline": "JP Morgan Maintains Overweight on Dutch Bros, Raises Price Target to $58", "summary": "", "symbols": ["BROS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598201/jp-morgan-maintains-overweight-on-dutch-bros-raises-price-target-to-58", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598204, "time": "2024-12-19 12:09:41", "headline": "AGCO Sees 2025 Adj. EPS $4.00-$4.50, Net Sales ~$9.6B", "summary": "", "symbols": ["AGCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598204/agco-sees-2025-adj-eps-4-00-4-50-net-sales-9-6b", "tags": ["earnings"]}
{"id": 42598275, "time": "2024-12-19 12:11:05", "headline": "RBC Capital Maintains Outperform on Silgan Hldgs, Raises Price Target to $63", "summary": "", "symbols": ["SLGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598275/rbc-capital-maintains-outperform-on-silgan-hldgs-raises-price-target-to-63", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598281, "time": "2024-12-19 12:11:21", "headline": "KULR Technology Group Stock Is Rising Today: What's Going On?", "summary": "KULR Technology Group, Inc. (NYSE: KULR) shares are trading higher Thursday on what appears to be continued momentum from the company&#39;s announcement that it regained compliance with the NYSE American&#39;s stockholder equity requirements. Benchmark upgraded the stock following the news. Here&#39;s what you need to know.", "symbols": ["KULR"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/analyst-ratings/upgrades/24/12/42598281/kulr-technology-group-stock-is-rising-today-whats-going-on", "tags": ["analyst_up", "why_moving"]}
{"id": 42598284, "time": "2024-12-19 12:11:25", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on First Horizon, Raises Price Target to $24", "summary": "", "symbols": ["FHN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598284/keefe-bruyette-woods-maintains-market-perform-on-first-horizon-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598322, "time": "2024-12-19 12:12:42", "headline": "RBC Capital Maintains Outperform on LyondellBasell Industries, Lowers Price Target to $92", "summary": "", "symbols": ["LYB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598322/rbc-capital-maintains-outperform-on-lyondellbasell-industries-lowers-price-target-to-92", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598354, "time": "2024-12-19 12:13:04", "headline": "Wall Street Pins Hopes On Friday's Crucial Fed Inflation Report: Miracle Needed To Shift Narrative", "summary": "PCE price index release on Friday will be crucial for market recovery from recent sell-off. However, the outlook is not reassuring as inflation is expected to exceed Fed&#39;s 2% target. Fed&#39;s revised inflation projections and hawkish language suggest cautious approach to rate cuts. Friday&#39;s PCE report could sway market sentiment. Bank of America projects a slight increase in Core PCE, but economist Aditya Bhave believes there is no significant reacceleration in inflation.", "symbols": ["DIA", "QQQ", "SPY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42598354/wall-street-pins-hopes-on-fridays-crucial-fed-inflation-report-yet-a-miracle-is-needed-to-shift-the-narrative", "tags": ["guidance"]}
{"id": 42598369, "time": "2024-12-19 12:14:04", "headline": "Zoomcar Shares Resume", "summary": "", "symbols": ["ZCAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42598369/zoomcar-shares-resume", "tags": []}
{"id": 42598374, "time": "2024-12-19 12:14:35", "headline": "Raymond James Initiates Coverage On Premium Brands Hldgs with Outperform Rating, Announces Price Target of C$100", "summary": "", "symbols": ["TSX:PBH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598374/raymond-james-initiates-coverage-on-premium-brands-hldgs-with-outperform-rating-announces-price-targ", "tags": ["analyst_init"]}
{"id": 42598377, "time": "2024-12-19 12:14:56", "headline": "Barclays Upgrades NorthWestern Energy Group to Overweight, Raises Price Target to $56", "summary": "", "symbols": ["NWE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598377/barclays-upgrades-northwestern-energy-group-to-overweight-raises-price-target-to-56", "tags": ["analyst_up", "price_target_up"]}
{"id": 42598438, "time": "2024-12-19 12:15:23", "headline": "RBC Capital Maintains Sector Perform on Huntsman, Lowers Price Target to $20", "summary": "", "symbols": ["HUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598438/rbc-capital-maintains-sector-perform-on-huntsman-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598478, "time": "2024-12-19 12:16:28", "headline": "Raymond James Maintains Market Perform on Canadian Western Bank, Raises Price Target to C$59", "summary": "", "symbols": ["TSX:CWB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598478/raymond-james-maintains-market-perform-on-canadian-western-bank-raises-price-target-to-c-59", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598509, "time": "2024-12-19 12:17:51", "headline": "RBC Capital Maintains Sector Perform on Dow, Lowers Price Target to $44", "summary": "", "symbols": ["DOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598509/rbc-capital-maintains-sector-perform-on-dow-lowers-price-target-to-44", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598545, "time": "2024-12-19 12:19:00", "headline": "BMO Capital Maintains Outperform on Apollo Global Management, Raises Price Target to $186", "summary": "", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598545/bmo-capital-maintains-outperform-on-apollo-global-management-raises-price-target-to-186", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598548, "time": "2024-12-19 12:19:04", "headline": "Barclays Upgrades Cadence Bank to Overweight, Raises Price Target to $44", "summary": "", "symbols": ["CADE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598548/barclays-upgrades-cadence-bank-to-overweight-raises-price-target-to-44", "tags": ["analyst_up", "price_target_up"]}
{"id": 42598550, "time": "2024-12-19 12:19:30", "headline": "RBC Capital Maintains Outperform on Corteva, Raises Price Target to $73", "summary": "", "symbols": ["CTVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598550/rbc-capital-maintains-outperform-on-corteva-raises-price-target-to-73", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598554, "time": "2024-12-19 12:19:57", "headline": "BMO Capital Maintains Market Perform on Blackstone, Raises Price Target to $157", "summary": "", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598554/bmo-capital-maintains-market-perform-on-blackstone-raises-price-target-to-157", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598566, "time": "2024-12-19 12:21:05", "headline": "BMO Capital Maintains Market Perform on TPG, Raises Price Target to $73", "summary": "", "symbols": ["TPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598566/bmo-capital-maintains-market-perform-on-tpg-raises-price-target-to-73", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598590, "time": "2024-12-19 12:22:01", "headline": "BMO Capital Maintains Outperform on Victory Capital Holdings, Raises Price Target to $78", "summary": "", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598590/bmo-capital-maintains-outperform-on-victory-capital-holdings-raises-price-target-to-78", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598626, "time": "2024-12-19 12:23:38", "headline": "Barclays Upgrades Pinnacle Finl Partners to Overweight, Raises Price Target to $135", "summary": "", "symbols": ["PNFP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598626/barclays-upgrades-pinnacle-finl-partners-to-overweight-raises-price-target-to-135", "tags": ["analyst_up", "price_target_up"]}
{"id": 42598636, "time": "2024-12-19 12:24:52", "headline": "Gold Falls Sharply, Lamb Weston Shares Plunge", "summary": " ", "symbols": ["BPTH", "LITM", "LW", "MU", "OMER", "TPET"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42598636/gold-falls-sharply-lamb-weston-shares-plunge", "tags": []}
{"id": 42598637, "time": "2024-12-19 12:24:57", "headline": "B of A Securities Maintains Buy on Vertex Pharmaceuticals, Lowers Price Target to $522", "summary": "", "symbols": ["VRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598637/b-of-a-securities-maintains-buy-on-vertex-pharmaceuticals-lowers-price-target-to-522", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598651, "time": "2024-12-19 12:25:44", "headline": "'Mystery Drone' Sightings Spark Investigations, Politicians Respond: 'Shoot Them Down,' Trump Says", "summary": "Mysterious drone sightings have been reported across New Jersey and other northeastern states since mid-November 2024, causing concern among residents and prompting investigations by authorities.\u00a0", "symbols": ["PLTR", "RTX"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/social-media/24/12/42598651/mystery-drone-sightings-all-over-the-country-trump-says-what-to-know-about-investigations-lawmakers-reactions", "tags": []}
{"id": 42598688, "time": "2024-12-19 12:26:17", "headline": "B of A Securities Maintains Neutral on Prothena Corp, Lowers Price Target to $22", "summary": "", "symbols": ["PRTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598688/b-of-a-securities-maintains-neutral-on-prothena-corp-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598704, "time": "2024-12-19 12:27:12", "headline": "RBC Capital Maintains Outperform on Celanese, Lowers Price Target to $88", "summary": "", "symbols": ["CE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598704/rbc-capital-maintains-outperform-on-celanese-lowers-price-target-to-88", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598705, "time": "2024-12-19 12:27:16", "headline": "Bio-Path Holdings Shares Were On The Rise: What's Going On?", "summary": "Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares are surging Thursday following the company&#39;s announcement of encouraging preclinical results for BP1001-A, a potential treatment for obesity and Type 2 diabetes. Here&#39;s what you need to know.", "symbols": ["BPTH"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/24/12/42598705/bio-path-holdings-shares-were-on-the-rise-whats-going-on", "tags": ["why_moving"]}
{"id": 42598716, "time": "2024-12-19 12:27:45", "headline": "Morgan Stanley Maintains Overweight on Ally Financial, Raises Price Target to $42", "summary": "", "symbols": ["ALLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598716/morgan-stanley-maintains-overweight-on-ally-financial-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598735, "time": "2024-12-19 12:28:16", "headline": "From Anime To Abu Dhabi: Analyst Sees NIP Group Transforming Entertainment And Tech", "summary": "NIP Group&#39;s revenue is estimated to grow 14% in 2025, with strong long-term growth driven by M&amp;A, geographic expansion, and innovation.", "symbols": ["NIPG"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/12/42598735/nip-group-to-see-14-revenue-growth-in-2025-analyst-projects-solid-long-term-growth", "tags": ["earnings"]}
{"id": 42598739, "time": "2024-12-19 12:28:33", "headline": "Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges", "summary": "Omeros announces positive results from a pivotal narsoplimab trial in TA-TMA, showing significant survival benefits and advancing regulatory submissions.", "symbols": ["OMER"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/12/42598739/omeros-antibody-improves-overall-survival-in-rare-complication-after-stem-cell-transplant-stock-surges", "tags": ["fda"]}
{"id": 42598746, "time": "2024-12-19 12:28:41", "headline": "Morgan Stanley Maintains Overweight on SLM, Raises Price Target to $32", "summary": "", "symbols": ["SLM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598746/morgan-stanley-maintains-overweight-on-slm-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598768, "time": "2024-12-19 12:29:35", "headline": "Morgan Stanley Maintains Equal-Weight on UWM Hldgs, Lowers Price Target to $6.5", "summary": "", "symbols": ["UWMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598768/morgan-stanley-maintains-equal-weight-on-uwm-hldgs-lowers-price-target-to-6-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598791, "time": "2024-12-19 12:30:28", "headline": "Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $13", "summary": "", "symbols": ["RKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598791/morgan-stanley-maintains-equal-weight-on-rocket-companies-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598804, "time": "2024-12-19 12:30:44", "headline": "TD Cowen Maintains Hold on General Mills, Lowers Price Target to $64", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598804/td-cowen-maintains-hold-on-general-mills-lowers-price-target-to-64", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598808, "time": "2024-12-19 12:30:50", "headline": "A Closer Look at Cintas's Options Market Dynamics", "summary": " ", "symbols": ["CTAS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42598808/a-closer-look-at-cintass-options-market-dynamics", "tags": []}
{"id": 42598822, "time": "2024-12-19 12:31:22", "headline": "Morgan Stanley Maintains Equal-Weight on American Express, Raises Price Target to $305", "summary": "", "symbols": ["AXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598822/morgan-stanley-maintains-equal-weight-on-american-express-raises-price-target-to-305", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598842, "time": "2024-12-19 12:32:02", "headline": "TD Cowen Maintains Buy on Matador Resources, Raises Price Target to $75", "summary": "", "symbols": ["MTDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598842/td-cowen-maintains-buy-on-matador-resources-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598855, "time": "2024-12-19 12:32:37", "headline": "Morgan Stanley Maintains Underweight on SoFi Techs, Raises Price Target to $13", "summary": "", "symbols": ["SOFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598855/morgan-stanley-maintains-underweight-on-sofi-techs-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 42598890, "time": "2024-12-19 12:33:48", "headline": "TD Cowen Maintains Buy on Micron Technology, Lowers Price Target to $125", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598890/td-cowen-maintains-buy-on-micron-technology-lowers-price-target-to-125", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598894, "time": "2024-12-19 12:34:43", "headline": "Morgan Stanley Maintains Equal-Weight on Micron Technology, Lowers Price Target to $98", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598894/morgan-stanley-maintains-equal-weight-on-micron-technology-lowers-price-target-to-98", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598902, "time": "2024-12-19 12:35:11", "headline": "10 Information Technology Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["ADBE", "AVGO", "CLSK", "IREN", "MSFT", "MSTR", "NVDA", "PLTR", "RGTI", "SOUN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42598902/10-information-technology-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 42598904, "time": "2024-12-19 12:35:15", "headline": "7 Consumer Discretionary Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["AMZN", "BKNG", "HD", "MELI", "NKE", "TSLA", "WEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42598904/7-consumer-discretionary-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 42598905, "time": "2024-12-19 12:35:20", "headline": "7 Industrials Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["BE", "DE", "GEV", "HON", "UPWK", "URI", "ZIM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42598905/7-industrials-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 42598915, "time": "2024-12-19 12:35:42", "headline": "TD Cowen Upgrades LPL Finl Hldgs to Buy, Raises Price Target to $413", "summary": "", "symbols": ["LPLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598915/td-cowen-upgrades-lpl-finl-hldgs-to-buy-raises-price-target-to-413", "tags": ["analyst_up", "price_target_up"]}
{"id": 42598916, "time": "2024-12-19 12:35:43", "headline": "Morgan Stanley Maintains Overweight on Western Digital, Lowers Price Target to $93", "summary": "", "symbols": ["WDC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42598916/morgan-stanley-maintains-overweight-on-western-digital-lowers-price-target-to-93", "tags": ["analyst_other", "price_target_down"]}
{"id": 42598931, "time": "2024-12-19 12:36:25", "headline": "Block Positioned For Margin Expansion And EPS Growth: Goldman Sachs Analyst", "summary": "Analyst reiterates Buy rating on SQ with $102 price target, expecting growth in gross profit, margin expansion, and GPV acceleration in 2025.", "symbols": ["ARKF", "DAPP", "SQ"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42598931/analyst-bullish-on-block-cites-strength-in-seller-and-cash-app-growth", "tags": ["analyst_other", "earnings"]}
{"id": 42599021, "time": "2024-12-19 12:40:16", "headline": "Piper Sandler Maintains Neutral on BP, Lowers Price Target to $32", "summary": "", "symbols": ["BP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599021/piper-sandler-maintains-neutral-on-bp-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599031, "time": "2024-12-19 12:40:27", "headline": "TD Cowen Initiates Coverage On Sunrun with Buy Rating, Announces Price Target of $21", "summary": "", "symbols": ["RUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599031/td-cowen-initiates-coverage-on-sunrun-with-buy-rating-announces-price-target-of-21", "tags": ["analyst_init"]}
{"id": 42599081, "time": "2024-12-19 12:41:30", "headline": "What's Going On With Super Micro Computer (SMCI) Stock?", "summary": "Super Micro Computer shares are flat Thursday, down 13% over the past five sessions. The stock may face headwinds as the Federal Reserve on Wednesday signaled a more cautious approach to rate cuts.", "symbols": ["SMCI"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42599081/whats-going-on-with-super-micro-computer-smci-stock-6", "tags": ["why_moving"]}
{"id": 42599089, "time": "2024-12-19 12:41:44", "headline": "US Stocks Edge Up, Micron Suffers Worst Day Since March 2020, Bond Yields Surge: What's Driving Thursday's  Markets?", "summary": "The day after a volatile Federal Reserve meeting, Wall Street grappled with the stark reality of Fed Chair Jerome Powell\u2018s cautious tone on cutting interest rates in 2024.", "symbols": ["ACN", "BTCUSD", "CAG", "CTAS", "DIA", "DRI", "FDS", "FDX", "IWM", "KMX", "LW", "MU", "NKE", "PAYX", "QQQ", "SPY", "TLT", "XLB", "XLK", "XLRE", "XLU"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/24/12/42599089/us-stocks-edge-up-micron-suffers-worst-day-since-march-2020-bond-yields-surge-whats-driving-markets-thursday", "tags": []}
{"id": 42599092, "time": "2024-12-19 12:41:45", "headline": "Piper Sandler Maintains Overweight on ConocoPhillips, Lowers Price Target to $114", "summary": "", "symbols": ["COP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599092/piper-sandler-maintains-overweight-on-conocophillips-lowers-price-target-to-114", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599094, "time": "2024-12-19 12:41:46", "headline": "Hims & Hers Health Are Falling Today: What's Going On?", "summary": "Hims &amp; Hers Health, Inc. (NYSE: HIMS) are trading lower Thursday. The U.S. Food and Drug Administration (FDA) issued a new decision regarding the status of tirzepatide injection shortages, which have impacted the market for GLP-1 receptor agonists. Here&#39;s what you need to know.", "symbols": ["HIMS"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42599094/hims-hers-health-are-falling-today-whats-going-on", "tags": ["why_moving", "fda"]}
{"id": 42599103, "time": "2024-12-19 12:42:03", "headline": "TD Cowen Initiates Coverage On Sunnova Energy Intl with Hold Rating, Announces Price Target of $5", "summary": "", "symbols": ["NOVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599103/td-cowen-initiates-coverage-on-sunnova-energy-intl-with-hold-rating-announces-price-target-of-5", "tags": ["analyst_init"]}
{"id": 42599122, "time": "2024-12-19 12:42:46", "headline": "Piper Sandler Maintains Overweight on Mesoblast, Raises Price Target to $15", "summary": "", "symbols": ["MESO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599122/piper-sandler-maintains-overweight-on-mesoblast-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 42599152, "time": "2024-12-19 12:43:39", "headline": "TD Cowen Initiates Coverage On NEXTracker with Hold Rating, Announces Price Target of $41", "summary": "", "symbols": ["NXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599152/td-cowen-initiates-coverage-on-nextracker-with-hold-rating-announces-price-target-of-41", "tags": ["analyst_init"]}
{"id": 42599154, "time": "2024-12-19 12:43:48", "headline": "Elon Musk As Speaker Of The House? Rand Paul Shows Support, Says People Would 'Lose Their Ever-Lovin' Minds'", "summary": "Billionaire Elon Musk wears many hats as the leader of companies like Tesla Inc (NASDAQ:TSLA), SpaceX, The Boring Company, Neuralink and X.", "symbols": ["ETHUSD", "MATICUSD", "TSLA", "USDC", "USDCUSD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/politics/24/12/42599154/elon-musk-as-speaker-of-the-house-rand-paul-shows-support-says-people-would-lose-their-ever-lovin-minds", "tags": []}
{"id": 42599155, "time": "2024-12-19 12:43:49", "headline": "Piper Sandler Maintains Overweight on Chevron, Lowers Price Target to $173", "summary": "", "symbols": ["CVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599155/piper-sandler-maintains-overweight-on-chevron-lowers-price-target-to-173", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599169, "time": "2024-12-19 12:44:55", "headline": "TruGolf Positioned For Multi-Year Growth From Subscription Revenue And Franchise Potential: Analyst", "summary": "Analyst projects TruGolf Holdings will see 20% revenue growth in 2025, driven by franchise expansion and new software subscriptions.", "symbols": ["TRUG"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/12/42599169/trugolf-holdings-to-see-solid-growth-from-international-franchise-expansion-analyst-projects-20-revenue-growth-next-year", "tags": ["earnings"]}
{"id": 42599172, "time": "2024-12-19 12:44:58", "headline": "Piper Sandler Maintains Neutral on Occidental Petroleum, Lowers Price Target to $51", "summary": "", "symbols": ["OXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599172/piper-sandler-maintains-neutral-on-occidental-petroleum-lowers-price-target-to-51", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599239, "time": "2024-12-19 12:46:11", "headline": "Piper Sandler Maintains Overweight on Shell, Lowers Price Target to $72", "summary": "", "symbols": ["SHEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599239/piper-sandler-maintains-overweight-on-shell-lowers-price-target-to-72", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599240, "time": "2024-12-19 12:46:12", "headline": "BTIG Initiates Coverage On Cartesian Therapeutics with Buy Rating, Announces Price Target of $42", "summary": "", "symbols": ["RNAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599240/btig-initiates-coverage-on-cartesian-therapeutics-with-buy-rating-announces-price-target-of-42", "tags": ["analyst_init"]}
{"id": 42599261, "time": "2024-12-19 12:47:16", "headline": "Piper Sandler Maintains Neutral on TotalEnergies, Lowers Price Target to $62", "summary": "", "symbols": ["TTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599261/piper-sandler-maintains-neutral-on-totalenergies-lowers-price-target-to-62", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599263, "time": "2024-12-19 12:47:31", "headline": "BTIG Initiates Coverage On Avalo Therapeutics with Buy Rating, Announces Price Target of $40", "summary": "", "symbols": ["AVTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599263/btig-initiates-coverage-on-avalo-therapeutics-with-buy-rating-announces-price-target-of-40", "tags": ["analyst_init"]}
{"id": 42599281, "time": "2024-12-19 12:48:23", "headline": "Piper Sandler Maintains Overweight on Exxon Mobil, Lowers Price Target to $127", "summary": "", "symbols": ["XOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599281/piper-sandler-maintains-overweight-on-exxon-mobil-lowers-price-target-to-127", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599293, "time": "2024-12-19 12:49:29", "headline": "Piper Sandler Maintains Overweight on Micron Technology, Lowers Price Target to $120", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599293/piper-sandler-maintains-overweight-on-micron-technology-lowers-price-target-to-120", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599299, "time": "2024-12-19 12:50:32", "headline": "Piper Sandler Maintains Overweight on Rubrik, Raises Price Target to $83", "summary": "", "symbols": ["RBRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599299/piper-sandler-maintains-overweight-on-rubrik-raises-price-target-to-83", "tags": ["analyst_other", "price_target_up"]}
{"id": 42599317, "time": "2024-12-19 12:51:46", "headline": "Raymond James Upgrades Business First Bancshares to Outperform, Announces $30 Price Target", "summary": "", "symbols": ["BFST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599317/raymond-james-upgrades-business-first-bancshares-to-outperform-announces-30-price-target", "tags": ["analyst_up"]}
{"id": 42599325, "time": "2024-12-19 12:53:11", "headline": "4 Micron Analysts Size Up Q1 Earnings: 'An Opportunity To Add'?", "summary": "Micron Technology Inc (NASDAQ:MU) analysts lowered near-term price targets on Thursday following the company&#39;s first-quarter earnings results. Despite the disappointing quarter, analysts generally remain optimistic longer term, especially in the High-Bandwidth Memory market.", "symbols": ["MU"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42599325/4-micron-analysts-size-up-q1-earnings-an-opportunity-to-add", "tags": ["earnings"]}
{"id": 42599327, "time": "2024-12-19 12:53:17", "headline": "Raymond James Upgrades U.S. Bancorp to Outperform, Announces $57 Price Target", "summary": "", "symbols": ["USB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599327/raymond-james-upgrades-u-s-bancorp-to-outperform-announces-57-price-target", "tags": ["analyst_up"]}
{"id": 42599330, "time": "2024-12-19 12:53:22", "headline": "CVS Shares Are Falling Today: What's Going On?", "summary": "CVS Health Corporation&#39;s stock (NYSE: CVS) is trading lower Thursday amid news of a lawsuit filed by the U.S. Department of Justice (DOJ) against CVS Pharmacy Inc., a subsidiary of CVS Health. Here&#39;s what you need to know.", "symbols": ["CVS"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42599330/cvs-shares-are-falling-today-whats-going-on", "tags": ["why_moving", "legal"]}
{"id": 42599385, "time": "2024-12-19 12:54:19", "headline": "Citigroup Maintains Neutral on Cleveland-Cliffs, Lowers Price Target to $11", "summary": "", "symbols": ["CLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599385/citigroup-maintains-neutral-on-cleveland-cliffs-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599431, "time": "2024-12-19 12:56:45", "headline": "Birkenstock's High-end Lifestyle Positioning Provides Competitive Edge That Is Difficult To Replicate: Analyst", "summary": "Birkenstock&#39;s strong demand, high-end lifestyle positioning, and positive FY25 outlook contribute to its competitive advantage, says analyst.", "symbols": ["BIRK"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/12/42599431/birkenstocks-high-end-lifestyle-positioning-provides-competitive-edge-that-is-difficult-to-replicate-analyst", "tags": ["guidance"]}
{"id": 42599447, "time": "2024-12-19 12:57:45", "headline": "Piper Sandler Initiates Coverage On Ormat Technologies with Neutral Rating, Announces Price Target of $78", "summary": "", "symbols": ["ORA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599447/piper-sandler-initiates-coverage-on-ormat-technologies-with-neutral-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 42599449, "time": "2024-12-19 12:57:51", "headline": "Citigroup Maintains Buy on Nucor, Lowers Price Target to $160", "summary": "", "symbols": ["NUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599449/citigroup-maintains-buy-on-nucor-lowers-price-target-to-160", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599500, "time": "2024-12-19 13:00:14", "headline": "Deep Dive Into Tenable Holdings Stock: Analyst Perspectives (9 Ratings)", "summary": " ", "symbols": ["TENB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42599500/deep-dive-into-tenable-holdings-stock-analyst-perspectives-9-ratings", "tags": []}
{"id": 42599502, "time": "2024-12-19 13:00:14", "headline": "Peering Into RTX's Recent Short Interest", "summary": " ", "symbols": ["RTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42599502/peering-into-rtxs-recent-short-interest", "tags": []}
{"id": 42599511, "time": "2024-12-19 13:00:20", "headline": "Peering Into CVS Health's Recent Short Interest", "summary": " ", "symbols": ["CVS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42599511/peering-into-cvs-healths-recent-short-interest", "tags": []}
{"id": 42599517, "time": "2024-12-19 13:00:25", "headline": "How Is The Market Feeling About Western Alliance?", "summary": " ", "symbols": ["WAL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42599517/how-is-the-market-feeling-about-western-alliance", "tags": []}
{"id": 42599518, "time": "2024-12-19 13:00:25", "headline": "What Analysts Are Saying About Camping World Holdings Stock", "summary": " ", "symbols": ["CWH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42599518/what-analysts-are-saying-about-camping-world-holdings-stock", "tags": []}
{"id": 42599521, "time": "2024-12-19 13:00:30", "headline": "Citigroup Maintains Buy on Steel Dynamics, Lowers Price Target to $145", "summary": "", "symbols": ["STLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599521/citigroup-maintains-buy-on-steel-dynamics-lowers-price-target-to-145", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599522, "time": "2024-12-19 13:00:34", "headline": "Expert Outlook: First Horizon Through The Eyes Of 14 Analysts", "summary": " ", "symbols": ["FHN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42599522/expert-outlook-first-horizon-through-the-eyes-of-14-analysts", "tags": ["guidance"]}
{"id": 42599524, "time": "2024-12-19 13:00:45", "headline": "Assessing Western Digital: Insights From 12 Financial Analysts", "summary": " ", "symbols": ["WDC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42599524/assessing-western-digital-insights-from-12-financial-analysts", "tags": []}
{"id": 42599527, "time": "2024-12-19 13:00:56", "headline": "A Glimpse Into The Expert Outlook On Churchill Downs Through 5 Analysts", "summary": " ", "symbols": ["CHDN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42599527/a-glimpse-into-the-expert-outlook-on-churchill-downs-through-5-analysts", "tags": ["guidance"]}
{"id": 42599532, "time": "2024-12-19 13:01:00", "headline": "Piper Sandler Maintains Overweight on Accenture, Raises Price Target to $429", "summary": "", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599532/piper-sandler-maintains-overweight-on-accenture-raises-price-target-to-429", "tags": ["analyst_other", "price_target_up"]}
{"id": 42599537, "time": "2024-12-19 13:01:07", "headline": "Deep Dive Into Zymeworks Stock: Analyst Perspectives (10 Ratings)", "summary": " ", "symbols": ["ZYME"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42599537/deep-dive-into-zymeworks-stock-analyst-perspectives-10-ratings", "tags": []}
{"id": 42599614, "time": "2024-12-19 13:03:22", "headline": "Citigroup Maintains Neutral on General Mills, Lowers Price Target to $67", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599614/citigroup-maintains-neutral-on-general-mills-lowers-price-target-to-67", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599660, "time": "2024-12-19 13:04:19", "headline": "Bitfinex Hacker Of 'Biggest Heist Ever' Documentary Takes Responsibility\u2014But His Wife Has Other Ideas", "summary": "Ilya Lichtenstein confesses to Bitfinex hack and expresses remorse. Plans to use hacking skills in cybersecurity. Wife Heather Morgan turns to Cameo.", "symbols": [], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42599660/bitfinex-hacker-of-biggest-heist-ever-documentary-takes-responsibilitybut-his-wife-has-other-ideas", "tags": []}
{"id": 42599673, "time": "2024-12-19 13:04:51", "headline": "Amazon Has 20,000 Rivian Electric Delivery Vans In Fleet: Here's What Could Be Next For Both Companies", "summary": "A look at what&#39;s next for Amazon and Rivian after the 20,000 electric delivery vans milestone figure was hit.", "symbols": ["AMZN", "RIVN", "T"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/trading-ideas/24/12/42599673/amazon-has-20000-rivian-electric-delivery-vans-in-fleet-heres-what-could-be-next-for-both-companies", "tags": []}
{"id": 42599725, "time": "2024-12-19 13:06:03", "headline": "Citigroup Maintains Buy on Schlumberger, Lowers Price Target to $50", "summary": "", "symbols": ["SLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42599725/citigroup-maintains-buy-on-schlumberger-lowers-price-target-to-50", "tags": ["analyst_other", "price_target_down"]}
{"id": 42599745, "time": "2024-12-19 13:06:32", "headline": "Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday After Back Pain Trial Data?", "summary": "Vertex Pharmaceuticals&#39; suzetrigine reduced pain in Phase 2 trials for lumbosacral radiculopathy. Plans for Phase 3 trials follow regulatory discussions.", "symbols": ["VRTX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/12/42599745/why-is-vertex-pharmaceuticals-stock-trading-on-thursday-lower-after-back-pain-trial-data", "tags": ["why_moving", "fda"]}
{"id": 42599867, "time": "2024-12-19 13:11:52", "headline": "IonQ Positioned To Dominate Quantum Computing Era: Analyst Highlights Unique Trapped-Ion Advantage", "summary": "IonQ initiated with a Buy rating and $50 price target by D.A. Davidson &amp; Co., offering a standout pure-play investment in the quantum computing sector.", "symbols": ["IONQ", "QTUM", "SPRX"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42599867/analyst-bullish-on-ionq-trapped-ion-architecture-and-quantum-cloud-platform-driving-innovation", "tags": ["offering"]}
{"id": 42599887, "time": "2024-12-19 13:13:03", "headline": "What's Going On With Trio Petroleum Stock Thursday?", "summary": "Trio stock is moving higher on Thursday after the company announced that it will acquire certain petroleum and natural gas properties held by Novacor.", "symbols": ["TPET"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42599887/whats-going-on-with-trio-petroleum-stock-thursday", "tags": ["why_moving", "merger"]}
{"id": 42599923, "time": "2024-12-19 13:15:15", "headline": "Price Over Earnings Overview: Merit Medical Systems", "summary": " ", "symbols": ["MMSI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42599923/price-over-earnings-overview-merit-medical-systems", "tags": ["earnings"]}
{"id": 42600049, "time": "2024-12-19 13:18:59", "headline": "XRP Price Down 9%% But Ripple CEO Brad Garlinghouse Eyes RLUSD To Fuel Future Rally", "summary": "Despite a 9% price drop, optimism among XRP (CRYPTO: XRP) traders remains strong, with many holding their positions and anticipating upward momentum.", "symbols": ["BTCUSD", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42600049/xrp-price-down-9-but-ripple-ceo-brad-garlinghouse-eyes-rlusd-to-fuel-future-rally", "tags": ["management"]}
{"id": 42576911, "time": "2024-12-19 08:25:07", "headline": "EXCLUSIVE: MIRA Pharmaceuticals Files FDA Application To Start Human Trials For Its Lead Pain Treatment", "summary": "MIRA Pharmaceuticals submits an IND for Ketamir-2, aiming to treat neuropathic pain with 100% pain reversal shown in preclinical studies.", "symbols": ["MIRA"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42576911/exclusive-mira-pharmaceuticals-files-fda-application-to-start-human-trials-for-its-lead-pain-treatment", "tags": ["fda"]}
{"id": 42600118, "time": "2024-12-19 13:23:35", "headline": "Barclays Maintains Overweight on East West Bancorp, Raises Price Target to $125", "summary": "", "symbols": ["EWBC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42600118/barclays-maintains-overweight-on-east-west-bancorp-raises-price-target-to-125", "tags": ["analyst_other", "price_target_up"]}
{"id": 42600155, "time": "2024-12-19 13:24:09", "headline": "EXCLUSIVE: Nvidia, Broadcom Tipped To Dominate AI Compute Wave By Kurv CEO", "summary": "Tech&#39;s chipmakers, like Nvidia and Broadcom, are leading the AI boom with soaring demand and limited supply. EPS growth and demand signals are positive, making them top stocks to watch.", "symbols": ["AVGO", "NVDA"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42600155/exclusive-nvidia-broadcom-tipped-to-dominate-ai-compute-wave-by-kurv-ceo", "tags": ["earnings", "management"]}
{"id": 42600222, "time": "2024-12-19 13:26:41", "headline": "Stifel Sees Opportunity In DT Midstream Pullback: Upgrades Rating On Diversified Growth Potential", "summary": "Stifel analyst upgrades DT Midstream to Buy and raises price target, citing attractive opportunity for investors and potential for investment grade upgrade.", "symbols": ["CSD", "DTM", "ENFR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42600222/stifel-sees-upside-for-dt-midstream-pipeline-deal-boosts-ebitda-and-free-cash-flow", "tags": ["analyst_up", "price_target_up"]}
{"id": 42600293, "time": "2024-12-19 13:30:35", "headline": "Blue Star Foods To Be Delisted From Nasdaq Following Minimum Bid Price Violation, Trading Suspension Effective December 20, 2024", "summary": "", "symbols": ["BSFC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42600293/blue-star-foods-to-be-delisted-from-nasdaq-following-minimum-bid-price-violation-trading-suspension", "tags": []}
{"id": 42600323, "time": "2024-12-19 13:31:43", "headline": "Spotlight on Chevron: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["CVX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42600323/spotlight-on-chevron-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 42600325, "time": "2024-12-19 13:31:54", "headline": "This Is What Whales Are Betting On Upstart Hldgs", "summary": " ", "symbols": ["UPST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42600325/this-is-what-whales-are-betting-on-upstart-hldgs", "tags": []}
{"id": 42600472, "time": "2024-12-19 13:38:51", "headline": "Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services", "summary": "U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.", "symbols": ["BMY", "CI", "CNC", "CVS", "DGX", "ELV", "GSK", "HQY", "HUM", "IHE", "IHF", "IYH", "JNJ", "LLY", "MRK", "NVO", "NVS", "PFE", "UNH", "VHT", "WBA"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42600472/your-healthcare-costs-are-soaring-us-spending-reached-5-trillion-in-2023-with-major-increase-in-obesity-and-diabetes-drugs-hospital-services", "tags": []}
{"id": 42600482, "time": "2024-12-19 13:39:26", "headline": "Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials", "summary": "Merck shares Phase 3 trial results for its HIV-1 regimen, doravirine/islatravir, showing safety and comparable efficacy to existing therapies.", "symbols": ["MRK"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42600482/mercks-investigational-two-drug-regime-for-hiv-meets-primary-goal-in-two-late-stage-trials", "tags": ["fda"]}
{"id": 42600565, "time": "2024-12-19 13:42:12", "headline": "Barrington Research Maintains Outperform on Kadant, Raises Price Target to $410", "summary": "", "symbols": ["KAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42600565/barrington-research-maintains-outperform-on-kadant-raises-price-target-to-410", "tags": ["analyst_other", "price_target_up"]}
{"id": 42600598, "time": "2024-12-19 13:44:04", "headline": "Nike's Earnings Loom With Bearish Signals: Will The Swoosh Bounce Back?", "summary": "Nike (NKE) to report Q2 earnings on Thursday. Wall Street expects 64 cents EPS and $12.13 billion revenues. Stock down 37.30% over past year, but analysts see 17% upside potential.", "symbols": ["FL", "NKE"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/12/42600598/nikes-earnings-loom-with-bearish-signals-will-the-swoosh-bounce-back", "tags": ["earnings"]}
{"id": 42600650, "time": "2024-12-19 13:46:17", "headline": "Benzinga Market Summary: S&P Rises Following GDP And Jobless Claims Data", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42600650/benzinga-market-summary-s-p-rises-following-gdp-and-jobless-claims-data", "tags": []}
{"id": 42600739, "time": "2024-12-19 13:50:48", "headline": "Shares of quantum computing companies are trading lower. The industry may be pulling back following recent strength.", "summary": "", "symbols": ["QBTS", "QMCO", "QUBT", "RGTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42600739/shares-of-quantum-computing-companies-are-trading-lower-the-industry-may-be-pulling-back-following-r", "tags": []}
{"id": 42600913, "time": "2024-12-19 14:00:19", "headline": "Forecasting The Future: 18 Analyst Projections For East West Bancorp", "summary": " ", "symbols": ["EWBC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42600913/forecasting-the-future-18-analyst-projections-for-east-west-bancorp", "tags": []}
{"id": 42600915, "time": "2024-12-19 14:00:25", "headline": "A Glimpse Into The Expert Outlook On Deere Through 12 Analysts", "summary": " ", "symbols": ["DE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42600915/a-glimpse-into-the-expert-outlook-on-deere-through-12-analysts", "tags": ["guidance"]}
{"id": 42600917, "time": "2024-12-19 14:00:33", "headline": "Expert Outlook: IREN Through The Eyes Of 10 Analysts", "summary": " ", "symbols": ["IREN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42600917/expert-outlook-iren-through-the-eyes-of-10-analysts", "tags": ["guidance"]}
{"id": 42600918, "time": "2024-12-19 14:00:44", "headline": "Analyst Expectations For Civitas Resources's Future", "summary": " ", "symbols": ["CIVI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42600918/analyst-expectations-for-civitas-resourcess-future", "tags": []}
{"id": 42600923, "time": "2024-12-19 14:00:57", "headline": "What Analysts Are Saying About Targa Resources Stock", "summary": " ", "symbols": ["TRGP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42600923/what-analysts-are-saying-about-targa-resources-stock", "tags": []}
{"id": 42600926, "time": "2024-12-19 14:01:03", "headline": "Spotlight on Cava Group: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42600926/spotlight-on-cava-group-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 42600929, "time": "2024-12-19 14:01:04", "headline": "Forecasting The Future: 15 Analyst Projections For Celanese", "summary": " ", "symbols": ["CE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42600929/forecasting-the-future-15-analyst-projections-for-celanese", "tags": []}
{"id": 42600934, "time": "2024-12-19 14:01:09", "headline": "What the Options Market Tells Us About GE Aero", "summary": " ", "symbols": ["GE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42600934/what-the-options-market-tells-us-about-ge-aero", "tags": []}
{"id": 42600937, "time": "2024-12-19 14:01:14", "headline": "What the Options Market Tells Us About Intel", "summary": " ", "symbols": ["INTC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42600937/what-the-options-market-tells-us-about-intel", "tags": []}
{"id": 42600988, "time": "2024-12-19 14:03:17", "headline": "DJT Stock Eyes Golden Cross As Truth+ Expands Its Reach", "summary": "Short-term indicators and Trump&#39;s involvement with parent company TMTG create a mixed outlook for investors.", "symbols": ["DJT"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/general/social-media/24/12/42600988/djt-stock-eyes-golden-cross-as-truth-expands-its-reach", "tags": ["guidance"]}
{"id": 42601043, "time": "2024-12-19 14:05:19", "headline": "'Intel Shortlists Suitors for Programmable Chip Arm Altera' - Bloomberg", "summary": "", "symbols": ["INTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42601043/intel-shortlists-suitors-for-programmable-chip-arm-altera-bloomberg", "tags": []}
{"id": 42601142, "time": "2024-12-19 14:09:03", "headline": "Bloomberg: Francisco Partners And Silver Lake Competing Alongside Lattice Semiconductor In Second Round For Altera", "summary": "", "symbols": ["LSCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42601142/bloomberg-francisco-partners-and-silver-lake-competing-alongside-lattice-semiconductor-in-second-rou", "tags": []}
{"id": 42601180, "time": "2024-12-19 14:12:02", "headline": "Boeing Shares Are Taking Off Today: What's Going On?", "summary": "Boeing Company (NYSE: BA) shares are trading higher Thursday after the company announced Pegasus Airlines placed an order for up to 200 Boeing 737-10 airplanes, including a firm order for 100 aircraft. Here&#39;s what you need to know.", "symbols": ["BA"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42601180/boeing-shares-are-taking-off-today-whats-going-on", "tags": ["why_moving"]}
{"id": 42601193, "time": "2024-12-19 14:13:43", "headline": "Senator Lummis Introduces Strategic Bitcoin Reserve Proposal", "summary": "Senator Cynthia Lummis (R-Wyo.) has introduced a proposal that would grant the Federal Reserve the authority to own Bitcoin (CRYPTO: ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42601193/senator-lummis-introduces-strategic-bitcoin-reserve-proposal", "tags": []}
{"id": 42601262, "time": "2024-12-19 14:16:50", "headline": "ZenaTech Shares Halted To The Upside; Stock Now Up 76.50%", "summary": "", "symbols": ["ZENA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42601262/zenatech-shares-halted-to-the-upside-stock-now-up-76-50", "tags": ["halt"]}
{"id": 42601319, "time": "2024-12-19 14:19:17", "headline": "The Hill: 'House GOP eyes plan B stopgap with separate two-part debt limit commitment'", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42601319/the-hill-house-gop-eyes-plan-b-stopgap-with-separate-two-part-debt-limit-commitme", "tags": []}
{"id": 42601327, "time": "2024-12-19 14:19:31", "headline": "Amazon Investors Unbothered As Warehouse Workers Walk Off The Job: What's Going On With The E-Commerce Giant's Stock?", "summary": "Amazon.com Inc (NASDAQ:AMZN) shares are trading higher Thursday despite thousands of workers walking off job sites in an effort to push the company to engage in contract negotiations. Amazon reportedly said it doesn&#39;t expect operations to be impacted. ", "symbols": ["AMZN"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/24/12/42601327/amazon-investors-unbothered-as-warehouse-workers-walk-off-the-job-whats-going-on-with-the-e-commerce-giants-stock", "tags": ["why_moving", "contract"]}
{"id": 42601363, "time": "2024-12-19 14:22:12", "headline": "ZenaTech Shares Resume", "summary": "", "symbols": ["ZENA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42601363/zenatech-shares-resume", "tags": []}
{"id": 42601366, "time": "2024-12-19 14:22:43", "headline": "What's Going On With Mesoblast Shares Thursday?", "summary": "Mesoblast Limited (NASDAQ:MESO) stock is trading higher Thursday after the company announced the U.S. Food and Drug Administration (FDA) approved Ryoncil.", "symbols": ["MESO"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/news/fda/24/12/42601366/whats-going-on-with-mesoblast-shares-thursday", "tags": ["why_moving", "fda"]}
{"id": 42601377, "time": "2024-12-19 14:23:36", "headline": "FedEx Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["FDX"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42601377/fedex-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 42601428, "time": "2024-12-19 14:25:09", "headline": "Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline", "summary": " ", "symbols": ["BPTH", "LITM", "LW", "MU", "OMER", "TPET"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42601428/nasdaq-jumps-100-points-us-initial-jobless-claims-decline", "tags": []}
{"id": 42601555, "time": "2024-12-19 14:30:17", "headline": "(GILD) - Analyzing Gilead Sciences's Short Interest", "summary": " ", "symbols": ["GILD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42601555/gild-analyzing-gilead-sciencess-short-interest", "tags": []}
{"id": 42601567, "time": "2024-12-19 14:30:22", "headline": "(VRNS) - Analyzing Varonis Systems's Short Interest", "summary": " ", "symbols": ["VRNS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42601567/vrns-analyzing-varonis-systemss-short-interest", "tags": []}
{"id": 42601570, "time": "2024-12-19 14:30:27", "headline": "Peering Into LPL Finl Hldgs's Recent Short Interest", "summary": " ", "symbols": ["LPLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42601570/peering-into-lpl-finl-hldgss-recent-short-interest", "tags": []}
{"id": 42601645, "time": "2024-12-19 14:32:01", "headline": "Phio Pharmaceuticals Announces $1.15M Registered Direct Offering Priced At-the-Market Under Nasdaq Rules", "summary": "", "symbols": ["PHIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42601645/phio-pharmaceuticals-announces-1-15m-registered-direct-offering-priced-at-the-market-under-nasdaq-ru", "tags": ["offering"]}
{"id": 42601906, "time": "2024-12-19 14:48:00", "headline": "Decoding NextEra Energy's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["NEE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42601906/decoding-nextera-energys-options-activity-whats-the-big-picture", "tags": []}
{"id": 42601907, "time": "2024-12-19 14:48:05", "headline": "Check Out What Whales Are Doing With COP", "summary": " ", "symbols": ["COP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42601907/check-out-what-whales-are-doing-with-cop", "tags": []}
{"id": 42601987, "time": "2024-12-19 14:51:46", "headline": "Bitcoin Price Craters 6.5% To $96,500: What Is Going On?", "summary": "Bitcoin (CRYPTO: BTC) prices continued their downward trajectory on Thursday, falling 6.5% over the past 24 hours as markets digest the Federal Reserve ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42601987/bitcoin-price-craters-65-to-96500-what-is-going-on", "tags": []}
{"id": 42602212, "time": "2024-12-19 15:00:14", "headline": "7 Analysts Assess AGCO: What You Need To Know", "summary": " ", "symbols": ["AGCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42602212/7-analysts-assess-agco-what-you-need-to-know", "tags": []}
{"id": 42602217, "time": "2024-12-19 15:00:22", "headline": "Breaking Down Associated Banc: 10 Analysts Share Their Views", "summary": " ", "symbols": ["ASB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42602217/breaking-down-associated-banc-10-analysts-share-their-views", "tags": []}
{"id": 42602218, "time": "2024-12-19 15:00:22", "headline": "Options Corner: Play Both Sides Of Uranium Energy With A Long Straddle", "summary": "Although Uranium Energy has benefited from tailwinds, both political and technical pressures warrant a neutral approach with UEC stock.", "symbols": ["UEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42602218/uec-stock-uncertainty-opens-directionally-neutral-long-straddle-strategy", "tags": []}
{"id": 42602223, "time": "2024-12-19 15:00:29", "headline": "A Glimpse Into The Expert Outlook On Steel Dynamics Through 9 Analysts", "summary": " ", "symbols": ["STLD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42602223/a-glimpse-into-the-expert-outlook-on-steel-dynamics-through-9-analysts", "tags": ["guidance"]}
{"id": 42602225, "time": "2024-12-19 15:00:37", "headline": "Analyst Expectations For Zebra Technologies's Future", "summary": " ", "symbols": ["ZBRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42602225/analyst-expectations-for-zebra-technologiess-future", "tags": []}
{"id": 42602229, "time": "2024-12-19 15:00:46", "headline": "Nucor Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)", "summary": " ", "symbols": ["NUE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42602229/nucor-stock-a-deep-dive-into-analyst-perspectives-6-ratings", "tags": []}
{"id": 42602237, "time": "2024-12-19 15:00:55", "headline": "Beyond The Numbers: 7 Analysts Discuss Terex Stock", "summary": " ", "symbols": ["TEX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42602237/beyond-the-numbers-7-analysts-discuss-terex-stock", "tags": []}
{"id": 42602249, "time": "2024-12-19 15:01:26", "headline": "A Look Into Aehr Test System Inc's Price Over Earnings", "summary": " ", "symbols": ["AEHR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42602249/a-look-into-aehr-test-system-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 42602318, "time": "2024-12-19 15:03:47", "headline": "C-Suite Buy of the Week: Unusual Insider Trading Trends as 2025 Approaches", "summary": " ", "symbols": ["AVDL", "SCVL", "TREE"], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/24/12/42602318/c-suite-buy-of-the-week-unusual-insider-trading-trends-as-2025-approaches", "tags": ["insider"]}
{"id": 42575914, "time": "2024-12-19 07:56:08", "headline": "Phio Pharmaceuticals shares are trading higher after the company announced that the Safety Monitoring Committee recommended dose escalation in its Phase 1B trial evaluating PH-762 for various advanced cancers, including cutaneous squamous cell carcinoma, melanoma, and Merkel cell carcinoma.", "summary": "", "symbols": ["PHIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42575914/phio-pharmaceuticals-shares-are-trading-higher-after-the-company-announced-that-the-safety-monitorin", "tags": ["why_moving", "fda"]}
{"id": 42576587, "time": "2024-12-19 08:14:33", "headline": "Soho House shares are trading higher after the company received a $9.00 per share acquisition offer from a consortium backed by Executive Chairman Ron Burkle and Yucaipa. The board has formed a special committee to evaluate the proposal.", "summary": "", "symbols": ["SHCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42576587/soho-house-shares-are-trading-higher-after-the-company-received-a-9-00-per-share-acquisition-offer-f", "tags": ["why_moving"]}
{"id": 42602503, "time": "2024-12-19 15:11:48", "headline": "Dave Portnoy Says He Owns $1.5 Million Bitcoin, $1.3 Million XRP: 'Bet It And Set It, Not Trading'", "summary": "Barstool Sports founder Dave Portnoy shared on a recent stream that he owns millions of dollars in Bitcoin (CRYPTO: BTC) and XRP (CRYPTO: XRP), which comes after he recently", "symbols": ["BTCUSD", "XRPUSD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/24/12/42602503/dave-portnoy-says-he-owns-15-million-bitcoin-13-million-xrp-bet-it-and-set-it-not-trading", "tags": []}
{"id": 42602591, "time": "2024-12-19 15:15:12", "headline": "P/E Ratio Insights for Sempra", "summary": " ", "symbols": ["SRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42602591/pe-ratio-insights-for-sempra", "tags": []}
{"id": 42602764, "time": "2024-12-19 15:25:14", "headline": "$100 Invested In Tyler Technologies 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["TYL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42602764/100-invested-in-tyler-technologies-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42602901, "time": "2024-12-19 15:30:34", "headline": "Price Over Earnings Overview: Ubiquiti", "summary": " ", "symbols": ["UI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42602901/price-over-earnings-overview-ubiquiti", "tags": ["earnings"]}
{"id": 42602974, "time": "2024-12-19 15:34:41", "headline": "Marriott Vacations Extends Share Repurchase Program Through December 2025", "summary": "", "symbols": ["VAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42602974/marriott-vacations-extends-share-repurchase-program-through-december-2025", "tags": ["buyback"]}
{"id": 42603073, "time": "2024-12-19 15:40:49", "headline": "Natural Gas Nears 2-Year Highs, Inflation Fears Mount As Utility Costs Climb: 3 Energy Stocks Rise", "summary": "Natural gas prices jump 6.5% on robust demand and geopolitical uncertainties, eyeing highest close since January 2023. Domestic demand soars with record-breaking consumption in 2024 and EU&#39;s search for alternative suppliers. Natural gas stocks outperform in energy sector.&gt;U.S. natural gas prices surge on demand and geopolitical uncertainties, reaching highest close since Jan 2023. Record-breaking domestic consumption in 2024 and EU&#39;s search for alternative suppliers also drive prices.", "symbols": ["EQT", "KMI", "UNG", "WMB"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/24/12/42603073/natural-gas-prices-rally-to-over-2-year-highs-cloud-the-outlook-for-inflation-3-energy-stocks-rise-thursday", "tags": []}
{"id": 42603286, "time": "2024-12-19 15:49:00", "headline": "Punchbowl Reporter: 'HOUSE REPUBLICANS are eyeing a package to extend govt funding for three months, suspend the debt limit until Jan 2027.'", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/politics/24/12/42603286/punchbowl-reporter-house-republicans-are-eyeing-a-package-to-extend-govt-funding-for-three-month", "tags": []}
{"id": 42603496, "time": "2024-12-19 16:00:17", "headline": "Where U.S. Bancorp Stands With Analysts", "summary": " ", "symbols": ["USB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42603496/where-u-s-bancorp-stands-with-analysts", "tags": []}
{"id": 42603508, "time": "2024-12-19 16:00:28", "headline": "11 Analysts Have This To Say About Victory Capital Holdings", "summary": " ", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42603508/11-analysts-have-this-to-say-about-victory-capital-holdings", "tags": []}
{"id": 42603510, "time": "2024-12-19 16:00:36", "headline": "Breaking Down Accenture: 16 Analysts Share Their Views", "summary": " ", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42603510/breaking-down-accenture-16-analysts-share-their-views", "tags": []}
{"id": 42603515, "time": "2024-12-19 16:00:47", "headline": "Deep Dive Into Varonis Systems Stock: Analyst Perspectives (8 Ratings)", "summary": " ", "symbols": ["VRNS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42603515/deep-dive-into-varonis-systems-stock-analyst-perspectives-8-ratings", "tags": []}
{"id": 42603516, "time": "2024-12-19 16:00:56", "headline": "Vince Holding Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)", "summary": " ", "symbols": ["VNCE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42603516/vince-holding-stock-a-deep-dive-into-analyst-perspectives-6-ratings", "tags": []}
{"id": 42603522, "time": "2024-12-19 16:01:04", "headline": "Avinger Has Received A Notice Of Allowance For A U.S. Patent Titled \"CATHETER DEVICE WITH DETACHABLE DISTAL END (FOR THE TREATMENT OF PERIPHERAL ARTERY DISEASE)\".", "summary": "", "symbols": ["AVGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42603522/avinger-has-received-a-notice-of-allowance-for-a-u-s-patent-titled-catheter-device-with-detachabl", "tags": []}
{"id": 42603529, "time": "2024-12-19 16:01:08", "headline": "The Analyst Verdict: Incyte In The Eyes Of 15 Experts", "summary": " ", "symbols": ["INCY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42603529/the-analyst-verdict-incyte-in-the-eyes-of-15-experts", "tags": []}
{"id": 42603576, "time": "2024-12-19 16:02:19", "headline": "Seacoast Banking Renews $100M Share Repurchase Program", "summary": "", "symbols": ["SBCF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603576/seacoast-banking-renews-100m-share-repurchase-program", "tags": ["buyback"]}
{"id": 42603589, "time": "2024-12-19 16:02:38", "headline": "Disney Hits $2 Billion Domestic Box Office, Earns Top Honors", "summary": "Disney led the way for domestic box office in 2024 with over $2 billion thanks to hit franchises. Here&#39;s a look at the winning studios and what&#39;s next in 2025.", "symbols": ["AAPL", "AMC", "AMZN", "CMCSA", "CNK", "DIS", "LGF", "PARA", "PARAA", "SONY", "WBD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/24/12/42603589/disney-hits-2-billion-domestic-box-office-wins-top-honors-global-box-office-2025-to-grow-8-to-33b-analyst-says", "tags": []}
{"id": 42603590, "time": "2024-12-19 16:02:41", "headline": "Scholastic Q2 Adj $1.82 Misses $2.30 Estimate, Sales $544.60M Miss $553.97M Estimate", "summary": "", "symbols": ["SCHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42603590/scholastic-q2-adj-1-82-misses-2-30-estimate-sales-544-60m-miss-553-97m-estimate", "tags": []}
{"id": 42603592, "time": "2024-12-19 16:02:43", "headline": "FedEx Announces Intent To Pursue Full Separation Of FedEx Freight", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603592/fedex-announces-intent-to-pursue-full-separation-of-fedex-freight", "tags": []}
{"id": 42603596, "time": "2024-12-19 16:02:50", "headline": "Interlink Electronics Reports Acquisition Of Businesses Of UK-Based Conductive Transfers Limited And Its Affiliate, Global Print Solutions; No Terms Disclosed", "summary": "", "symbols": ["LINK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42603596/interlink-electronics-reports-acquisition-of-businesses-of-uk-based-conductive-transfers-limited-and", "tags": []}
{"id": 42603606, "time": "2024-12-19 16:03:03", "headline": "Scholastic Reaffirms Fiscal 2025 Guidance", "summary": "", "symbols": ["SCHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603606/scholastic-reaffirms-fiscal-2025-guidance", "tags": ["guidance"]}
{"id": 42603610, "time": "2024-12-19 16:03:08", "headline": "FedEx To Spin Off FedEx Freight Into A Separate Publicly Traded Company Within 18 Months", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603610/fedex-to-spin-off-fedex-freight-into-a-separate-publicly-traded-company-within-18-months", "tags": []}
{"id": 42603632, "time": "2024-12-19 16:03:59", "headline": "FedEx Q2 2025 Adj. EPS $4.05 Beats $3.91 Estimate, Sales $22B Miss $22.112B Estimate", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42603632/fedex-q2-2025-adj-eps-4-05-beats-3-91-estimate-sales-22b-miss-22-112b-estimate", "tags": ["earnings"]}
{"id": 42603633, "time": "2024-12-19 16:04:06", "headline": "Donald J. Trump Posts On Truth \"SUCCESS in Washington! Speaker Mike Johnson and the House have come to a very good Deal for the American People. The newly agreed to American Relief Act of 2024 will keep the Government open, fund our Great Farmers and others, and provide relief for those severely impacted by the devastating hurricanes....\"", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42603633/donald-j-trump-posts-on-truth-success-in-washington-speaker-mike-johnson-and-the-", "tags": ["contract"]}
{"id": 42603651, "time": "2024-12-19 16:04:24", "headline": "Energy Transfer Enters 20-year LNG Sale And Purchase Agreement With Chevron Related To Its Lake Charles LNG Project", "summary": "", "symbols": ["CVX", "ET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603651/energy-transfer-enters-20-year-lng-sale-and-purchase-agreement-with-chevron-related-to-its-lake-char", "tags": ["contract"]}
{"id": 42603731, "time": "2024-12-19 16:05:32", "headline": "Modular Medical Will Collaborate With Nudge BG To Bring To Market An Adaptive Full Closed Loop Automated Insulin Delivery System That Does Not Require Mealtime Announcements; Effort Will Be Led Be Nudge BG Founder And Noted AID Expert, Lane Desborough", "summary": "", "symbols": ["MODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42603731/modular-medical-will-collaborate-with-nudge-bg-to-bring-to-market-an-adaptive-full-closed-loop-au", "tags": []}
{"id": 42603736, "time": "2024-12-19 16:05:41", "headline": "FedEx Sees FY25 Adjusted EPS of $16.45-$17.45 (Excluding MTM adjustments) vs Prior Guidance $17.90-$18.90; Sees FY25 Adjusted EPS $19.00-$20.00 (excluding MTM adjustments and business optimization costs) vs Prior Guidance of $20.00-$21.00", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603736/fedex-sees-fy25-adjusted-eps-of-16-45-17-45-excluding-mtm-adjustments-vs-prior-guidance-17-90-18-90", "tags": ["earnings", "guidance"]}
{"id": 42603742, "time": "2024-12-19 16:05:55", "headline": "Curbline Properties Declares Special Cash Dividend Of $0.25 Per Share", "summary": "", "symbols": ["CURB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603742/curbline-properties-declares-special-cash-dividend-of-0-25-per-share", "tags": ["dividend"]}
{"id": 42603769, "time": "2024-12-19 16:06:29", "headline": "12 Information Technology Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["BOXL", "ENFN", "MU", "MVIS", "NSYS", "NVNI", "ONDS", "QMCO", "QUBT", "RGTI", "SOBR", "VRAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/12/42603769/12-information-technology-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 42603773, "time": "2024-12-19 16:06:31", "headline": "Mission Produce Q4 2024 Adj. EPS $0.28, Sales $354.400M Beat $220.400M Estimate", "summary": "", "symbols": ["AVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42603773/mission-produce-q4-2024-adj-eps-0-28-sales-354-400m-beat-220-400m-estimate", "tags": ["earnings"]}
{"id": 42603775, "time": "2024-12-19 16:06:35", "headline": "12 Industrials Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["AMRC", "BURU", "CVR", "FGL", "GRFX", "KULR", "LICN", "MLKN", "RR", "TOMZ", "VSTE", "XCH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/12/42603775/12-industrials-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 42603780, "time": "2024-12-19 16:06:40", "headline": "12 Health Care Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["ABP", "AEMD", "BPTH", "ISPC", "MESO", "MRKR", "MYNZ", "OMER", "PBM", "PLRX", "PLRZ", "VRTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/12/42603780/12-health-care-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 42603790, "time": "2024-12-19 16:06:46", "headline": "12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["CTHR", "FRSX", "FTEL", "LEN", "LRN", "LXEH", "RIME", "SHCO", "SPGC", "SYPR", "ZAPP", "ZCMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/12/42603790/12-consumer-discretionary-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 42603851, "time": "2024-12-19 16:07:57", "headline": "Mission Produce Sees Q1 Industry Volumes Consistent With Period Year Proir; Pricing Higher YoY By ~20%", "summary": "", "symbols": ["AVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603851/mission-produce-sees-q1-industry-volumes-consistent-with-period-year-proir-pricing-higher-yoy-by-20", "tags": []}
{"id": 42603852, "time": "2024-12-19 16:07:57", "headline": "Four Corners Property Trust Reveals Acquisition Of A P.F. Chang's Property For $4.8M", "summary": "", "symbols": ["FCPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42603852/four-corners-property-trust-reveals-acquisition-of-a-p-f-changs-property-for-4-8m", "tags": []}
{"id": 42603864, "time": "2024-12-19 16:08:19", "headline": "Mobix Labs Q3 2025 EPS $(0.35) Up From $(0.42) YoY; Revenue $2.95M Up From $433K YoY", "summary": "", "symbols": ["MOBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42603864/mobix-labs-q3-2025-eps-0-35-up-from-0-42-yoy-revenue-2-95m-up-from-433k-yoy", "tags": ["earnings"]}
{"id": 42603878, "time": "2024-12-19 16:08:53", "headline": "Ultragenyx Doses First Patient In Pivotal Phase 3 Aspire Study Evaluating GTX-102 In Angelman Syndrome", "summary": "", "symbols": ["RARE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42603878/ultragenyx-doses-first-patient-in-pivotal-phase-3-aspire-study-evaluating-gtx-102-in-angelman-syn", "tags": ["fda"]}
{"id": 42603881, "time": "2024-12-19 16:09:16", "headline": "OraSure Technologies Acquires Sherlock Biosciences; No Financial Terms Disclosed", "summary": "", "symbols": ["OSUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42603881/orasure-technologies-acquires-sherlock-biosciences-no-financial-terms-disclosed", "tags": ["merger"]}
{"id": 42603883, "time": "2024-12-19 16:09:28", "headline": "Mister Car Wash To Voluntarily Transfer The Listing Of Its Common Stock From NYSE To Nasdaq Effective December 31, 2024, After Market Close", "summary": "", "symbols": ["MCW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603883/mister-car-wash-to-voluntarily-transfer-the-listing-of-its-common-stock-from-nyse-to-nasdaq-effectiv", "tags": []}
{"id": 42603937, "time": "2024-12-19 16:10:35", "headline": "AMCON Distributing Announces $0.28 Special Dividend", "summary": "", "symbols": ["DIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603937/amcon-distributing-announces-0-28-special-dividend", "tags": ["dividend"]}
{"id": 42603945, "time": "2024-12-19 16:10:55", "headline": "Itron And Xcel Energy Collaborate To Manage Growing Number Of Distributed Energy Resources in Colorado, Including Residential Battery Energy Storage, To Support Grid Flexibility And Customer Choice", "summary": "", "symbols": ["ITRI", "XEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603945/itron-and-xcel-energy-collaborate-to-manage-growing-number-of-distributed-energy-resources-in-colora", "tags": []}
{"id": 42603947, "time": "2024-12-19 16:10:57", "headline": "Expedia Group Names Scott Schenkel As Chief Financial Officer", "summary": "", "symbols": ["EXPE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603947/expedia-group-names-scott-schenkel-as-chief-financial-officer", "tags": []}
{"id": 42603977, "time": "2024-12-19 16:11:16", "headline": "Pyxis Oncology Plans Portfolio Prioritization, Focusing Resources On Advancing Its Lead Clinical Program, PYX-201;  Decides To Suspend Further Clinical Investment In PYX-106", "summary": "", "symbols": ["PYXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603977/pyxis-oncology-plans-portfolio-prioritization-focusing-resources-on-advancing-its-lead-clinical-prog", "tags": ["fda"]}
{"id": 42603988, "time": "2024-12-19 16:11:45", "headline": "Aptose Granted Extension To Evidence Compliance For Continued Nasdaq Listing", "summary": "", "symbols": ["APTO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42603988/aptose-granted-extension-to-evidence-compliance-for-continued-nasdaq-listing", "tags": []}
{"id": 42604002, "time": "2024-12-19 16:12:40", "headline": "enGene Holdings FY EPS $(1.46) Misses $(1.38) Estimate", "summary": "", "symbols": ["ENGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42604002/engene-holdings-fy-eps-1-46-misses-1-38-estimate", "tags": ["earnings"]}
{"id": 42604009, "time": "2024-12-19 16:13:11", "headline": "Bowman Consulting Secures Two Contracts, With Combined Value Of Nearly $900K, To Provide Asset Management And Data Collection Services", "summary": "", "symbols": ["BWMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604009/bowman-consulting-secures-two-contracts-with-combined-value-of-nearly-900k-to-provide-asset-manageme", "tags": []}
{"id": 42604022, "time": "2024-12-19 16:13:17", "headline": "Mobix Labs Sees Q1 2025 Revenue $3.05M-$3.15M", "summary": "", "symbols": ["MOBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604022/mobix-labs-sees-q1-2025-revenue-3-05m-3-15m", "tags": ["earnings"]}
{"id": 42604023, "time": "2024-12-19 16:13:29", "headline": "Bitcoin, Ethereum, XRP Plunge Over 6% Each, Dogecoin Drowns 14% On Turbulent Post-FOMC Thursday", "summary": "Cryptocurrency markets are trading lower on Thursday, with Bitcoin falling below the $100,000 mark following Wednesday\u2019s Fed meeting.", "symbols": ["BTCUSD", "DAOUSD", "DOGEUSD", "ETHUSD", "SHIBUSD", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42604023/bitcoin-ethereum-xrp-plunge-over-6-each-dogecoin-drowns-14-in-turbulent-post-fomc-thursday", "tags": []}
{"id": 42604050, "time": "2024-12-19 16:14:13", "headline": "TradePulse Power Inflow Alert: First Citizens Bancshares Inc (FCNCA) Moves Up Over 31 Points After Alert", "summary": " ", "symbols": ["FCNCA"], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/trading-ideas/24/12/42604050/tradepulse-power-inflow-alert-first-citizens-bancshares-inc-fcnca-moves-up-over-31-points-after-ale", "tags": []}
{"id": 42604079, "time": "2024-12-19 16:15:05", "headline": "Molecular Templates Announce Delisting Notice", "summary": "", "symbols": ["MTEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604079/molecular-templates-announce-delisting-notice", "tags": []}
{"id": 42604137, "time": "2024-12-19 16:15:25", "headline": "Here's How Much You Would Have Made Owning Pure Storage Stock In The Last 5 Years", "summary": " ", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42604137/heres-how-much-you-would-have-made-owning-pure-storage-stock-in-the-last-5-years", "tags": []}
{"id": 42604176, "time": "2024-12-19 16:15:35", "headline": "Nike Q2 2025 GAAP EPS $0.78 Beats $0.65 Estimate, Sales $12.354B Beat $12.133B Estimate", "summary": "", "symbols": ["NKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42604176/nike-q2-2025-gaap-eps-0-78-beats-0-65-estimate-sales-12-354b-beat-12-133b-estimate", "tags": ["earnings"]}
{"id": 42604192, "time": "2024-12-19 16:16:07", "headline": "NIKE Inventories $8B, Flat YoY", "summary": "", "symbols": ["NKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42604192/nike-inventories-8b-flat-yoy", "tags": []}
{"id": 42604209, "time": "2024-12-19 16:16:28", "headline": "From Bitcoin to Multi-Coin: The Formula for Choosing a Winning Digital Asset Index for Investors", "summary": "The S&amp;P 500 is frequently viewed as a barometer for the overall health of the US stock market by analysts, journalists, and investors. With the recent market momentum, crypto indexes will soon be held in the same regard.", "symbols": ["BTCUSD", "ETHUSD"], "source": "benzinga", "author": "nick+hashkeybenzinga@angle42.co", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42604209/from-bitcoin-to-multi-coin-the-formula-for-choosing-a-winning-digital-asset-index-for-inve", "tags": []}
{"id": 42604231, "time": "2024-12-19 16:17:00", "headline": "Presidio Property Approves Share Buyback Of Up To $6M Of Outstanding Series A Stock And $4M Of Outstanding Series D", "summary": "", "symbols": ["SQFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604231/presidio-property-approves-share-buyback-of-up-to-6m-of-outstanding-series-a-stock-and-4m-of-outstan", "tags": ["buyback"]}
{"id": 42604244, "time": "2024-12-19 16:17:08", "headline": "Veralto  Boosts Quarterly Dividend By 22% From $0.09 To $0.11 Per Share", "summary": "", "symbols": ["VLTO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604244/veralto-boosts-quarterly-dividend-by-22-from-0-09-to-0-11-per-share", "tags": ["dividend"]}
{"id": 42604247, "time": "2024-12-19 16:17:14", "headline": "NIKE Direct Revenues $5B, Down 13%", "summary": "", "symbols": ["NKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42604247/nike-direct-revenues-5b-down-13", "tags": []}
{"id": 42604259, "time": "2024-12-19 16:17:24", "headline": "Optex Systems FY24 EPS $0.56 Up From $0.34 YoY; Revenue $34M Up From $25.66M YoY", "summary": "", "symbols": ["OPXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42604259/optex-systems-fy24-eps-0-56-up-from-0-34-yoy-revenue-34m-up-from-25-66m-yoy", "tags": ["earnings"]}
{"id": 42604320, "time": "2024-12-19 16:18:33", "headline": "Sight Sciences Announces The Results Of A Budget Impact Analysis For Its TearCare System For The Treatment Of Meibomian Gland Disease Showing Cost Savings Over Existing Reimbursed Treatment Options", "summary": "", "symbols": ["SGHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42604320/sight-sciences-announces-the-results-of-a-budget-impact-analysis-for-its-tearcare-system-for-the-", "tags": []}
{"id": 42604339, "time": "2024-12-19 16:19:23", "headline": "United States Steel Expects Q4 Adjusted EPS Of ($0.29) - ($0.25), Est $0.16; Adjusted EBITDA To Be Approximately $150M", "summary": "", "symbols": ["X"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604339/united-states-steel-expects-q4-adjusted-eps-of-0-29-0-25-est-0-16-adjusted-ebitda-to-be-approximatel", "tags": ["earnings"]}
{"id": 42604423, "time": "2024-12-19 16:21:18", "headline": "RBB Bancorp Announces Announces That Effective January 1, 2025, Johnny Lee, Currently President And Chief Banking Officer Of Royal Business Bank, Will Be Appointed As President Of The Company, President And CEO Of The Bank And A Director Of The Company And Bank. Effective As Of May 22, 2025, Mr. Lee Will Be Appointed As CEO Of The Company", "summary": "", "symbols": ["RBB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604423/rbb-bancorp-announces-announces-that-effective-january-1-2025-johnny-lee-currently-president-and-chi", "tags": ["management"]}
{"id": 42604354, "time": "2024-12-19 16:20:02", "headline": "ACRES Commercial Realty Reauthorizes Additional $5M Share Repurchase Program", "summary": "", "symbols": ["ACR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604354/acres-commercial-realty-reauthorizes-additional-5-million-share-repurchase-program", "tags": ["buyback"]}
{"id": 42604457, "time": "2024-12-19 16:22:39", "headline": "Innovative Solns FY 2024 Adj. EPS $0.40, Inline, Sales $47.200M Miss $49.141M Estimate", "summary": "", "symbols": ["ISSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42604457/innovative-solns-fy-2024-adj-eps-0-40-inline-sales-47-200m-miss-49-141m-estimate", "tags": ["earnings"]}
{"id": 42604463, "time": "2024-12-19 16:23:07", "headline": "ACNB Corp And Traditions Bancorp Announce Receipt Of Shareholder Approvals For Acquisition", "summary": "", "symbols": ["ACNB", "TRBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42604463/acnb-corp-and-traditions-bancorp-announce-receipt-of-shareholder-approvals-for-acquisition", "tags": []}
{"id": 42604496, "time": "2024-12-19 16:24:24", "headline": "NorthWestern Energy To Supply Power For Butte, Montana Data Center Atlas Power Group; The New Energy Supply Load Is Expected To Be 75 Megawatts Beginning In 2026, With Forecasted Growth Of Up To Another 75 Megawatts In The Subsequent 3 To 5 Years", "summary": "", "symbols": ["NWE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604496/northwestern-energy-to-supply-power-for-butte-montana-data-center-atlas-power-group-the-new-energy-s", "tags": []}
{"id": 42604506, "time": "2024-12-19 16:24:56", "headline": "Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership", "summary": "", "symbols": ["GILD", "XLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604506/gilead-sciences-acquires-7-85m-xilio-therapeutics-shares-at-1-04-each-raising-ownership-to-over-10-a", "tags": ["merger"]}
{"id": 42604510, "time": "2024-12-19 16:25:06", "headline": "Recap: Mission Produce Q4 Earnings", "summary": " ", "symbols": ["AVO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42604510/recap-mission-produce-q4-earnings", "tags": ["earnings"]}
{"id": 42604513, "time": "2024-12-19 16:25:12", "headline": "Scholastic Earnings Report: Q2 Overview", "summary": " ", "symbols": ["SCHL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42604513/scholastic-earnings-report-q2-overview", "tags": ["earnings"]}
{"id": 42604625, "time": "2024-12-19 16:28:34", "headline": "Trading Halt: Halted at 4:28:30 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["IONS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42604625/trading-halt-halted-at-4-28-30-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 42604665, "time": "2024-12-19 16:30:14", "headline": "Here's How Much You Would Have Made Owning Old Dominion Freight Line Stock In The Last 15 Years", "summary": " ", "symbols": ["ODFL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42604665/heres-how-much-you-would-have-made-owning-old-dominion-freight-line-stock-in-the-last-15-years", "tags": []}
{"id": 42604872, "time": "2024-12-19 16:31:38", "headline": "Victory Capital Plans New $200M Share Repurchase Program", "summary": "", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604872/victory-capital-plans-new-200m-share-repurchase-program", "tags": ["buyback"]}
{"id": 42604893, "time": "2024-12-19 16:32:09", "headline": "Faraday Future To Give FX Business Update And Show First FX Prototype Mules In Las Vegas, NV From January 5-7; The Arrival Of The First FX Mules In The U.S. The End Of December Will Kick Off The Product Development And U.S. Regulatory Testing Phase", "summary": "", "symbols": ["FFIE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604893/faraday-future-to-give-fx-business-update-and-show-first-fx-prototype-mules-in-las-vegas-nv-from-jan", "tags": []}
{"id": 42604909, "time": "2024-12-19 16:32:45", "headline": "Jowell Global H1 EPS $(1.74) Up From $(3.33) YoY, Sales $85.68M Up From $84.41M YoY", "summary": "", "symbols": ["JWEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42604909/jowell-global-h1-eps-1-74-up-from-3-33-yoy-sales-85-68m-up-from-84-41m-yoy", "tags": ["earnings"]}
{"id": 42604914, "time": "2024-12-19 16:33:00", "headline": "Gladstone Investment Signs Definitive Agreement To Acquire Ricardo Defense; No Terms Disclosed", "summary": "", "symbols": ["GAIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42604914/gladstone-investment-signs-definitive-agreement-to-acquire-ricardo-defense-no-terms-disclosed", "tags": ["merger", "contract"]}
{"id": 42604929, "time": "2024-12-19 16:33:32", "headline": "Apartment Investment and Management Company Declares A Special Cash Dividend In The Amount Of $0.60 Per Share To Be Paid On January 31, 2025", "summary": "", "symbols": ["AIV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604929/apartment-investment-and-management-company-declares-a-special-cash-dividend-in-the-amount-of-0-60-p", "tags": ["dividend"]}
{"id": 42604942, "time": "2024-12-19 16:33:54", "headline": "Prestige Wealth Announced It Has Regained Nasdaq Compliance", "summary": "", "symbols": ["PWM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42604942/prestige-wealth-announced-it-has-regained-nasdaq-compliance", "tags": []}
{"id": 42604991, "time": "2024-12-19 16:35:53", "headline": "GEE Group Q4 Adj $(0.02) Misses $0.02 Estimate, Sales $28.35M Miss $38.53M Estimate", "summary": "", "symbols": ["JOB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42604991/gee-group-q4-adj-0-02-misses-0-02-estimate-sales-28-35m-miss-38-53m-estimate", "tags": []}
{"id": 42605029, "time": "2024-12-19 16:37:27", "headline": "Ostin Technology Group Announces 1-For-10 Reverse Share Split, Will Begin Trading On An Adjusted Basis On December 26, 2024", "summary": "", "symbols": ["OST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42605029/ostin-technology-group-announces-1-for-10-reverse-share-split-will-begin-trading-on-an-adjusted-basi", "tags": []}
{"id": 42605031, "time": "2024-12-19 16:37:37", "headline": "Red River Bancshares Board Approves Renewal Of Its Stock Repurchase Program, Authorizing Purchase Up To $5M Of Common Stock In 2025", "summary": "", "symbols": ["RRBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42605031/red-river-bancshares-board-approves-renewal-of-its-stock-repurchase-program-authorizing-purchase-up", "tags": ["buyback"]}
{"id": 42605034, "time": "2024-12-19 16:37:40", "headline": "FedEx Stock Rallies On Better-Than-Expected Q2 EPS, Freight Spin-Off Announcement", "summary": "FedEx reports its second-quarter results after Thursday&#39;s closing bell and announced the spin off of FedEx Freight.", "symbols": ["FDX"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/12/42605034/fedex-stock-rallies-on-better-than-expected-q2-eps-freight-spin-off-announcement", "tags": ["earnings"]}
{"id": 42605215, "time": "2024-12-19 16:43:41", "headline": "Eos Energy Receives First Loan Advance From Department Of Energy's Loan Programs Office In The Amount Of $68.3M", "summary": "", "symbols": ["EOSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42605215/eos-energy-receives-first-loan-advance-from-department-of-energys-loan-programs-office-in-the-amount", "tags": []}
{"id": 42605414, "time": "2024-12-19 16:48:57", "headline": "Nike Q2 Earnings: Revenue Beat, EPS Beat, Shares Jump \u2014 'Nike Being Nike Again'", "summary": "Nike reports second-quarter revenue of $12.35 billion, beating analyst\u00a0estimates\u00a0of $12.13 billion. The company\u00a0reports second-quarter earnings of 78 cents per share, beating analyst estimates of 65 cents per share.", "symbols": ["NKE"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/general/sports/24/12/42605414/nike-q2-earnings-revenue-beat-eps-beat-shares-jump-nike-being-nike-again", "tags": ["earnings"]}
{"id": 42604502, "time": "2024-12-19 16:24:44", "headline": "Innovative Solns Q4 EPS $0.18 Up From $0.15 YoY, Sales $15.38M Up From $12.99M YoY", "summary": "", "symbols": ["ISSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42604502/innovative-solns-q4-eps-0-18-up-from-0-15-yoy-sales-15-4m-up-from-12-9m-yoy", "tags": ["earnings"]}
{"id": 42605602, "time": "2024-12-19 17:00:12", "headline": "Here's How Much You Would Have Made Owning Morningstar Stock In The Last 15 Years", "summary": " ", "symbols": ["MORN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42605602/heres-how-much-you-would-have-made-owning-morningstar-stock-in-the-last-15-years", "tags": []}
{"id": 42605607, "time": "2024-12-19 17:00:16", "headline": "What Analysts Are Saying About Oshkosh Stock", "summary": " ", "symbols": ["OSK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42605607/what-analysts-are-saying-about-oshkosh-stock", "tags": []}
{"id": 42605619, "time": "2024-12-19 17:00:27", "headline": "Forecasting The Future: 12 Analyst Projections For Corteva", "summary": " ", "symbols": ["CTVA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42605619/forecasting-the-future-12-analyst-projections-for-corteva", "tags": []}
{"id": 42605629, "time": "2024-12-19 17:00:37", "headline": "6 Analysts Have This To Say About Shake Shack", "summary": " ", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42605629/6-analysts-have-this-to-say-about-shake-shack", "tags": []}
{"id": 42605635, "time": "2024-12-19 17:00:50", "headline": "4 Analysts Have This To Say About NorthWestern Energy Group", "summary": " ", "symbols": ["NWE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42605635/4-analysts-have-this-to-say-about-northwestern-energy-group", "tags": []}
{"id": 42605651, "time": "2024-12-19 17:01:02", "headline": "Scholastic Shares Fall On Worse-Than-Expected Q2 Results: Details", "summary": "Scholastic reports its second-quarter results after Thursday&#39;s closing bell. Here&#39;s a look at the details of the report.", "symbols": ["SCHL"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/education/24/12/42605651/scholastic-shares-fall-on-worse-than-expected-q2-results-details", "tags": ["earnings"]}
{"id": 42605657, "time": "2024-12-19 17:01:05", "headline": "Deep Dive Into First Hawaiian Stock: Analyst Perspectives (10 Ratings)", "summary": " ", "symbols": ["FHB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42605657/deep-dive-into-first-hawaiian-stock-analyst-perspectives-10-ratings", "tags": []}
{"id": 42605666, "time": "2024-12-19 17:01:21", "headline": "Wallbox Gets NYSE Notice Of Non-Compliance Regarding Trading Share Price Listing Rule", "summary": "", "symbols": ["WBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42605666/wallbox-gets-nyse-notice-of-non-compliance-regarding-trading-share-price-listing-rule", "tags": []}
{"id": 42605667, "time": "2024-12-19 17:01:22", "headline": "Affirm Holdings Stock: A Deep Dive Into Analyst Perspectives (18 Ratings)", "summary": " ", "symbols": ["AFRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42605667/affirm-holdings-stock-a-deep-dive-into-analyst-perspectives-18-ratings", "tags": []}
{"id": 42605740, "time": "2024-12-19 17:03:37", "headline": "AAR Resolves Foreign Corrupt Practices Act Investigations With DoJ And SEC; Total Amount Payable Under Order Is $55.59M", "summary": "", "symbols": ["AIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42605740/aar-resolves-foreign-corrupt-practices-act-investigations-with-doj-and-sec-total-amount-payable-unde", "tags": []}
{"id": 42605747, "time": "2024-12-19 17:04:02", "headline": "Mission Produce Shares Grow After Strong Q4 Results: Details", "summary": "Mission Produce reports its fourth-quarter results after Thursday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["AVO"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/12/42605747/mission-produce-shares-grow-after-strong-q4-results-details", "tags": ["earnings"]}
{"id": 42605759, "time": "2024-12-19 17:04:35", "headline": "Luigi Mangione's Notebook Reveals Plot, Feds Say: UnitedHealth Group Investor Conference Called 'True Windfall'", "summary": "Luigi Mangione faces four federal charges on top of the 11 New York state charges related to the murder of UnitedHealthcare CEO Brian Thompson.", "symbols": ["DIS", "UNH"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/24/12/42605759/luigi-mangione-faces-death-penalty-details-show-attack-planned-for-months-the-target-is-insuranceit-checks-every-box", "tags": ["management"]}
{"id": 42605886, "time": "2024-12-19 17:09:28", "headline": "BlackBerry Q3 2025 Adj EPS $0.02 Beats $(0.01) Estimate", "summary": "", "symbols": ["BB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42605886/blackberry-q3-2025-adj-eps-0-02-beats-0-01-estimate", "tags": ["earnings"]}
{"id": 42606020, "time": "2024-12-19 17:12:52", "headline": "Kroger Enters Agreements For $5.0B Accelerated Share Repurchase Program", "summary": "", "symbols": ["KR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606020/kroger-enters-agreements-for-5-0b-accelerated-share-repurchase-program", "tags": ["buyback"]}
{"id": 42606023, "time": "2024-12-19 17:13:06", "headline": "US Steel Stock Stumbles On Weak Q4 Outlook", "summary": "United States Steel Corp. shares are trading lower in Thursday&#39;s after-hours session after the company issued fourth-quarter guidance below analyst estimates.", "symbols": ["X"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/guidance/24/12/42606023/us-steel-stock-stumbles-on-weak-q4-outlook", "tags": ["guidance", "why_moving"]}
{"id": 42606037, "time": "2024-12-19 17:13:52", "headline": "ETF Market Sets Records In 2024 As Inflows Reach $1.6 Trillion: 7 Funds Leading Charge", "summary": "ETFs rewriting financial rules, 2024 record year for industry with $1.6 trillion inflows and $15.1 trillion AUM, active ETFs rising, SPY vs VOO rivalry.", "symbols": ["IBIT", "IVV", "QQQ", "SPLG", "SPY", "VOO", "VTI"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42606037/etf-market-hits-records-in-2024-inflows-reach-16-trillion-7-funds-top-ranking", "tags": []}
{"id": 42606039, "time": "2024-12-19 17:14:06", "headline": "AVITA Medical Secures FDA 510(k) Clearance For Cohealyx", "summary": "", "symbols": ["RCEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606039/avita-medical-secures-fda-510-k-clearance-for-cohealyx", "tags": ["fda"]}
{"id": 42606059, "time": "2024-12-19 17:15:11", "headline": "Here's How Much $100 Invested In Arch Capital Group 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["ACGL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42606059/heres-how-much-100-invested-in-arch-capital-group-10-years-ago-would-be-worth-today", "tags": []}
{"id": 42606157, "time": "2024-12-19 17:16:17", "headline": "BlackBerry Expects Q4 Total Revenue Of $126M - $135M (Est $161.49M), Non-GAAP Basic EPS Of $(0.01) - $0.01 (Est $0.01)", "summary": "", "symbols": ["BB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606157/blackberry-expects-q4-total-revenue-of-126m-135m-est-161-49m-non-gaap-basic-eps-of-0-01-0-01-est-0-0", "tags": ["earnings"]}
{"id": 42606200, "time": "2024-12-19 17:19:04", "headline": "BlackBerry Now Expects FY25 Total Revenue Of $517M - $526M (Est $603.12M), Non-GAAP Basic EPS Of $(0.02) - Breakeven (Est $(0.02))", "summary": "", "symbols": ["BB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606200/blackberry-now-expects-fy25-total-revenue-of-517m-526m-est-603-12m-non-gaap-basic-eps-of-0-02-breake", "tags": ["earnings"]}
{"id": 42606282, "time": "2024-12-19 17:20:57", "headline": "Four Corners Property Trust Reports Acquisition Of A MercyOne Outpatient Clinic Property For $2.8M", "summary": "", "symbols": ["FCPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42606282/four-corners-property-trust-reports-acquisition-of-a-mercyone-outpatient-clinic-property-for-2-8m", "tags": []}
{"id": 42606308, "time": "2024-12-19 17:22:52", "headline": "BlackBerry Q3 2025 Sales $143.00M Miss $150.76M Estimate", "summary": "", "symbols": ["BB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42606308/blackberry-q3-2025-sales-143-00m-miss-150-76m-estimate", "tags": []}
{"id": 42606326, "time": "2024-12-19 17:24:02", "headline": "Sendas Distribuidora Intends To Proceed With Voluntary Delisting Of Its ADSs From NYSE", "summary": "", "symbols": ["ASAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606326/sendas-distribuidora-intends-to-proceed-with-voluntary-delisting-of-its-adss-from-nyse", "tags": []}
{"id": 42606381, "time": "2024-12-19 17:27:06", "headline": "Preferred Bank Finds Unreconciled Difference In Its Calculation Of Its Right Of Use Asset And Lease Liabilities; Expects Additional Q4 Expense To Reduce Q4 EPS By $0.43", "summary": "", "symbols": ["PFBC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606381/preferred-bank-finds-unreconciled-difference-in-its-calculation-of-its-right-of-use-asset-and-lease", "tags": ["earnings"]}
{"id": 42606391, "time": "2024-12-19 17:28:28", "headline": "Primis Financial Board Approves Stock Repurchase Program For Up To 740,600 Of Outstanding Shares Of Common Stock", "summary": "", "symbols": ["FRST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606391/primis-financial-board-approves-stock-repurchase-program-for-up-to-740-600-of-outstanding-shares-of", "tags": ["buyback"]}
{"id": 42606398, "time": "2024-12-19 17:29:32", "headline": "ARS Pharmaceuticals Says Express Scripts Has Added neffy (Epinephrine Nasal Spray) To Its Commercial National Formularies", "summary": "", "symbols": ["SPRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606398/ars-pharmaceuticals-says-express-scripts-has-added-neffy-epinephrine-nasal-spray-to-its-commercial-n", "tags": []}
{"id": 42606465, "time": "2024-12-19 17:30:19", "headline": "Here's How Much $100 Invested In Marsh & McLennan 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["MMC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42606465/heres-how-much-100-invested-in-marsh-mclennan-10-years-ago-would-be-worth-today", "tags": []}
{"id": 42606490, "time": "2024-12-19 17:30:46", "headline": "Par Pacific Expects 2025 Capital Expenditure And Turnaround Outlay Guidance Of $210M - $240M", "summary": "", "symbols": ["PARR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606490/par-pacific-expects-2025-capital-expenditure-and-turnaround-outlay-guidance-of-210m-240m", "tags": ["guidance"]}
{"id": 42606523, "time": "2024-12-19 17:32:27", "headline": "ALLETE Says FERC Approved Proposed Transaction With CPP Investments And Global Infrastructure Partners", "summary": "", "symbols": ["ALE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606523/allete-says-ferc-approved-proposed-transaction-with-cpp-investments-and-global-infrastructure-partne", "tags": []}
{"id": 42606541, "time": "2024-12-19 17:36:01", "headline": "Silvaco Says US Court Of Appeals For The Ninth Circuit Affirmed US District Court's Dismissal Of All Claims Brought By Aldini", "summary": "", "symbols": ["SVCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42606541/silvaco-says-us-court-of-appeals-for-the-ninth-circuit-affirmed-us-district-courts-dismissal-of-all", "tags": ["legal"]}
{"id": 42606549, "time": "2024-12-19 17:37:18", "headline": "BlackBerry Beats Q3 Earnings Estimates, But Soft Guidance Keeps Shares In Check", "summary": "BlackBerry reports third-quarter revenue of $162 million. The company reports third-quarter adjusted earnings of 2 cents per share, beating analyst estimates for a loss of 1 cent per share, according to Benzinga Pro.", "symbols": ["BB"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/12/42606549/blackberry-beats-q3-earnings-estimates-but-soft-guidance-keeps-shares-in-check", "tags": ["earnings", "guidance"]}
{"id": 42606678, "time": "2024-12-19 17:45:16", "headline": "$1000 Invested In Jones Lang LaSalle 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["JLL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42606678/1000-invested-in-jones-lang-lasalle-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42606848, "time": "2024-12-19 18:00:11", "headline": "If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["VRSK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42606848/if-you-invested-100-in-this-stock-15-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 42607005, "time": "2024-12-19 18:15:12", "headline": "Here's How Much You Would Have Made Owning Chipotle Mexican Grill Stock In The Last 15 Years", "summary": " ", "symbols": ["CMG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42607005/heres-how-much-you-would-have-made-owning-chipotle-mexican-grill-stock-in-the-last-15-years", "tags": []}
{"id": 42607148, "time": "2024-12-19 18:30:16", "headline": "$1000 Invested In Nike 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["NKE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42607148/1000-invested-in-nike-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42607280, "time": "2024-12-19 18:43:00", "headline": "Elon Musk Vs. RFK Jr.: Obesity Crisis Debate Sparks Struggle For Trump's Influence", "summary": "Debate over tackling U.S. obesity epidemic sparks contrasting views from Trump&#39;s orbit: lifestyle changes vs. easier access to weight-loss drugs.", "symbols": ["NVO"], "source": "benzinga", "author": "Maureen Meehan", "url": "https://www.benzinga.com/general/health-care/24/12/42607280/elon-musk-vs-rfk-jr-obesity-crisis-debate-sparks-struggle-for-trumps-influence", "tags": []}
{"id": 42607293, "time": "2024-12-19 18:45:13", "headline": "$1000 Invested In Meta Platforms 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42607293/1000-invested-in-meta-platforms-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42607398, "time": "2024-12-19 18:55:00", "headline": "Dogecoin Down 17% In One Month, Will Meme Crypto Reach 25 Cents Or 69 Cents First? 78% Of Readers Say\u2026", "summary": "Dogecoin (CRYPTO: DOGE) hit new yearly highs recently as the overall cryptocurrency sector has traded higher since Donald Trump won the", "symbols": ["DOGEUSD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42607398/dogecoin-down-17-in-one-month-will-meme-crypto-reach-25-cents-or-69-cents-first-78-of-readers-say", "tags": []}
{"id": 42607401, "time": "2024-12-19 18:55:09", "headline": "Trading Halt: Halt status updated at 6:55:00 PM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["IONS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42607401/trading-halt-halt-status-updated-at-6-55-00-pm-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 42607502, "time": "2024-12-19 19:04:58", "headline": "Cansortium Completes RIV Capital Acquisition, Adding New York Retail, Wholesale, Cannabis Cultivation Operations", "summary": "FLUENT and RIV Capital complete a merger, creating a well-positioned cannabis operator with a strong balance sheet and strategic footprint.", "symbols": ["CNPOF", "CNTMF", "CSE:RIV", "CSE:TIUM", "RIV"], "source": "benzinga", "author": "Maureen Meehan", "url": "https://www.benzinga.com/news/retail-sales/24/12/42607502/cansortium-completes-riv-capital-acquisition-adding-new-york-retail-wholesale-cannabis-cultivation-operations", "tags": ["merger"]}
{"id": 42607658, "time": "2024-12-19 19:13:15", "headline": "EV Lease Nearly Free With $0 Down, $0 Month Offer In This State", "summary": "Select electric vehicle customers in one state can lease a new Fiat 500e for nearly $0 thanks to tax incentives.", "symbols": ["STLA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/24/12/42607658/ev-lease-nearly-free-with-0-down-0-month-offer-in-this-state", "tags": []}
{"id": 42607733, "time": "2024-12-19 19:24:47", "headline": "Here's What The Latest Congressional AI Report Could Mean For Big Tech", "summary": "The House Artificial Intelligence Task Force released a report on Tuesday with recommendations on how Congress can boost the development of AI while also protecting against potential risks of the technology.", "symbols": ["GOOG", "GOOGL", "INTC", "META", "TSM"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/government/regulations/24/12/42607733/heres-what-the-latest-congressional-ai-report-could-mean-for-big-tech", "tags": []}
{"id": 42607744, "time": "2024-12-19 19:26:05", "headline": "House Rejects Trump-Endorsed Backup Plan To Prevent Government Shutdown And Suspend Debt Limit: Lawmakers Chant 'Hell No'", "summary": "The House rejected Speaker Mike Johnson&#39;s debt-limit suspension plan, increasing the risk of a government shutdown ahead of Friday&#39;s deadline on Thursday, December 19, 2024.", "symbols": [], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/24/12/42607744/house-rejects-trump-endorsed-backup-plan-to-prevent-government-shutdown-and-suspend-debt-limit-lawmakers-chant-hell-no", "tags": []}
{"id": 42608224, "time": "2024-12-19 20:33:13", "headline": "Cathie Wood's Thursday Moves: Dumps Buzzing Stocks Tesla And Palantir", "summary": "On Thursday, Dec. 19, 2024 Cathie Wood-led Ark Invest sold shares of Tesla and Palantir, both of which have run up considerably for the month.", "symbols": ["ARKK", "PLTR", "TSLA"], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/24/12/42608224/cathie-woods-thursday-moves-dumps-buzzing-stocks-tesla-and-palantir", "tags": []}
{"id": 42608267, "time": "2024-12-19 20:42:59", "headline": "Instagram Boss Shows How You Can Turn Yourself Into A Puppet \u2014 And That's Just The Beginning", "summary": "Meta plans to launch an AI-powered video editing feature in 2025, leveraging its Movie Gen AI to enable creators to transform videos with text prompts, as teased by Instagram boss Adam Mosseri.", "symbols": ["ADBE", "META"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/12/42608267/meta-flexes-movie-gen-ai-as-instagram-boss-teases-video-editing-magic-for-2025", "tags": []}
{"id": 42608297, "time": "2024-12-19 20:46:18", "headline": "Tom Lee Explains Why 'Fewer Cuts In 2025' Could Boost The Market, Urges Investors To 'Buy The Dip' Amid Recent Volatility", "summary": "U.S. stock markets could benefit from fewer interest rate cuts in 2025 despite recent volatility, according to Fundstrat&#39;s head of research Tom Lee, who sees the Federal Reserve&#39;s hawkish stance as potentially beneficial for investors.\n", "symbols": ["DIA", "SPY"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/24/12/42608297/tom-lee-explains-why-fewer-cuts-in-2025-could-boost-the-market-urges-investors-to-buy-the-dip-amid-recent-volatility", "tags": []}
{"id": 42608314, "time": "2024-12-19 20:51:26", "headline": "Bitcoin, Ethereum, Dogecoin Retreat Further As Crypto Liquidations Top $1 Billion: Analyst Lays Out Scenario For BTC Losing $96K Support", "summary": "The cryptocurrency market cracked further Thursday as risk sentiment remained low following the Federal Reserve\u2019s hawkish statements.", "symbols": ["BTC", "BTCUSD", "DOGEUSD", "ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42608314/bitcoin-ethereum-dogecoin-retreat-further-as-crypto-liquidations-top-1-billion-analyst-lays-out-scenario-for-btc-losing-96k-support", "tags": []}
{"id": 42608382, "time": "2024-12-19 21:07:12", "headline": "Nike, Fedex, Blackberry, Rigetti, And Tesla: Why These 5 Stocks Are On Investors' Radars Today", "summary": "Major U.S. indices closed Thursday with mixed results. The Dow Jones Industrial Average edged up by 0.04% for the day.", "symbols": ["BB", "FDX", "NKE", "RGTI"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/24/12/42608382/nike-fedex-blackberry-rigetti-and-tesla-why-these-5-stocks-are-on-investors-radars-today", "tags": []}
{"id": 42608525, "time": "2024-12-19 21:35:03", "headline": "China Keeps Benchmark Lending Rates Steady As Fed Signals Fewer Cuts Ahead", "summary": "China kept its benchmark lending rates unchanged on Friday, with the one-year loan prime rate held at 3.1% and the five-year LPR at 3.6%. ", "symbols": [], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/asia/24/12/42608525/china-keeps-key-interest-rates-unchanged-amid-feds-shift-toward-fewer-rate-cuts", "tags": []}
{"id": 42608634, "time": "2024-12-19 22:00:02", "headline": "Self-Proclaimed Bitcoin Inventor Craig Wright Awarded Prison Sentence For Defying Court Order", "summary": "Australian computer scientist Craig Wright, who has consistently claimed to be Bitcoin (CRYPTO: BTC) creator Satoshi Nakamoto, was held in contempt of court on Thursday and handed out a one-year suspended prison sentence for continuing to sue developers.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/24/12/42608634/self-proclaimed-bitcoin-inventor-craig-wright-awarded-prison-sentence-for-defying-court-order", "tags": ["contract", "legal"]}
{"id": 42608667, "time": "2024-12-19 22:08:35", "headline": "Bluesky Planning Payment Platform That Could Arrive In 12 Months, Says COO Rose Wang, Aims To Align Financial Incentives With Users", "summary": "Bluesky plans to launch its own payment platform within 12 months and introduce subscription features early next year to enhance user monetization and self-expression.", "symbols": ["GOOG", "GOOGL", "META"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/12/42608667/bluesky-plans-to-build-its-own-payment-platform-and-it-could-take-12-months-says-coo-rose-wang-subscriptions-to-launch-early-next-year", "tags": []}
{"id": 42608814, "time": "2024-12-19 22:55:13", "headline": "Elon Musk's DOGE Role In Government Set For 'Fascinating Tough Fight,' Says Analyst \u2014 Walter Isaacson Sees Challenges For Tesla CEO's Federal Path", "summary": "New Street Research analyst Pierre Ferragu has expressed support for Tesla Inc. CEO Elon Musk&#39;s upcoming role in the newly announced Department of Government Efficiency while acknowledging the challenges ahead in reforming federal operations.", "symbols": ["LMT", "TSLA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/24/12/42608814/elon-musks-doge-role-in-government-set-for-fascinating-tough-fight-says-analyst-walter-isaacson-sees-challenges-for-tesla-ceos-federal-path", "tags": ["management"]}
{"id": 42608825, "time": "2024-12-19 22:55:48", "headline": "Shytoshi Kusama Shares 'Huge News' As Shiba Inu Partners With Chainlink To Boost Shibarium, Ecosystem Tokens", "summary": "Shiba Inu (CRYPTO: SHIB) entered into a partnership with the decentralized oracle network Chainlink (CRYPTO: LINK) Thursday in a bid to expand its ecosystem.", "symbols": ["BONEUSD", "ETHUSD", "LINKUSD", "SHIBUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/24/12/42608825/shytoshi-kusama-says-huge-news-as-shiba-inu-partners-with-chainlink-to-boost-shibarium-ecosystem-tokens", "tags": ["contract"]}
{"id": 42608964, "time": "2024-12-19 23:21:02", "headline": "Samsung One UI 6.1.1 Update Is Turning This Galaxy Series Phones Into Paperweights: Bricking, Random Reboots And Overheating Reported", "summary": "Samsung Galaxy S22 users are reporting severe issues, including permanent device bricking, random reboots, and overheating, after installing the One UI 6.1.1 update, with costly motherboard replacements suggested as the only fix.", "symbols": ["AAPL", "SSNLF"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/24/12/42608964/samsung-one-ui-6-1-1-update-is-turning-this-galaxy-series-phones-into-paperweights-bricking-random-reboots-and-overheating-reported", "tags": []}
{"id": 42609103, "time": "2024-12-19 23:54:32", "headline": "Donald J. Trump Gifted 114.75M Shares Of Trump Media & Technology Group To Trump Revocable Trust; No Shares Were Sold During Transfer", "summary": "", "symbols": ["DJT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42609103/donald-j-trump-gifted-114-75m-shares-of-trump-media-technology-group-to-trump-revocable-trust-no-sha", "tags": []}
{"id": 42609104, "time": "2024-12-19 23:54:45", "headline": "Donald Trump Jr. Transferred 114.75M Shares Of Trump Media & Technology Group To Revocable Trust, Including 553,176 Shares Held In Escrow Until March 2025; No Shares Were Sold During Transfer", "summary": "", "symbols": ["DJT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42609104/donald-trump-jr-transferred-114-75m-shares-of-trump-media-technology-group-to-revocable-trust-includ", "tags": []}
